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PREFACE 
The continued interest and quest in designing new heterocycles and their derivatives stem 
mainly in view of their variety of applications particularly from biological point of view. 
The idea conceived to work for Ph.D. thesis in this area aims to synthesize new 
biologically important heterocyclic derivatives from cheap and readily available starting 
materials. For this purpose, compounds of pharmaceutical value such as 3-
formylchromones, 5-chloro-3-methyl-1 -phenylpyrazole-4-carboxaldehyde, 5-azido-3-
methyl-l-phenyipyrazole-4-carboxaldehyde and 3-bromo-4-hydroxycoumarin were taken 
as starting materials for the generation of novel molecular frameworks. The summary of 
the work carried out is briefly presented here. 
Chapter-1 
Chromones, pyrazoles and coumarins display remarkable biochemical and 
pharmacological actions and hold a place apart in the field of pharmacognosy. Biological 
and industrial applications associated with these molecules motivated us to select them as 
potential candidates for the synthesis of novel heterocycles. Thus, this chapter describes 
various reactions of starting materials mentioned in the thesis such as 3-formylchromone, 
5-chloro3-methyl-l-phenylpyrazole-4-carboxaldehyde, S-azido-3-methyl-l-
phenylpyrazole-4-carboxaldehyde and 3-bromo-4-hydroxycoumarin with special 
emphasis on reactions with active methyl and methylene compounds, which were taken 
for study throughout the thesis. 
Chapter-2 
Chalcones are one of the major classes of natural products with widespread distribution 
in fruits, vegetables, spices, tea and soy based foodstuff and has been subject of great 
interest for possessing interesting pharmacological activities. Keeping in view the 
potential biological activities of chromones, pyrazoles and chalcones it was perceived 
that the synergism of heterocyclic moieties in single nucleus might result in the formation 
of some worthwhile molecules from the biological point of view. Thus, as a preliminary 
study, attempts were made to synthesize a novel series of chromonyl (3a-f) and pyrazolyl 
chalcones (5a-c) having biological significance by the reaction of 3-formylchromones 
(la-b), 5-chloro3-methyl-I-phenylpyrazoIe-4-carboxaldehyde (4), respectively with 
various acetylbarbituric acid derivatives (2a-c) through Claisen-Schmidt condensation 
under conventional heating method in moderate to good yields. Further, in accordance to 
the increasing interest in the medicinal chemistry community in technologies and 
concepts that facilitate a more rapid environmentally benign synthesis, the reactions were 
carried out under microwave-assisted solvent-free conditions in shorter time period along 
with excellent yields of products. Chromonyl chalcones (3a-f) were also prepared using 
Zn(proline)2 as a recyclable Lewis acid catalyst in environmentally friendly solvent 
'water' as reaction medium in good yields. This work also describes the superiority of 
green synthetic methods over conventional heating procedure. All the newly synthesized 
compounds were characterized by elemental and spectral analysis. 
Chapter-3 
Among the various heterocyclic compounds, derivatives of chalcones such as 
pyrazolines, pyrazoles, pyrimdines, dibromodihydroderivatives are acquiring much 
significance in the field of dmg designing processes. Also, one of the most attractive 
concepts in chemistry for sustainability is 'green' chemistry, which is the utilization of a 
set of principles that reduces or eliminates the use or generation of hazardous substances 
in the design, manufacture, and applications of chemical products. Keeping in mind these 
set of principles efforts were made to synthesize biologically important heterocyclic 
analogues of chalcones both under conventional heating and solvent-free microwave 
irradiation technique in good yields. Thus, a series of novel heterocycles (2a-7) were 
synthesized employing chromonyl chalcones (la-c) and pyrazolyl chalcones (3a-c) as 
starting materials in short period of time. The present study also compares the efficacy of 
reaction techniques under the conventional and the microwave irradiation methods. All 
the newly synthesized compounds were characterized by elemental and spectral analysis. 
Chapter-4 
The Knoevenagel condensation reaction is an effective C=C bond formation reaction 
between carbonyi or heterocarbonyl compounds and any compounds having an active 
methylene group. This reaction has been reported to take place both under conventional 
solvents with a series of acidic or basic catalysts and in solvent-free conditions. 
Unfortunately, many of these methods have some drawbacks such as use of expensive, 
stoichiometric amount of reactants, low yields, extended time, tedious procedure etc. 
Thus, a novel approach was adopted for the synthesis of series of Knoevenagel 
condensation products (3a-i, 6a-f) from 5-chloro-3-methyl-l-phenylpyrazole-4-
carboxaldehyde (1) and 5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde (4) with 
various cyclic active methylene compounds (2a-i, 5a-f)) using water soluble and 
recyclable Zn(proline)2 as a Lewis acid catalyst for the first time, under solvent-free 
condition or by using water as a reaction medium in good yields. In each conversion, the 
catalyst was successfully recovered and recycled without significant loss in yield and 
selectivity. All the synthesized compounds were characterized by spectroscopic data. 
Chapter-5 
Due to the widespread applications associated with coumarin derivatives from 
pharmacological, agrochemicals and industrial point of view, attempts were made to 
synthesize new series of dicoumarol derivatives (3a-d) by the reaction of 3-bromo-4-
hydroxycoumarin (1) with various heteroaldehydes (2a-d) in good yields. The method 
was advantageous in terms of reduced reaction time, high yield of products, simple 
experimental work-up procedure etc, thus, adding a useful procedure to existing 
methodologies. 
Chapter-6 
The infections caused by various microorganisms pose a serious challenge to the medical 
community and need for an effective therapy has led to a search for novel antimicrobial 
agents. For this reason, all the newly synthesized compounds described in the thesis were 
evaluated for their in vitro antimicrobial activity against Streptococcus pyogenes, 
Methicillin resistant Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella 
pneumonia, Bacillus subtilis. Salmonella typhimurium and Escherichia coli bacterial 
strains and fungal cultures oi Candida albicans, Aspergillus fumigatus, Aspergillus niger, 
Trichophyton mentagrophytes and Penicillium marneffei by disk diffusion assay with 
slight modifications. The minimum inhibitory concentration (MIC) was determined for 
the test compounds as well as for reference standards. The antibacterial and antifungal 
screening results (Table 1-14) revealed that, the newly generated compounds are potent 
antimicrobial agents. 
CHAPTER-1 
THEORETICAL 
1. INTRODUCTION 
Heterocycles are widespread elements in natural products and have attracted much 
attention from a wide area of science, including physical chemistry, medicinal chemistry, 
natural product chemistry, synthetic organic chemistry and polymer science.''^ Among 
the various classes of heterocycles, chromones, pyrazoles and coumarins occupy an 
important position. This chapter describes various reactions of starting materials 
mentioned in the thesis such as 3-formylchromone, 5-chloro3-methyl-l-phenylpyrazole-
4-carboxaldehyde, 5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde and 3-bromo-4-
hydroxycoumarin. 
1.1. 3-Formylchromone 
Chromones comprise a vast array of oxygen containing compounds ubiquitous in plants.^ 
They form basic nucleus of flavones' and have been recognized as the essential 
component of pharmacophores of a large number of bioactive molecules.^ Due to their 
low mammalian toxicity, chromone derivatives are present in large amounts in the diet of 
human'and display remarkable biochemical and pharmacological actions and hold a place 
apart in the field of pharmacognosy. Molecules containing chromone structure possess a 
myriad of biological activities ranging from antifungal,'" antimicrobial," antioxidant,'^ 
neuroprotective,'^ HlV-inhibitory'" to anticancer'^ activities. Till date, while some 
flavonoids, phenodioxol and flavopiridol have entered clinical trials and flavopiridol have 
been identified as fust cyciin dependent kinase inhibitor (entered phase II clinical trial),'^ 
the natural chromone Khellin'^ provided lead to totally synthetic antiallergic drug 
disodium cromoglycate.'* Similarly, Hormothamnione,'^ the first naturally occurring 
styrylchromone isolated from the blue green algae, Hormothamnione enteromophoides, 
has potent cytotoxicity to P-388 lymphocytic leukemia and HL-60 human promyelocytic 
leukemia cells. Chromone derivatives are also active at benzodiazepine receptors, 
lipoxygenase and cyclooxygenase.^° Thus, in view of its biological importance efforts 
have been made for isolation, synthesis, chemistry and biological screening of chromone 
derivatives?'" '^* Several methods are reported in the literature for the synthesis of 
chromones and their analogs. Two general approaches are commonly used for the 
synthesis of chromone derivatives, the first include formation of a new chromone ring by 
cyclisation of suitable substrates^^ and the second, functionalization of existing chromone 
containing precursors by introduction of new substituents. Thus, 3-formylchromone 2 
has been used as a scaffold in the synthesis of new fused heterocyclic system, ever since 
its convenient synthesis was reported in 1970s.^  Though various methods are known for 
the synthesis of 3-formylchromone 2^^'^^ Vilsmeier-Haack reaction is the most 
convenient as the reagent is very mild, high yielding and can be applied to polyfunctional 
molecules also. Thus, Nohara et al reported the synthesis of 3-formylchromone using 
Vilsmeier-Haack reagent (N,N-dimethyl formamide + phosphourous oxychloride) and o-
hydroxyacetophenone 1 (Scheme !).•" Mechanism of this reaction is depicted in Scheme 
2. 
^^^^^^COCHj 
lA, DMF/POCl, OH 0-5 C 
1 2 
Scheme 1. Synthesis of 3-formylchromone 2 using Vilsmeier-Haack reaction. 
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Scheme 2. Mechanistic pathway for the formation of 3-formylchromone 2. 
Synthetic application of 3-formylchromone 2 is mainly due to the presence of three 
electron deficient centres at C-2, C-4 carbon of the carbonyl group and C-3 formyl 
group. ' Hence, 3-formylchromone can react with various nucieophiles and lead to a 
variety of alkyJated,^ ^ heteroannulated'''* and spiroannulated^^ chroman-4-one derivatives 
3 
. \ 
or rearrangement products. It can also serve as dienophiles^^ in [4+2] cycloaddition of 
electron rich dienes, or as heterodienes^^ in inverse electron demand Diels-Alder 
reactions of enol ethers. It has been also used to prepare 1,3-dipolar compounds, namely, 
nitrones,^^ nitrile imines,''° and azomethine ylides.'" In addition, they are photochemically 
very active and have lead to the generation of some exotic heterocyclic compound.'*'^  
Although, 3-formylchromone has emerged as valuable synthon for incorporation of the 
chromone moiety into a number of molecular framework, but its synthetic utility is 
limited due to easy opening of the chromone ring''^  and strategies are being developed to 
circumvent'*'' this problem. To depict the versatility of 3-formylchromone 2 in the 
synthesis of new heterocycles a few examples with special emphasis on reaction with 
active methyl and active methylene compounds are discussed here. 
1.1.1. Reaction of 3-formylchromones with active methyl compounds 
1.1.1a. Reactions with arylmethyl ketones and acetaldehyde 
Shankar et al and Polykov et al reported the synthesis of chromonyl chalcones (3) by 
reaction of 2 with various substituted acetophenones in methanol using KOH as a basic 
catalyst. Reactions were completed at room temperature in 3 h with yields of products 
70-76%'*^ (Scheme 3). 
O 
Ar 
CH,OH/KOH 
CH, 
O O 
3 R = H.CHjO 
Ar = Q H j , 4-Cl C(,H4, A-CV 
CfcH,,, 4-OMe C(,H4 
Scheme 3. Formation of chromonyl chalcones (3). 
Tuskaev et al reported a more convenient procedure for the synthesis of chromonyl 
chalcones (4) under acidic conditions using anhydrous acetic acid in the presence of 
catalytic amount of perchloric acid or by triethylorthoformate and perchloric acid. 
Reactions took 30-60 min at 80-90 "C for completion with yields 48-85%'*^ (Scheme 4). 
R2 
2 + R; 
Acetic acid/ 
Perchloric acid 
Triethylorthoformate/ 
Perchloric acid 
R = CH3 
R, = H, CHj, OH 
Rj = H, t-But 
Rj = H, CH3, CgHj, OH, OCH3, 
F, CI, Br, NO2 
R4=H,t-But,CH3,OCH3,Cl 
Scheme 4. Synthesis of chromonyl chalcones (4). 
Cycloaddition of 2 with ethyl vinyl ether and subsequent hydrolysis of 
benzopyranopyrone intermediates results 3-(4-oxo-4//-l-benzopyran-3-yl)acroleins in 
moderate yields (21-49%).'*^^ Polykov described an efficient synthesis of acroleins (5) in 
70-99% yields by the reaction of 2 with acetaldehyde in dimethylformamide catalyzed 
by aqueous piperidine followed by acidic hydrolysis'*'"'(Scheme 5). 
. 0^ 
+ CH 
O 
II 
3 -C H 
DMF/ Piperidine 
>. 
5 
R= H, 6-CH3, 6-OH, 7-CH3, 
6-C2HJ, 6-OCH3, 6-NO2, 
7-OAc, 8-F 
Scheme 5. Synthesis of acroleins (5) from 3-formylchromones. 
1.1.1b. Condensation of 2 with methyl-substituted o)^gen heterocycles 
Condensation of 2 with methyl-substituted oxygen heterocycles such as 3-R'-4,5,5-
trimethyl-2,5-dihydrofuran-2-ones or 3-R'-4,6,6-trimethyl-5,6-dihydropyran-2-ones 
yielded chromone derivatives 6 and 7 in acetic anhydride at 80-90 °C in 65-75% yields 
(Scheme 6). Product 8 was obtained by refluxing 2 with 4-methylcoumarin in toluene."** 
However, when the reaction was extended to 2-methyl-3-acetylchromone the reaction 
preferably occurred at the 2-methyl group rather than methyl group acetyl moiety to 
furnish 9, both under conventional heating and microwave irradiation technique. The 
conventional heating carried out in acetic anhydride-potassium acetate medium required 
2-3 h at 120-130 °C, while microwave irradiation reduced the time by 40 sec-2 min 
(Scheme 7). 
49 
H3C. 
H3C 
HjC 
Ov O 
AC2O/ACOK 
R = H, 6-CH3, 7-CH3,6-OH, 
6-C!, 6-Br, 8-Cl 
HjC 
HsCA^O^O 
CH3 
AC2O/ACOK 
R= H 6-CH3, 7-CH3, 6-OH, 
6-CI, 6-Br, 8-C! 
> l = / 
O 
7 R'= CN, CONH2, COOC2H5 
Scheme 6. Condensation of 3-formylchromones with methyl-substituted oxygen 
heterocycles. 
Toluene 
>i= 
R= H, 6-CH3, 7-CH3, 
6-OH, 6-Cl, 6-Br, 8-Cl 
R'= CN, CONH2, COOC2H5 
AcjO/AcOK 
R= H, CH3, CI 
R ' = H , C H 3 , 6 - C 1 
CH. O 
6,7-(CH3)2 9 
Scheme 7. Condensation of 3-formylchromones with methyl-substituted oxygen 
heterocycles. 
1.1.1c. Condensation of 2 with 3-alkyl-4-phenyl-3-cyclobutene-l,2-diones 
Chromone derivative 10a was obtained by reaction of 2 with 3-methyl-4-phenyl-3-
cyclobutene-l,2-dione in aluminium chloride-dichloromethane medium for 3.5 h with 
yield 41% (R=H). Treatment of 3-ethyl-4-phenyl-cyclobut-3-ene-l,2-dione with 3-
formylchromone 2 generated 10b in 26% (R= CHa/" (Scheme 8). 
. 0 . 
RHjCv / AlCK/CHoCI- 6"5 2'-''2 
C6H5 V o lOa-b 
R=(a) = H o 
(b) = CH3 
Scheme 8. Condensation of 3-formylchromones with 3-alkyl-4-phenyl-3-cyclobutene-l,2-
diones. 
7 
1.1.Id. Condensation of 2 with 2-methylbenzothiazole and 2-methylbenzimidazole 
derivatives 
An efficient procedure for the synthesis of benzothiazoliums salts (11) was reported by 
Gasparova et al, which involves the preparation of 3-alkyl or 3-arylbenzothiazolium 
halides and their subsequent condensation with 2. 2-Methyl benzothiazolium salts were 
treated with 2 in acetonitrile to give (11) in 29-85% after 3-35 min of the microwave 
irradiation or 0.5-8 h heating. Condensation of 2 with 2-methylbenzothiazole or 2-
methylbenzimidazole carried out in DMSO-boric acid medium at 120 °C resulted the 
compounds (12a-c) in 50-68% yield. The same reaction when carried out at 60 °C yielded 
(13a-b) in 81-85% ^ ' (Scheme 9). 
13a.b° ° " ^- w 
H3BO3- DMSO/ 60 "C 
H3BOJ-DMSO/I2OX 
a = R = CH3, A = S 
b = R = CH3,A = NH 
, 
•'c 
>°C 
' 
0^ !h""' 
' 
CH3CN / 0^/^CH3 
CH2R1X 
12a-c \ = = / DMF 
[R=Ci] O 0 11 XR,H2C 
a = R = CH3,A=S 
b = R=Cl,A=S 
c = R = CH3, A = NH 
A = S, C(CH3)2 
X = CH3S04,I 
R,= H 
Scheme 9. Condensation of 3-formylchromones with 2-methylbenzothiazole and 2-
methylbenzim idazole derivatives. 
8 
1.1.le. Condensations of 2 with 4-nitro and 2,4-dinitrotoluene 
Styrylchromone (14a) were synthesized in 24-50% by treating p-nitrotoluene with 2 in 
refluxing ethanol. Sonawane et al also reported the synthesis of styrylchromones by 
refluxing 3-formylchromones with 2,4-dinitrotoluene in pyridine^ ^ (Scheme 10). 
2 + 
R= H, CH3, CI 
a = R'=N02.R^=H 
b = R'=R^=N02 
Scheme 10. Synthesis of styrylchromones from 3-formylchromones. 
1.1.2. Reaction of 3-formylchromones with active methylene compounds 
Nucleophilic addition reaction of 3-formyl chromone 2 mainly leads to condensation 
products. In this category, reactions with active methylene compounds are well 
documented. Some of the examples are discussed below. 
1.1.2a. Condensation of 2 with malonic acid derivatives 
Reaction of 2 with malonic acid^^ or diethylmalonate^'' in the presence of base such as 
pyridine afforded £-y?-(4-oxo-4//-l-benzopyran-3-yl)acrylic acids (Ri=H) or ethyl 
acrylates (Ri= C2H5) (15a-b) through Knoevenagel condensation. Similarly the reaction 
of 2 with cyanoacetic acid gave i^-;ff-(4-oxo-4//-l-benzopyran-3-yl)acrylonitriles (16a) 
(R' = H) in 56-74% yield.^ ^ Further, Ellis reported the formation of 16b (R = H, Ri = CN) 
by the reaction of 2 with malononitrile in 72% yield after 10 min heating at 42 "C.^ ^ The 
reaction of 2 with cyanoacetamide provided 2-cyano-3-(6-ethyl-(4-oxo-4//-I-
benzopyran-3-yl)acrylamide (17) in 42% yield after 5 min reflux in pyridine"^ (Scheme 
11). 
.COOR, 
"COORj 
,CN 
CONH2 
Ri 
COOR 
O 
15a-b 
COOR, 
R, = (a) = H 
(b) = C2H5 
R = H, 6-Br, 6-NO2, 
6,8-(CH2)2 
16a-b 
CN 
R,= (a) = H 
(b) = CN 
R = H, 6-Br, 
6-NO2, 
6,8-(CH2)2 
17 
iJj R = H,C2H5,N02 
R, = CN 
Scheme 11. Condensation of 3-formylchromones with malonic acid derivatives. 
1,1.2b. Condensation of 2 with ethylacetoacetate 
Jones et al reported the reaction of 2 with ethyl acetoacetate in sodium acetate-acetic 
anhydride medium to provide the expected condensation product 18. However, with 
excess of ethylacetoacetate under basic conditions, the ring opening of pyrone ring take 
place to afford 19 (Scheme 12).^* 
10 
+ HjCCCH^COzEt ^^^^' >. 
CHO AcjO, A 
CO,Et 
HjCCCHzCOjEt 
(excess) 
Piperidine, EtOH 
O O 
18 
O 
HjCCCHaCOzEt 
Piperidine, EiOH 
Scheme 12. Formation of 18,19 by the reaction of 3-formylchromone 2 with 
ethylacetoacetate. 
1.1.2c. Condensation with barbituric acid derivatives 
3-Formylchromone was readily condensed with pyrimidine derivatives under different 
reaction conditions. The reaction with barbituric acid in refluxing pyridine completed 
within 10 min to give condensation product 20 with 94% yield. The reaction with 1,3-
dimethyl-4-iminouracil is condition dependent. The reaction in water afforded the 
Knoevenagel condensation product (21) in 39% yield, while in ethanol-water medium in 
presence of catalytic amount of pyridine gave the product (22) in 28% yield. The 
reactions with substituted barbituric acid or thiobarbituric acid afford Knoevenagel 
condensation products (23) in 13-21% yield in acetone under triethylamine-pyridine 
catalysis, whereas acetic acid-acetic anhydride medium was suitable for the preparation 
of pyrimidopyranoyrimidines (24) in 12-64% yield^ '^^  (Scheme 13). 
11 
,0 
H,0/ EtOH 
Pyridine 
EtjN/ Pyridine 
R - CH3,C2H5 
x = o, s 
AC2O 
O 
24 X 
Scheme 13. Condensationof 3-formylchromone with barbituric acid derivatives. 
1.1.2d. Condensation with 5-membered heterocycles 
Products of type (25) were obtained by the reaction of 3-formylchromones with 2-thioxo-
imidazolidine-4-one under different reaction conditions. Reactions in glacial acetic acid 
in the presence of piperidine completed in 20 min with 74-78% yield. Also 0.5-2 h 
heating of the reaction mixture in acetic anhydride-potassium acetate mixture gave the 
12 
products in comparable yield. Microwave irradiation shortened the reaction time to 4-10 
61 
min with 62-96% yield"' (Scheme 14). 
H 
N 
H O 
AcOH-Piperidine / 
AcjO-AcOK/MW 
N—H 
O 25 o 
R=H,CH3,CH30,Br,N02 
Scheme 14. Formation of product 25 from 2-formylchromone. 
Acetic anhydride-sodium acetate catalyzed condensation of 2 with 2-thioxothiazolidine-
4-one (rhodanin) afforded the product (26a) in 43-66% yield. Similarly reaction with 
ethyl rhodanine in potassium acetate-absolute ethanol gave product (26b) in 95% yieid.^ ^ 
Microwave irradiation in acetic anhydride-potassium acetate medium reduced the time of 
reaction to 5min. Condensation of 2 with 3-aminoacetylrhodanine in ethanol gave the 
product {21 f^" (Scheme 15). 
o Ri 
N R 
R= H, CHj, CI O 
(a)R,= H 
(b)R,= C2Hj 
-R. 
R|=NHAc 
Scheme 15. Formation of products 26 and 27 by the reaction of 3-formylchromones wiui 
rhodanine. 
i; 
Condensation of 2 with 2-imino-l-methylimidazolidine-4-one (creatinine) in acetic 
anhydride catalyzed by potassium acetate under microwave irradiation (1-4 min) as well 
as by classical heating for 1-2 h yielded the product (28a) in 40-84%. Product (28b) was 
conveniently synthesized by the reaction of creatinine with ethylchloroformate in DMF at 
0-5 °C over 30 min followed by subsequent condensation with S-formylchromones. 
Reaction of 2 with creatinine in DMSO using boric acid as a catalyst for 3 h afforded (29) 
in 68-98% yield^"" (Scheme 16). 
H,c NHR, 
AcOK 
R = H, CH3, CI, Br, NO2 
(a) R2 = COCH3 
(b) R2 = COOH 
H3BO3 
R=H,CH3,Cl,Br,N02 
Scheme 16. Formation of products 28 and 29 by the reaction of 3-formylchromones with 
creatinine. 
Knoevenagel condensation products (30) were obtained by the condensation of 2 with 3-
methylisoxazol-5(4//)-one or with 3-phenylisoxazol-5(4//)-one in chloroform-ethanol 
medium at room temperature or by 3 h heating in ethanol in 81-89% yields^^'*"' (Scheme 
17). 
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CHClj-EtOH/EtOH, A ^ 
R= H, CH3, CI, Br 
R-i'^ CHj.CgHs 
Scheme 17. Formation of Knoevenagel condensation type products (30) from 3-
formylchromones. 
Reaction of 2 with 3-methyl-l-phenyipyrazoline-5-one gives Knoevenagel products-both 
in acetic acid and in solvent-free microwave irradiation with 47-85% yields. Comparable 
yields (56-86%) of (31) were also reported under microwave irradiation of 2 with 3-
methyl-l-phenylpyrazoIine-5-one on alumina support or by "classical" heating in 
dioxane-triethylamine medium.^ Reaction of 3-formylchromones with 4-hydroxy-l-
methyl-3-(5-oxo-2-pyrazoline-3-yl)quinoline-2(li/)-one in glacial acetic acid in the 
presence of sodium acetate supplied quinoline derivatives (32) which are interesting 
intermediates for the preparation of various heterocycles^^ (Scheme 18). 
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AcOH or MW 
CM 6"5 
O CH3 
R = H, 6-Cl, NO2, OAc, OCH3,7-CH3, CI, F, Br, 
OAc, OCH3 
H 
-N 
«-oii: 
CH3 
R = H,Cl,Br 
H3C 
Scheme 18. Synthesis of products 31 and 32 from 3-fonnylchromones and substituted 
pyrazoline-5-one. 
1.1.2e. Condensation with six memberedfused heterocycles, phenylacetic acids, aryl or 
heteroarylsubstituted acetonitriles 
Condensation of 3-formylchroniones with 1-naphthylacetonitrile under microwave 
irradiation yielded the product (33) in 10 min with 39-46% yield, while conventional 
heating took 17-20 h with moderate yield (30-38%). Similar types of reactions were also 
reported under different reaction conditions in high yields^ (Scheme 19). 
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CN 
ACOK-AC2O/MW 
CN H,C 
CHi 
6 33 
R= H, CH3, Br 
"Y^yN-N /;^CH3 
R=H 
CN H 
-O 
Scheme 19. Formation of products 33, 34, 35 by the reaction of 3-formylchromones with 
aryl or heteroarylsubstituted acetonitriles. 
Condensation of 2 with phenylacetic acid in acetic anhydride in the presence of 
piperidine as a catalyst furnished the products (36) in 47-68 % yield^' (Scheme 20). 
COOH COOH 
Ac20-Piperidine 
36 
R= H, CH3, CI 
Scheme 20. Condensation of 3-formylchromones with phenylacetic acid. 
v ^ 
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Reaction with 2//-l,4-benzothiazine-3(4/f)-one in acetic anhydride-potassium acetate 
medium gave corresponding Knoevenagel condensation product (38) in 6-10 h with 
yields 15-43%, while microwave irradiation shortened reaction time to 7-20 min with an 
increase in yields to 33-62%.^ ^ Reaction with 4-chromanone in ethanol-triethylamine 
medium resulted benzopyrano-2,3-dihydrobenzopyranones 37 after 3 h reflux in 67-80% 
yields^^ (Scheme 21). 
37 O R=H, CI 
R,= H, CH3, CI, Br 
R2~H, CH3 
H 
AcoO-AcOK 
/MW 
R=H, CH3, OCOCH3, CI 
Scheme 21. Formation of products 37 and 38 from 3-formylchromones. 
In 1967, Eiden et al obtained a 1:2 adduct 39 from the reaction of 3-formylchromone 2 
and 5,5-dimethyl cyclohexane-l,3-dione in aqueous ethanoi.^^ However, when the same 
reaction was attempted in pyridine, it gave the same adduct 39, which was dehydrated to 
18 
xantone analogue 40 while attempting recrystalization in ethanol containing HCl7° On 
the other hand, when condensation of 3-formyi chromone 2 with dimedone was carried 
out in acetic anhydride in the presence of potassium acetate, both under "the classical" 
and microwave irradiation condition, expected Knoevenagel product 41 was obtained 
(Scheme 22). 
66 
Scheme 22. Reaction of 3-formyl chromone 2 with dimedone under different reaction 
conditions. 
Analogous reactions of 3-formyl chromone 2 with oxiindole,^° indanedione'*' N-
benzoylglycine,''^  2-methyl[l,3]thiazolo[3,2-6][l,2,4]triazol-5(6i:0-one^^ and 1,2'-
biindenylidine-3,r,3'-trione^^ involving Knoevenagel condensation leads to the formation 
condensation products 42-46 respectively (Scheme 23). 
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AcOK-
AcjO 
Scheme 23. Recation of 2 with different active methylene compounds. 
In 2001, Shingare et al reported an efficient and simple synthetic route to uncatalysed 
Knoevenagel condensation reaction of 3-formylchromone 2 with malononitrile, 
cyanoacetic acid and cyanoacetamide in distilled water yielding respective ylidenenitriies 
47a-c in quantitative yield. This procedure represents an ecofriendly and economically 
viable method that avoids both an organic solvent and need for a catalyst with shorter 
reaction time and higher selectivity^"* (Scheme 24). 
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< : 
Water/ Heat 
1-2 h 
Z 
a = CN, 
b = COOH, 
c = C0NH2 
Scheme 24. Formation ofylidenenitriles (47) from 2. 
1.2. 5-ChIoro-3-methyl-l-phenylpyrazole-4-carboxaldehyde and 5-azido-3-methyl-l-
phenylpyrazole-4-carboxaldehyde 
Nitrogen containing heterocyclic compounds are large, diverse and key building blocks 
used to build up compounds from biological or medicinal interest to plastics and much 
efforts have been made to synthesize and derivatize these compounds.'^ Pyrazole 
derivatives and heterocycle-annulated pyrazoles are studied extensively because of their 
simple preparation, broad spectrum biological activities such as fungicidal,^  
-7*7 " I Q IQ 9.{\ 
antidepressent, antipyretic, anti-inflammatory, antibacterial etc. Indeed, pyrazole 
based derivatives have shown several biological activities as seen in COX-2,^' P38 MAP 
kinase,*^ and CDK2/cyclin A inhibitors.*^ Many of them are currently being tested and/or 
clinically evaluated for new drug discovery. Looking to their manifold properties, 
synthesis of pyrazoles and their derivatives remains of great interest in the synthetic 
organic chemistry. In this regard, 5-chloropyrazoles and 5-azidopyrazoles have proved as 
an important synthons. Synthesis and some reactions of 5-chloro-3-methyl-l-
phenylpyrazole-4-carboxaldehyde and 5-azido-3-methyl-l -phenylpyrazole-4-
carboxaldehyde are discussed below. 
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1.2.1. Synthesis of5-chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde (48) 
Compound 48 can be conveniently synthesized by the formylation of 3-methyi-l-phenyl-
pyrazol-5(4i/)-one using Vilsmeier-Haack reagent (DMF/POCb).^ '* 
H3C 
r 
H,C. \ . XHO 
N ^ O 
I 
Ph 
DMF/POCU N. 
N CI 
I 
Ph 
48 
Scheme 25. Synthesis of 5-chloro-3-methyl-l-pherrylpyrazole-4-carboxaldehyde (48) 
using Vilsmeier-Haack reagent. 
1.2.2. Synthesis of5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde (49) 
Azidoformyl pyrazole 49 can be easily synthesized from chloroformyl pyrazole (48) 
using DMSO and NaNs.*^ 
,CHO 
DMSO-NaNj 
I 1 
Ph Ph 
HjC-^^ ^ C H O 
48 49 
Scheme 26. Synthesis of5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde (49). 
1.2.1a. Reaction of 5-chloro-3-meihyl-l-phenylpyrazole-4-carboxaldehyde (48) with 
active methylene and methyl compounds 
Due to reactive aldehydic group in 48 various functionalizations (Inter and intra 
molecular) have been carried out with active methylene compounds to afford 
pharmacologically active heterocycles (Scheme 27).*^ 
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hippuric acid / NaOAc / AcjO 
XhO HiC 
CH2(CN)2 
"CI 
Piperidine 
Knoevenagel condesation 
Ph 
48 
^COOCjHs 
/ Ethanol / Piperidine 
CH2(CN)2/NH40Ac 
at 120 °C without 
solvent 
CeHsCHjCN / PTC 
N. J L COOCjHj N . JL CONH2 
X N H,C Yirr 
Ph 
53 
Ph 
54 
N 
I 
Ph 
55 
CI 
Scheme 27. Reaction of chloroformylpyrazole 48 with active methylene compounds. 
Condensation of 48 with phenyl pyrazolone at reflux temperature in ethanol containing 
catalytic amount of piperidine afforded the corresponding Knoevenagel product 56 in 
80% within 10 h (Scheme 28).*^ The compound, thus, obtained may serve as 
intermediate for the synthesis of other heterocyclic compounds either through Michael 
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addition (due to the presence of a,P-unsaturated system) or through nucleophilic 
substitution (at C-5 carbon centre bearing CI group). 
P h . \ 
N N 
H3C ,CHO 
4 V ^ 
•CH3 H3C 
\\ EtOH-Piperidine 
N CI O N . / 
N 
Ph Ph 
Scheme 28. Formation of Knoevenagel condensation product by the reaction of 48 with 
3-methyl-l-phenylpyrazol-5-one. 
Similarly the synthesis of 5-(substituted pyrazolyl-4-methylidene)(thio)barbituric acids 
57 was carried out employing barbituric acids or thiobarbituric acid in absolute ethanol 
containing acetic acid** (Scheme 29). 
X 
O 
N w \ 
CHO 
R2\ ./Jk, /R 
N N 
N 
. . ^ ^ 
EtOH-AcOH 
N CI o""^ N ^ X 
I 1 
Ph R2 
R i = CH3, CgHs 
R 2 = H , C H 3 
x=o,s 
48 
N " CI 
Ph 
57 
Scheme 29. Synthesis of 5-(substitutedpyrazolyl-4-methylidene)(thio)barbituricacids 57 
from 48. 
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Condensation of 48 with acetophenones in ethanol under basic condition resulted in the 
formation of a,P unsaturated compounds 58 in 8-10 h with 75% yield. The compound 58 
on treatment with various hydrazines, hydroxylamine and ureas afforded corresponding 
pyrazolines, isoxazoles and pyrimidines in 50-80% (Scheme 30). 
R 
\ 
H,C 
R=H,N02,OCH3 
N w 
N 
Ph 
48 
EtOH-KOH 
k. 
Acetophenones 
HjC, 
NH2NH2, PhNHNHj, 
NH2OH 
X= N-H, 
N-Ph, O 
59 60 
Scheme 30. Formation of various products 58, 59 and 60 from 48. 
1.2.1b. 5-Chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde as a synihon for 
intramolecular 1,3-Dipolar Cycloadditions 
5-Chloropyrazole-4-ca'"baldehyde 48, possessing a halogen and aidehydic function in an 
or/Ao-relationship is a potential candidate for 1,3-dipolar cycloaddition reactions to 
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synthesize fused heterocycles. L'abbe et al transformed 48 into tri and tetracyclic 
heterocycles 62-67, first by substituting the chlorine atom by unsaturated nucleophiles 
such as allenethiolate to give allylsulfanyl-4-formyl pyrazole 61 and then by modifying 
the aldehydic function into a 1,3 dipole (Scheme 31,32). 
H-.C 
N, 
,CHO H3C 
Allyl isothiourea / Base 
N CI I 
Ph 
j .,^ ^ ^CHO 
48 61 
Scheme 31. Formation of allylsulfanyl-4-formylpyrazole 61. 
The aldehyde 61 was converted into nitrile oxide, nitrone, nitrile imine, azomethine ylide 
and azomethine imine, which cyclised spontaneously to fused heterocycles 62-67 
(Scheme 32) 89 
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PhCHjCONHNHCH 
HsC^ . . / 
.COCHjPh 
N—N 
H,C 
(I)TsNHNH2 
(Il)PhN2*Cr, pyridine 
(HI) 165 "C low pressure 
H,C, 
COiEt 
67 
Scheme 32. Conversion of allylsulfanyl-4-formyl pyrazole 61 to fused heterocycles 62-
67. 
1.2.1c. Use of 5-chloro-4-formylpyrazole in the synthesis ofMannich bases 
Chloropyrazole carbaldehyde 48 has been transformed into Mannich bases 69 by carrying 
out reaction with 3-substituted-5-mercapto-l,2,4-triazoles, formaldehyde and a secondary 
amine. First the Schiff bases 68, were, synthesized by the treatment of 48 with triazoles in 
ethanol, in the presence of cone. H2SO4 (Scheme 33). 
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HjC CHO 
-N \ 
+ 
EtOH A 
N ' '"SH CH, 
N SH ^ N CI ConcHzSO^ | 
I I N=CH 
NHj Ph „ ^ 
cv n 
I 
48 68 Ph 
Scheme 33. Synthesis of Schiff bases, 3-(substituted)-4-l-phenyl-2-methyl-5-chloro-
4-pyrazolidene)ammo-5-mercapto-l, 2,4-triazoles 68. 
Schiff bases 68 were then treated with a secondary amine in the presence of 
formaldehyde to yield Mannich base, l-aminomethyl-3-substituted-4-(l-phenyl-3-
methyl-5-chloro-4-pyrazolidene)amino-l,2,4-triazole-5-thione$ 69 (Scheme 34).*^ ° The 
reaction is highly regioselective and furnishes only the N-Mannich base and none of the 
S-Mannich derivative. Formation of N-Mannich base rather than S-Mannich base was 
confirmed by the 'H N M R spectra of Mannich base which showed signal at 5 5.0-5.2 
(typical of the N-CH2 group) and absence of any signal in the region of <5 4.0-4.5 (typical 
S-CH2 group). 
N N N CH2—N 
\ 
'^ ' ^ S " .CH3 R, ^^ ^ N ' ^ ' ^ S CH, 
, N I 
N = C H n if + "CHO + N H » N C H -
,N R2 
c r N c i ^ N 
Ph Ph 
68 69 
Scheme 34. Synthesis of Mannich base, l-aminomethyl-3-substituted-4-(l-phenyl-3-
methyl-5-chloro-4-pyrazolidene)amino-l,2,4-triazole-5-thiones 69. 
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1.2.Id. Reaction of 5-chloro-4-formylpyrazole with nitrogen bases 
When 5-chloro-4-formylpyrazole 48 was treated with hydrazine hydrate and 
phenylhydrazine in absolute ethanol at room temperature, corresponding 3-methyl-5-
chIoro-1-phenyl-l//-pyrazoIe-4-carbaldehyde hydrazones 70 were formed. These 
hydrazones on heating under fusion conditions yielded 3,6-disubstituted-i-phenyl-l/^, 
6//-pyrazolo[3,4-c] pyrazoies 71 (Scheme 35).^' 
H3C 
IT 
XHO 
N CI 
I 
Ph 
48 
H,C^ 
NNHR A 
MeOH 
II J II 
I I 
Ph R 
70 71 
R = H.Ph 
Scheme 35. Reaction of 48 with hydrazine and phenylhydrazine. 
Formation of some other nucleophilic addition products employing 48 and various 
binucleophiles as starting materials is summarized in Scheme 36.^'' 
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Scheme 36. Reaction of 48 with different nitrogen bases to yield compounds72-76. 
1.2.le. Reaction of 5-chloro-3-meihyl-l-phenylpyrazole-4-carboxaldehyde with 4-
chromanone 
Owing to the importance of fused benzopyrano compounds, 5//-[l]benzopyrano[4',3'-
e]pyrazolo[3,4-6]pyridines 78, were synthesized by Sabitha et al in 1999. Synthesis of 78 
was achieved by the reaction of 48 with 4-chromanone in NaOEt/EtOH at room 
temperature to give the intermediate 77. The intermediates 77 were isolated and cyciised 
to 78 by refluxing in NH4OAC-ACOH medium (Scheme 37).'^ ^ 
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cno 
I J 
N CI 
Ph 
48 R= H.CHjCI 
Scheme 37. Formation of 5H-[l]benzopyrano[4 ',3 '-e]pyrazolo[3,4-b]pyridmes78. 
1.2.1f. Chloroaldehyde 48 as a synthon to give thieno[2,3-c]pyrazole derivatives 
Thienopyrazole derivatives are of great significance because of their association with 
varied biological and pharmacological activities.^^ Various methods for the synthesis of 
thienopyrazoles have been reported in literature. ^' A much simplified version for the 
synthesis of thienopyrazole involves 48 as starting material. In this procedure 48 was 
condensed with methyl thioglycolate in the presence of NaOCHs in methanol to yield 
methyl-(3-methyl-l-phenyl-li/-thieno[2,3-c]pyrazoIe)-5-carboxylate 80. The reaction 
proceeds via the formation of intermediate, S-(4-formyl-3-methyl-l-phenyl-l//-pyrazol-
5-yl)-2-mercaptoacetate 79. The formation of 79 was confirmed by reacting 48 with 
methyl thioglycolate in methanol at 50°C in the absence of sodium methoxide. After 
isolation, the intermediate 79 was refluxed in methanol in the presence of sodium 
methoxide to afford 80 (Scheme 38).^ ^ 
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H,C, rHO HiC rHO 
H,C, 
OCHi 
Scheme 38. Formation of thieno[2,3-c]pyrazole 80. 
1.2.1g. Nucleophilic aromatic substitution reaction (S^Ar) of 5-chloro-3-meihyl-l-
phenylpyrazole-4-carboxaldehyde 
The pyrazole, as an electron-rich heteroaromatic nucleus, does not generally react with 
nucleophiles. Many workers^ '^^ ^ have shown that S^\x reaction of heterocycles 
containing a nearby halogen atom can be used for introducing a wide variety of 
heteroatom containing nucleophiles into the heterocyclic ring. However, only a few 
reports'^'' on SwAr reaction of 5-chloroformylpyrazole 48 have appeared. 
Lee et al, have introduced various N-containing heterocycles into pyrazole by taking 48 
as a starting material. Introduction of electron withdrawing, formyl group, in conjugated 
position of the ring activated the nucleophilic displacement of chlorine atom. The 
reaction was conveniently carried out by heating a mixture of 48 with readily available 
N-containing heterocycles .such as imidazole, pyrazole, indole, pyrrolidine, and 
morphoJi/ie (3 equiv.) and powdered KOH (1.5 equiv.) m DMF and gave 82 in good yield 
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(Scheme 39). It has been shown that aromatic heterocyclic nucleophiles react much faster 
than the saturated heterocyclic nucleophiles.'°' 
H.c 
N. 
N 
I 
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.CHO 
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Nu-H, KOH 
DMF, 120 °C 
N . 
N Nu 
I 
Ph 
82 
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pyrazole, 
pyrrolidine, 
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Scheme 39. S^Ar reaction of 5-chloroformylpyrazole. 
1.2.2a. Conversion of 5-azidopyrazole-4-carboxaldehyde (49) to pyrazolo/3,4-bJpyridine 
A one pot and convenient synthesis of multisubstituted pyrazolo[3,4-i] pyridines in 
moderate to high yields has been reported in two steps by Zheng et at. "'^  the reaction 
involves diazo transfer of 5-azido-l-phenylpyrazole-4-carboxaldehyde, 49 to ketones in 
ethanolic KOH give 5-amino-l-phenylpyrazole-4-carboxaIdehyde, which on subsequent 
Friedlander reaction with ketones yielded pyrazolo[3,4-6]pyridines (83) in 3-12 h with 
60-92% yield (Scheme 40). 
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Scheme 40. Conversion of 5-azidopyrazole-4-carboxaldehyde to pyrazolof3,4-bJ 
pyridine. 
1.2.2b. Conversion of 5-azidopyrazole-4-carboxaldehyde,49 to trlazolo[l,5-a]pyridines 
Reaction of 5-azido-4-formylpyrazoles 49 with dimethyl-3-oxo pentanedioate and triethyl 
amine results the pyrazolo[4,3-e][l,2,3]triazolo[l,5-a] pyridines (85) in high yields (77-
85%) by refluxing in ethanol for 5 min through unstable (3-pyrazol-3-yl-l,2,3-triazol-4-
yl) acetates 84 via Dimroth reaction'"^ (Scheme 41). 
COOMe 
H3C XHO 
N. 
Et^N 
\ N 
I 
C6H5 
49 
^ CO(CH2COOMe)2 " ^ ^ J ^ 
^N3 
N . 
COOMc 
N N 
\ 
C6H5 N = N 
not isolated 
COOMe 
COOMe 
Scheme 41. Conversion of 5-azidopyrazole-4-carboxaldehyde to triazolo[l,5-a] 
pyridines. 
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1.2.2c. Thermolysis of5-azido-4-formyl-l-phenylpyrazole 49. 
Mechanism of thermolysis of azido formylpyrazole 49 was studied by Begtrup et al in 
1995. It produces (4-cyanopyrazol-3-yl methyl) pyrazoles (86) and (87). 2 Cyano-3-
phenylazo-2-butenal (88) was also detected during the reaction. All the products are 
formed via substituted 2-cyano-3-azopropenals or a zwitterionic intermediates 
(Scheme 42). 
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OHC .N, 
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H3C N CgHj 
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H3C N ^CfiHj C6H5 
Scheme 42. Thermolysis pathway of5-azido-4-formyl-l-phenylpyrazole. 
1.3.3-Brorao-4-hydroxycoumarin 
The synthesis of coumarin derivatives has attracted considerable attention of organic and 
medicinal chemists as these compounds are widely used as fragrances, pharmaceuticals, 
and agrochemicals.'°^ Coumarins possess a variety of bioactivities including 
anticoagulant, estrogenic, dermal, photosensitizing, antimicrobial, vasodilative, 
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molluscacidal, anthelmintic, sedative and hypnotic, analgesic, and hypothermic 
activity.'"^''"^ Furthermore, three coumarin antibiotics, novobiocin, chJorobiocin, and 
coumermycin Al exhibit significant activity on certain tumor cells.'°' 
1.3.1 Synthesis of 3-bromo-4-hydroxycoumarm (89) 
Easy and convenient synthesis of 3-bromo-4-hydroxy coumarin was reported by the 
addition of bromine with vigorous stirring to a solution of 4-hydroxy coumarin in 
absolute ethanol.'°* 
OH OH 
-Br 
BrWEtOH 
89 
Scheme 43. Synthesis of 3-bromo-4-hydroxycoumarm (89). 
Zaman et al '°^ reported the reaction of 3-bromo-4-hydroxycoumarin with various 
aldehydes. The reaction with formaldehyde in alcoholic solution afforded 2,3-dihydro-2-
(2-hydroxybenzoyl)-4//-furo[3,2-c]benzopyran-4-one 90 and 2-(2-hydroxybenzoyl)-4//-
furo[3,2-c][l]benzopyran-4-one 91. The reaction with benzaldehyde followed the same 
course of reaction and with sal icy 1 aldehyde the product 6//,7//-7-(4-hydroxy-3-
coumaranyl)[l]benzopyrano[4,3-6][l]benzopyran-6-one 92 was isolated (Scheme 44 ). 
The reactions were carried out in refluxing ethanol. The yields of products varied from 
19-73%. 
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92 
Scheme 44. Synthesis of various products from 3-bromo-4-hydroxycoumarin. 
Vilsmeir-Haack reaction of 3-bromo-4-hydroxycoumarin, afforded 
bismethine[l]benzopyran-2,4-dione (93) instead of expected product 3-formyl-4-
hydroxycoumarin (94) (Scheme 45). The reaction was carried out with DMF/POCis with 
stirring at 4 °C. 109 
CHO 
OH 
DMF/POCI, 
94 
^ ^ 
DMF/POCl, 
OH V^(Me)21 
OH N(Me^ Q 
Scheme 45. Synthesis ofbismethine[l]benzopyran-2,4-dione 93 from 3-bromo-4-hydroxy 
coumarin 89. 
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3-Bromo-4-hydroxycoumarin 89 has been converted to various 3-thio-4-
hydroxycoumarins, which were used as intermediates for the synthesis of series of 
heterocyclic derivatives as shown in scheme 46."° 
OH OH 
o' ""o o''''^o'''^^^^-^ 
NaOC2Hj (NH2)2CS 
OH 
l(NH2)2CS 
89 
dil NaOH 
OH 
^ ^-. NH2 
"O ^ O © 
dil NaOH/ N2 
OH 
X-CHR-COOH 
^ 
NaOCzHj 
^ ' ' - ^ NH, 
0 " ^ 0 © ' 
COOH 
O "O 
Scheme 46. Formation of various 3-thio-4-hydroxycoumarin derivatives from 89. 
A new series of 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-6]quinoxalines 
95 was synthesized by shinde et al from 3-bromo-4-hydroxycoumarin 89 as potent 
antimicrobial agents'" (Scheme 47). 
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o^  ^o 
+ Br, 
9 ^ R ' 
N ^ ^ 10 R' 
H 12 11 
R = H, CHj, OCH3, Br, CI, F, NOj 
R ' = H , C H 3 
R 95 
Scheme 47. Formation of product 95 from 89. 
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CHAPTER-2 
SYNTHESIS OF NOVEL CHROMONYL AND PYRAZOLYL 
CHALCONES UNDER GREEN CONDITIONS 
2.1. REVIEW & LITERATURE 
2.1.1. Biological importance 
Chalcones are one of the major class of natural products with widespread distribution in 
fruits, vegetables, spices, tea and soy based foodstuff and has been subject of great 
interest for possessing interesting pharmacological activities.' The chalcones like 
phloretin, arbutin, chalconaringenin, phloridizin are frequent components of human diet. 
Representative examples of naturally occurring bioactive chalcones are xanthohumol, 
cardomonin and flavokawains. Xanthohumol is a principal prenylated flavanoid of the 
hop plant, and is characterized as 'broad spectrum' cancer chemopreventive agents in 
vitro? Cardomonin is a hydroxychalcones isolated from zingiberous plant species, which 
possesses antimutagenic, vasorelaxant and anti-inflammatory properties."* Flavokawains 
are found mainly in the kava plant and have been used in traditional medicine practices of 
the pacific islands.^ 
Chalcones or 1,3-diary 1-2-propene-1-ones, belong to the flavanoid family. Chemically 
chalcones consist of open-chain flavanoids in which two aromatic or heteroaromatic rings 
are joined by three carbons viz a,p-unsaturated carbonyl system. They display a wide 
spectrum of biological activities including antioxidant,^ antibacterial,' antileishmanial,^ 
anticancer,^ antiangiogenic,'^ anti-infective, anti-inflammatory," nitric oxide regulation,'^ 
anti-hyperglycemic,'^ antifungal, antipyretic, bactericidal, insecticidal,''* phytoestrogenic 
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activities'^ etc. Some of the naturally occurring chalcones with varied biological activity 
are listed below. 
2.1.2. Naturally occurring and biologically active chalcones "^ 
2.1.2a. Antibacterial chalcones 
-CHj 
CHj' HO 
Lipochalcone A Lipochalcone C 
H.C 
R ' = piperazine 
R = 4-methylpipera2ine 
R'=0CH2CH2N(CH5)2 
R '=OCH2CH2N(CH3)2 
2.1.2b. Antileishmanial chalcones 
R^=NHCH2CH2N(CH3)2 
R ' = N H C H 2 C H 2 N ( C H J ) 2 
R^=F R ' = H 
R^=CH 2N{CH3)2 R ' = H 
R^= R''= H 
R2=R''=H 
R ' ' = 0 C H 3 
R ' ' = 0 C H 3 
Lipochalcone C /~CH3 
H3C 
OCH. 
OH O 
R'=OH 
R'=H 
R '=H 
R =^H 
R^OH 
OH 
R^=0CH2CH=CH, 
2.1.2c. Antiviral chalcones 
OH 
R ' = R ^ = O H R ^ = R ^ = H 
R '=R^=H, R^^GCHJ, R'*=0H 
R ' = H , R^=R ' '=OH, R^=OCH3 
H3C0 
H3C 
CHO 
OH O OH 
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2.1.2d. Antimalarial chalcones 
0CH3 
Xanthohumol Crotaorixin 
H3CO 
Licoagrochalcone 
2.1.2e. Antifungal chalcones 
OH 
2.1.2f. Anti-inflammatory chalcones 
OH O 
R ' = O H R^= CH2CH=C(CH3)2 
R ' = O H 
R^=CH2CH(OH)C(CH3)=CH2 
R ' = H R ^ = 0 C H 3 
R'=H R^=H 
R' O p l^„2 R ' = R ' ' = * 0 C J H 7 
R ' = R ^ = 0 C 4 H 9 
R ' = R ^ = O C 2 H 5 
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2.1.3. Chemical relevance 
Chalcones are generally synthesized via Claisen-Schmidt condensation carried out in 
basic or acidic media under homogeneous conditions.'^ The reactions carried out in the 
presence of bases include aqueous NaOH,'^KOH,'^ Ba(0H)2,'' zeolites, hydrotalcites,^^ 
LiHDMS,^' calcined NaNOs, natural phosphates^^ etc. A number of acid-catalyzed 
methods are also sited in the literature which includes the use of AlCh,^ ^ dry HCl,^ '' 
Zn(bpy)(OAc)2,^ ^TiCl4,^ ^ Cp2ZrH2/NiCl2^^ and RuCb.^* Recent reports have revealed that 
catalysts like BF3.Et20,^ ^ SOCh/EtOH,^" Bronsted acidic ionic liquids^' etc are also used 
with more or less success. Unfortunately, many of these methods have drawbacks such as 
use of expensive stoichiometric amount of reactants, use of hazardous and 
environmentally polluting solvents, low yields, extended time, tedious procedure etc. 
Thus, the need for the development of an alternative route to construct biologically active 
novel heterocycles by reducing time from hours to minutes at ambient temperature is in 
demand. 
One of the major challenges facing chemists this century is to develop new 
transformations that are not only efficient, selective, and high yielding but also 
environmentally benign.^ ^ During the last decade, the topic of 'green' chemistry has 
received increasing attention.^ "' 'Green' chemistry aims at the total elimination or at least 
the minimization of waste/side products (atom economy) and the implementation of 
sustainable processes. The utilization of non-toxic chemicals, renewable materials and 
solvent-free conditions are the key issues of green synthetic strategy. The application of 
water as an environmentally benign and economically favorable alternative to organic 
solvents has developed into a highly uctive field of research addressing current 
50 
requirements in synthetic chemistry and catalysis. In contrast to common organic 
reaction media, it is nontoxic, non-flammable and cheap.^ ^ Use of water as a solvent is 
undoubtedly the best alternative as there will be no use of hazardous and toxic organic 
solvents and no need for vigorous drying of the solvents. 
In most chemical processes, major adverse effects towards the environment are due 
mainly to the consumption of energy for heating. To overcome this problem it is highly 
desirable to develop efficient methods that use alternative energy sources such as 
microwave irradiation, to facilitate chemical reactions. Ideal industrial chemical 
processes require energy saving, high conversion, high selectivity, and solvent-free 
reaction conditions with minimizing the processes themselves. A microwave heating 
technique is a promising candidate, replacing conventional boilers because microwave-
assisted organic syntheses can lead to large reductions in reaction time and to 
enhancement in conversion and selectivity compared to conventional heating.^ ^ These 
microwave effects could be attributed to the characteristic heating modes of MW through 
the interaction of oscillating electric and magnetic fields with ordered assemblies of polar 
molecules expressed as dielectric loss, leading to unusual phenomenon called 
superheating or hot-spots.^' Instantaneous heat release at the molecular level should 
favorably induce some thermal reactions between molecules which form a polar charge 
transfer state or a polar transition state as often observed in photo induced chemical 
reactions. Recently, the combination of these two prominent green chemistry principles, 
"microwaves" and "water", has become very popular and received substantial interest.^ * 
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2.2. PRESENT WORK 
It is worthwhile to mention here that the chromones form an important component of 
pharmacophores of a number of biologically active molecules of synthetic as well as 
natural origin having significant medicinal applications.^^ Consequently, chromone 
chemistry continues to draw considerable attention of synthetic organic and medicinal 
chemists.''° Chromones are widely distributed in nature, especially in the plant kingdom, 
and a wide spectrum of useful properties of biological importance are associated with 
them. Some of the biological activities ascribed to chromone derivatives include 
cytotoxic,'*'^ •'' p-glycoprotein binding,'"'^  neuroprotective,'"*' HIV inhibitory,'"^ 
antimicrobial,"*'*^^ cyclin-depentant kinase inhibitory,'*"' antifungal'*'' and antioxidant'*'^  
activities. Among the chromone moieties 3-formylchromones 1 are an important and 
well-studied class of 3-substituted chromones, which can serve as the starting materials 
for the synthesis of a broad range of heterocyclic systems due to the presence of three 
electrophilic centers in their molecules (The C-2 and C-4 atoms of the chromone system 
and the carbonyl carbon of 3-formyl group). 
Pyrazole derivatives are another important class of heterocyclic compounds and many 
pyrazole derivatives are reported to have the broad spectrum of biological activities, such 
as antihyperglycemic, analgesic, anti-inflammatory, antipyretic, antibacterial, 
hypoglycemic, sedative-hypnotic,'*^* and anticoagulant activity.'* '^' Recently, some 
arylpyrazoles were reported to show non-nucleoside HIV-1 reverse transcriptase 
inhibitory activity. '^ Extensive studies have been devoted to arylpyrazole derivatives 
such as Celecoxib, a well-known cyclo-oxygenase-2 inhibitor."*^ ^ 
52 
Keeping in view the biological importance of chalcones, chromone and pyrazole 
derivatives it was worthwhile to prepare novel chromonyl chalcones and pyrazolyl 
chalcones by employing 3-fomiy!chromones, 5-chloro-3-methyl-l-phenylpyrazole-4-
carboxaldehyde with various acetylbarbituric acid derivatives under green environment. 
2.3. RESULTS AND DISCUSSION 
Due to the exceptional reactivity of formyl group in 3-fonnylchromone as well as the 
versatile biological activities of chromone and barbituric acid derivatives ''^  several novel 
chromonyl chalcones (3a-0 were synthesized employing 3-formylchromones (la-b), 5-
acetyl-l,3-dimethylbarbituric acid (2a), 5-acetylbarbituric acid (2b) and 5-acetyl 
thiobarbituric acid (2c) (Scheme 1). As a preliminary study, we carried out the synthesis 
of chromonyl chalcones (3a-f) under conventional heating method using ethanol as a 
solvent in the presence of catalytic amount of pyridine. Although, the reactions were 
found to proceed smoothly, it took longer period for completion of reaction (7-16 h) with 
yields (62-79%). Keeping in mind the key principles of 'green' chemistry, we attempted 
the same reactions under microwave irradiation. The results obtained were surprising that 
most of the reactions were found to be completed within 6-11 min with substantial 
increase in yield of products (81-90%). Further the generality of reaction was envisaged 
by using the novel and recently explored Lewis acid catalyst Zn(proline)2'** in 'green 
solvent' water. The results were found to be equally effective (Table 1). The Zn(proline)2 
catalyst was easily preparable, stable, inexpensive and recyclable. The solubility nature of 
the catalyst facilitated the separation of products from the catalyst (Catalyst is soluble in 
water and insoluble in organic solvents). The used catalyst was recycled up to 3 cycles 
without significant loss of its catalytic activity and was used for the next reaction. 
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The infrared (IR) spectrum of 3a (Fig. 1) exhibited a sharp band at 1719 cm' for 
carbonyl groups of barbituric acid moiety. Another strongly absorbed band at 1657 cm' 
accompanied by a notch at 1650 cm"' was assigned to chromone and propenone carbonyl 
groups respectively. The ' H N M R spectrum (Fig. 2) showed trans olefin ic protons Ha 
and Hb of a,P-unsaturated carbonyl system as ortho coupled doublets at S 9.26 (.^15.7 
Hz) and 7.84 (^15.7 Hz) respectively. The value of spin-spin coupling constant Jab in 
the range 15-16 Hz is indicative of the ^-configuration of chalcone. The presence of 
chromone ring was established by the characteristic C-2 singlet at d 8.39 and a double 
doublet for C-5 proton at 6 8.32. The three aromatic protons of chromone moiety were 
discernible in the form of multiplet at d 7.49-7.76. The two N-CH3 protons of barbituric 
acid moiety were present as sharp singlets at S 3.37 and 3.39. Further, the structure was 
confirmed by mass spectrum (Fig. 3), which showed M^at m/z 354. The other important 
peaks were obtained as depicted in Scheme 2. The spectral data of other compounds 
followed similar pattern, and are explained in experimental section. 
Further, efforts were made to synthesize pyrazolyl chalcones (5a-c) employing 5-chloro-
3-methyl-l-phenylpyrazole-4-carboxaldehyde (4) and various 5-acetylbarbituric acid 
derivatives (2a-c) in presence of piperidine both under conventional and microwave 
irradiation method (Scheme 1). Chalcones were obtained in excellent yields (87-92%) 
under microwave irradiation technique in shorter time (6-10 min) and were comparable 
with conventional heating technique results (Table 1). 
The infrared (IR) spectrum of 5a (Fig. 4) showed the carbonyl absorption band of 
barbituric moiety at 1715 cm"'. The carbonyl group of propenone moiety appeared as 
strong and sharp absorption band at 1664 cm"'. Another sharp and strongly absorbed band 
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at 1618 cm' was assigned to carbon-carbon double bond of a,P-unsaturated system. The 
'H N M R spectrum (Fig. 5) showed trans olefinic protons Ha and Hb as ortho coupled 
doublets at S 8.55 {J=\5.9 Hz) and 8.00 {J=\62 Hz) respectively. The aromatic protons 
of pyrazole moiety were present in the form of multiplet at d 7.42-7.58. The N-CH3 
protons of barbituric acid moiety were discernible as two sharp singlets at 5 3.37 and 3.40 
whereas protons of CH3 group of pyrazole unit appeared as another sharp singlet at d 
2.59. Further confirmation of the structure was established by mass spectrum (Fig. 6), 
which showed M* at 400.12 as base peak. The spectral data of other compounds followed 
similar pattern. 
Tabic I. Synthesis of chromonyl and pyrazolyl chalcones. 
Entry Product In refluxing In refluxing Microwave 
ethanol/ methanol water irradiation 
1 
2 
3 
4 
5 
6 
7 
8 
9 
3a 
3b 
3c 
3d 
3e 
3f 
5a 
5b 
5c 
- No reaction 
Time 
7h 
7.5 h 
16h 
16h 
14h 
15 h 
12 h 
14 h 
8h 
Yield 
(%) 
78 
79 
62 
72 
74 
74 
72 
70 
78 
Time 
20min 
20min 
30 min 
30 min 
25 min 
30 min 
-
-
-
Yield 
(%) 
86 
84 
16 
79 
81 
80 
-
-
-
Time 
6 min 
6 min 
6 min 
9 min 
9 min 
11 min 
7 min 
10 min 
6 min 
Yield 
(%) 
88 
88 
81 
88 
90 
84 
90 
87 
92 
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Q O 
Ethanol /Pyridine, 
reflux , 
H H3C—C—Q *• R ^ 5 
+ II or Water/ Zn(proIine)2, 
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2a-c 
O Hb 9 
a=R=H 
b=R=CH3 
HiC 
N . 
3a= R=H Q= I I 3b=R=CH3 Q= J f 
/ C H 3 
CH3 
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CH3 
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Q= I I 3d=R=CH3 Q= J I 
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O 
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Scheme 1. Synthesis ofchromonyl chalcones (3a-J) andpyrazolyl chalcones (5a-c). 
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CH, 
m/z 279 
Scheme 2. Mass fragmentation of 3a. 
2,4. CONCLUSION 
In conclusion, we have developed green synthetic approaches for the generation of novel 
series of chromonyl and pyrazolyl chalcones in excellent yields. Further, first time novel 
synthesis of chromonyl chalcones was achieved under the influence of recyclable 
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Zn(proline)2 as Lewis acid catalyst in good yields. The experimental simplicity, excellent 
yields, short reaction times, mild reaction conditions, high purity, solvent-free or usage of 
water as a 'green solvent' and Zn(proline)2 as an efficient recyclable catalyst etc are the 
noteworthy advantages of the present procedure. 
2.5. EXPERIMENTAL 
Melting points were taken in Riechert Thermover instrument and are uncorrected. The IR 
spectra were recorded on Perkin Elmer RXI spectrometer in KBr, 'H NMR on Bruker 
DRX-300 and Bruker Avance 11 400 spectrometer using tetramethyl silane (TMS) as the 
internal standard and DMSO-de/CDCb as solvent. Mass spectra were obtained Jeol-SX-
102 (FAB), JEOL-Accu TOP JMS-TIOOLC DART-MS and Micro mass Quattro II triple 
quadrupol mass spectrometer. The microanalytical data were collected on Elementar 
vario EL Hi elemental analyzer. 3-Formylchromone and substituted-3-
formylchromone,''^ 5-chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde,''^ 5-
acetyl-l,3-dimethylbarbituric acid, 5-acetylbarbituric acid, 5-acetylthiobarbituric 
acid,''^ Zn(proline)2''^ were synthesized by reported methods. All other chemicals 
used were purchased from Merck (Mumbai, India), Fluka Chemicals 
(Switzerland) and used without further purification. The purity of the compounds 
was checked by thin layer chromatography (TLC) on glass plates coated with silica gel 
G254 (E.Merck) using chloroform-methanol (3:1) mixture as mobile phase and visualized 
by iodine vapors. All the experiments under microwave irradiation were carried out in a 
domestic microwave oven (National, Model NN-S557WF, 1.3 KW, 2450 MHz). 
2.5.1. Preparation of chromonyl chalcones (3a-f) under thermal heating condition 
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To a well stirred solution of 5-acetyl-l,3-dimethyibarbituric acid (5.05 mmol)/5-acetyl 
barbituric acid (5.05 mmol)/5-acetylthiobarbituric acid (5.05 mmol) in ethanol (25 mL) 
containing pyridine (0.5 mL), 3-formylchromone/substituted-3-formylchromone (5.05 
mmol) was added. The reaction mixture was then refluxed in a heating mantle for 7-16 h 
(Table 1) and cooled at room temperature. The solid, thus, obtained was filtered, washed 
with water, alcohol and dried to afford 3a-f. 
2.5.2. Preparation of chromonyl chalcones (3a-f) under microwave irradiation 
condition 
3-Formylchromone/substituted-3-formylchromone (5.05 mmol), 5-acetyl-K3-
dimethylbarbituric acid (5.05 mmol)/5-acetylbarbituric acid (5.05 mmol)/5-
acetylthiobarbituric acid (5.05 mmol) and pyridine (0.3 mL) were mixed thoroughly in a 
mortar, and air dried. The reaction mixture was then transferred to an open Pyrex beaker 
and subjected to microwave irradiation (Muitimode, full power). The progress of reaction 
was monitored by TLC and on completion, the reaction mixture was slurred in water (40 
mL). The solid, thus, obtained was filtered, washed with water, alcohol and dried to 
afford 3a-f. 
2.5.3. Zn(proline)2-cataIyzed synthesis of chromonyl chalcones (3a-f) in water 
A mixture of 3-formylchromone/substituted-3-formylchromone (5.05 mmol), 5-acetyl-
1,3-dimethylbarbituric acid (5.05 mmol)/5-acetylbarbituric acid (5.05 mmol)/5-
acetylthiobarbituric acid (5.05 mmol) and Zn(proline)2 (0.30 mmol) was dissolved in 
water (14 mL) and refluxed on a heating mantle for specified time (Table 1). After 
completion of the reaction (monitored by TLC), it was allowed to cool to room 
temperature. The reaction mixture was extracted with dichloromethane, dried over 
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anhydrous Na2S04, concentrated to furnish crude product, which was then recrystallized 
from suitable solvents. The catalyst was recovered by simple separation of aqueous and 
organic phases. The catalyst present in the aqueous layer was used for the subsequent 
reactions. 
Spectral data 
(2£)-l-(l,3-DimethyI-2,4,6-pyrimidinetrione-5-yI)-3-(4-oxo-4/?^-l-benzopyran-3-yl)-
2-propene-l-one (3a) 
Purified by recrystallization from chloroform. 
Bright yellow crystals. 
M.p 
IR(KBr)un,ax/cm"' 
' H N M R ( 4 0 0 M H Z , CDCb) 
MS-FAB (% rel. Int.) 
>300 °C. 
1657 (C=0), 1719 (C=0). 
S (ppm) 3.37 (s, 3H, N-CH3), 3.39 (s, 3H, N-
CH3), 7.49-7.76 (m, 3H, Ar-H), 7.84 (d, IH, 
^15 .7 Hz, Hb), 8.32 (dd, 1H, C-5), 8.39 (s, 
1H, C-2), 9.26 (d, IH, J= 15.7 Hz, Ha). 
m/z 354 (M^ 80), 353 (60), 336 (30), 307 
(65), 279 (5), 199(15), 171 (50), 155(50) 
154(100), 136(90), 122(5), 107(50). 
Elemental analysis for 
C,xH,4N20„ Calculated C, 61.02; H, 3.98; N 7.91; 
Found C, 61.05; H, 3.83; N, 7.84 %. 
(2£)-1 -(1,3-Dimethyl-2,4,6-py riniidinetrione-5-yl)-3-(6-methyl-4-oxo-4//-1 -
benzopyran-3-yl)-2-propene-l-one(3b) 
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Purified by recrystallization from chloroform. 
Bright yellow crystals. 
M.p : 
IR(KBr)i),™x/cm"' : 
' H N M R ( 4 0 0 M H Z , CDCb) : 
MS-FAB (% rei. Int.) 
>300 °C. 
1666 (C=0), 1716 (C=0). 
S (ppm) 2.48 (s, 3H, CH3), 3.38 (s, 3H, N-
CH3), 3.40 (s, 3H, N-CH3), 7.31-7.46 (m, 
3H, Ar-H), 7.87 (d, IH, ^ 1 6 . 3 Hz, Hb), 
8.27 (s, IH, C-2),9.18(d, lH,J=l5.8Hz, 
Ha). 
m/z 368 (M^ 30), 367 (10), 213 (5), 212 
(20), 155 (30), 154 (100), 136 (60), 122 
(30), 108(50). 
Elemental analysis for 
C19H16N2O6 : Calculated C, 61.95; H, 4.38; N, 7.61; 
Found C, 61.86; H, 4.27; N, 7.58 %. 
(2£)-3-(4-Oxo-4^-l-benzopyran-3-yI)-l-(2,4,6-pyrimidinetrione-5-yl)-2-propen-l-
one (3c) 
Purified by recrystallization from methanol-DMF (3:2 v/v) mixture. 
Bright yellow solid. 
M.p : >300 °C. 
IR (KBr) u„n,x/cm"' : 1643 (C=0), 1740 (C=0), 3078 (NH) 3200 
(NH). 
'H N M R (300 MHz, DMS0-d6) S (ppm) 7.40 (d, IH, J=15.2 Hz, Hb), 7.55-
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7.91 (m, 3H, Ar-H), 8.17 (dd, 1H, J= 
8.0 Hz, 1.6 Hz, C-5), 8.95 (s, IH, C-2), 9.09 
(d, lH,J=15.9Hz, Ha), 11.06(s, 1H,NH), 
11.76(s, 1H,NH). 
MS-FAB (% rel. Int.) : tn/z l>l(i (M^ 60), 325 (5), 279 (25), 251 
(5), 206 (10), 199 (70), 171 (65), 143 (40), 
99(5). 
Elemental analysis for 
C16H10N2O6 : CalculatedC, 58.90; H, 3.08;N, 8.58; 
Found C, 58.57; H, 3.14; N, 8.44 %. 
(2£)-3-(6-Methyl-4-oxo-4.ff-l-benzopyran-3-yl)-l-(2,4,6-pyrimidinetrione-5-yl)-2-
propen-1-one (3d) 
Purified by recrystallization from methanoi-DMF (3:2 v/v) mixture. 
Yellow solid. 
M.p : >300 °C. 
IR (KBr) uniax/cm' : 1647 (C=0), 1746 (C=0), 3025 (NH), 3188 
(NH). 
'HNMR(400MHz, DMSO-da) : ^ (ppm) 2.49 (s, 3H, CH3), 7.43-8.01 
(m, 3H, Ar-H), 7.87 (d, IH, J=15.8 Hz, Hb), 
8.44 (s, IH, C-2), 8.96 (d, lH,J=I5.8Hz, 
Ha), 10.71 (s, 1H,NH), 11.57(s, 1H,NH). 
MS-ESl : m/z 340.4 (M^), 321.6, 274.6, 214.4, 
213.4,202.6. 
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Elemental analysis for 
C17H12N2O6 : Calculated C, 60.00; H, 3.55; N, 8.23; 
Found C, 59.91; H, 3.61; N, 8.34 %. 
(2£)-l-(2-Mercapto-4,6-pyrimidinedione-5-yl)-3-(4-oxo-4.&-l-benzopyran-3-yl)-2-
propene-1-one (3e) 
Purified by recrystallization from methanol-DMF (3:2 v/v) mixture. 
Yellow solid. 
M.p 
lR(KBr)i)nn,x/cm"' 
'H NMR (300 MHz, DMSO-dg) 
: >300 °C. 
: 1060 (C=S), 1648 (C=0), 3027 (NH), 3189 
(NH). 
: d (ppm) 7.55-7.89 (m, 3H, Ar-H), 7.77 (d, 
lH,J=16.2Hz, Hb), 8.17(d, IH,J=7.8Hz, 
C-5), 8.99(8, lH,C-2), 9.09 (d, IH,J = 15.0 
Hz, Ha), 12.55 (s, 1H,NH), I2.61(s, IH, 
NH). 
MS-ESI : W/Z342.07 (M^), 341.06,324.10, 199.07, 
171.07,79.05. 
Elemental analysis for 
C16H10N2O5S : CalculatedC, 56.14; H, 2.94; N, 8.18. 
Found C, 56.04; H, 2.98; N, 8.01 %. 
(2£)-l-(2-Mercapto-4,6-pyrimidinedione-5-yl)-3-(6-methyi-4-oxo-4//-l-benzopyran-
3-yI)-2-propene-l-one (3f) 
Purified by recrystallization from methanol-DMF (2:3 v/v) mixture. 
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M.p : >300 °C. 
IR(KBr) Umax/cm"' : 1004 (C=S), 1652 (C=0), 3018 (NH), 3106 
(NH). 
' H N M R ( 4 0 0 M H Z , DMSO-dfe) : d (ppm) 2.49 (s, 3H, CH3), 7.47-7.97 (m, 
3H, Ar-H), 7.87 (d, IH, J =15.7 Hz, Hb). 
8.67 (s, IH, C-2), 9.04 (d, IH, J=15.8 Hz, 
Ha), 12.19 (s, 1H,NH), 12.73 (s, IH, NH). 
MS-ESl : w/z356.6(M^), 339.6,338.6,321.6,213.4. 
Elemental analysis for 
C17H12N2O5S : Calculated C, 57.30; H, 3.37; N, 7.86. Found 
C, 57.43; H, 3.51 ;N, 7.73%. 
2.5.4. Preparation of pyrazolyl chalcones (5a-c) under thermal heating conditions 
To a well stirred solution of 5-acetyl-l,3-dimethylbarbituric acid (5.05 mmol)/5-
acetylbarbituric acid (5.05 mmol)/5-acetylthiobarbituric acid (5.05 mmol) in methanol 
(20 mL) containing piperidine (0.2 mL), 5-chloro-3-methyl-l-phenylpyrazole-4-
carboxaldehyde (5.05 mmol) was added. The reaction mixture was then refluxed in a 
heating mantle for 8-14 h, cooled at room temperature. The bright yellow solid, thus, 
obtained was filtered, washed with water, alcohol and dried to afford 5a-c. 
2.5.5. Preparation of pyrazolyl chalcones (5a-c) under microwave irradiation 
conditions 
5-Chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde (5.05 mmol), 5-acetyl-i,3-
dimethylbarbituric acid (5.05 mmol)/5-acetyIbarbituric acid (5.05 mmol)/5-
acetylthiobarbituric acid (5.05 mmol) and piperidine (0.2 mL) were mixed thoroughly 
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with the help of pestle in a mortar, and air dried. The reaction mixture was then 
transferred to an open Pyrex beaker and subjected to microwave irradiation (Multimode, 
full power). The progress of reaction was monitored by TLC and on completion, the 
reaction mixture was slurred in water (30 mL). The solid, thus, obtained was filtered, 
washed with water, alcohol and dried to afford 5a-c. 
(2£)-3-(5-Chloro-3-methyl-l-phenylpyrazoI-4-yI)-l-(l,3-dimethyl-2,4,6-
pyriinidinetrione-5-yl)-2-propen-l-one(5a) 
Purified by recrystallization from chloroform. 
Yellow crystals. 
M.p. 
lR(KBr)D„,ax/cm"' 
' H N M R ( 3 0 0 M H Z , CDCI3) 
263-266 °C. 
: 1618 (C=C), 1664 (C=0), 1715 (C=0). 
: S (ppm) 2.59 (s, 3H, CH3), 3.37 (s, 3H, N-
CH3), 3.40 (s, 3H, N-CH3), 7.42-7.58 (m, 
5H, Ar-H), 8.00 (d, IH, J = 16.2 Hz, Hb), 
8.55 (d, IH,J = 15.9Hz, Ha). 
MS-ESI : w/z 400.12. (M^). 
Elemental analysis for 
C|c,H|7N404Cl : CalculatedC, 56.93; H, 4.27; N, 13.97. 
Found C, 56.76; H, 4.38; N, 13.91 %. 
(2£)-3-(5-Chloro-3-niethyl-l-phenylpyrazol-4-yI)-l-(2,4,6-pyriinidinetrione-5-yi)-2-
propen-1-one (5b) 
Purified by recrystallization from methanol-DMF (3:2 v/v) mixture. 
White powder. 
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M.p 
IR(KBr)unK,x/cm-
'H N M R (400 MHz, DMSO-ds) 
MS-FAB (% rel. Int) 
: >300 °C. 
: 1601 (C=C), 1657 (C=0), 1698 (C=0), 
3069 (NH), 3193 (NH). 
: S (ppm) 2.62 (s, 3H, CH3), 7.47-7.85 (m, 5H, 
Ar-H), 8.32 (d, IH, J=15.8 Hz, Hb), 
9.01 (d, l H , J = 15.8Hz, Ha), n.45(s, IH, 
NH), 11.60(s, 1H,NH). 
: m/z 372 (M^ 75), 371 (55), 336 (10), 261 
(20), 260 (10), 232 (40), 214 (15), 157 
(100). 
Elemental analysis for 
C|7H,3N404CI : CalculatedC, 54.77; H, 3.51; N, 15.02. 
Found C, 54.86; H, 3.64; N, 15.08 %. 
(2£)-3-(5-Chloro-3-methyl-l-phenylpyrazoI-4-yl)-l-(2-mercapto-4,6-
pyrimidinedione-5-yI)-2-propen-l-one(5c) 
Purified by recrystallization from methanol-DMF (3:2 v/v) mixture. 
Yellow powder. 
M.p. 
IR(KBR)uni.x/cm"' 
'H NMR (400 MHz, DMSO-ds) 
>300 °C. 
1057 (C=S), 1608 (C=C), 1647 (C=0), 1746 
(C=0), 3056 (NH), 3188 (NH). 
S (ppm) 2.56 (s, 3H, CH3), 7.47-7.97 (m, 5H, 
Ar-H), 7.87 (d, IH, /=15.7 Hz, Hb), 
9.04 (d, lH,J=15.8Hz, Ha), 12.19(s, IH, 
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MS-ESI 
Elemental analysis for 
C17H13N4O3SCI 
NH), 12.73 (s, 1H,NH). 
m/z 388.6 (M^), 361.6, 360.6, 310.6, 274.6, 
202.6. 
Calculated C, 52.51; H, 3.36; N, 14.40. 
Found: C, 52.57; H, 3.44; N, 14.32 %. 
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CHAPTER-3 
MICROWAVE-ASSISTED SOLVENT-FREE SYNTHESIS OF 
BIOLOGICALLY IMPORTANT NOVEL HETEROCYCLES FROM 
CHALCONES 
3.1. REVIEW & LITERATURE 
3.LL Biological importance 
Oxygen and nitrogen heterocycles are much sought after compounds in recent years 
because of their pronounced pharmacological activities. They are acquiring much 
significance in the field of drug designing processes. Condensation of nitrogen-containing 
binucleophilic reagents with a,P-unsaturated ketones is one of the most suitable synthetic 
pathway to the formation five, six membered partially hydrogenated heterocyclic 
compounds, which are potential pharmaceutical analogs.' High regioselectivity of the 
discussed reaction owing to the pronounced difference in electrophilic parameters of 
carbonyl and P-carbon reaction centers is the most important advantage of this reaction, 
which allows to synthesize several hardly accessible compounds, over the widely known 
analogous reactions of a,p-unsaturated ketones. 
Among the various heterocyclic compounds, derivatives of chalcones, pyrazolines 
occupy a unique position in biologically active compounds. Considerable interest has 
been focused on the pyrazoline structure, which has been known to possess a broad 
spectrum of biological activities such as tranquillizing, muscle relaxant, psychoanaleptic, 
and antidepressant activities.^ "^ The discovery of this class of drugs provides an 
outstanding case history of modem drug development and points out the unpredictability 
of biological activity from structural modification of a prototype drug molecule. 
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Literature survey reveals that numerous pyrazoline derivatives have found their clinical 
applications as non-steroidal anti-inflammatory drugs (NSAIDs). Antipyrine (2,3-
Dimethyl-l-phenyl-3-pyrazolin-5-one) was the first pyrazolone derivative used in the 
management of pain and inflammation. Several analogues of pyrazolidin-3,5-diones, 
pyrazolin-3-ones and pyrazolin-5-ones are also available as NSAIDs, e.g. felcobuzone, 
famprofazone, and ramifenazone.^ Besides these, many pyrazoline derivatives are also 
reported in literature as having potent anti-inflammatory activity.^ Moreover, pyrazolines 
and their derivatives have been reported to possess antibacterial, anticonvulsant, 
antihypertensive,^ antioxidant,'° antitumor" and anticancer activities.'^ Recently these 
classes of compounds are reported to show potential antiviral activity against flavivirus'^ 
and HIV.''* ]-Unsubstituted-3,5-diaryl-2-pyrazolines were reported to exhibit human 
Acyl CoA cholesterol acyltransferase activity,'^ as well as activity of low-density 
lipoprotein oxidation inhibitors.'^ In addition, l,3,5-triaryl-2-pyrazolines were reported to 
possess antidepressant properties'^ and monoamine oxidase (MAO) inhibitory 
activities.'^ Some recently explored pyrazoline derivatives with important biological 
activity are listed below. 
3.1.2. Biologically Important pyrazolines 
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3.1.2a. Antibacterial pyrazolines'^ 
R= H, OH, 2,6-OH, 2,4-OH 
R ' = 4 - C 0 C H 3 
R^= 4-Cl, 4-OCH3, 3,4-OCH3,2,4- OCH3 
.2,4 20,12a 3.l.2h. Antidepressant" and anticancer active ' pyrazolines 
R'=H,OH 
R^= H, CH3, Br, OH, OCH3 
R^= H, Br, OCH3. CI 
R''=H, N(CH3)2,OCH3 
OCH, 
OCH, 
J 2= R^=H,Cl,Br,0CH3 
R ' = H . C 1 
Antidepresssant pyrazolines 
OCR, 
R=H, 2-OCH3 
CO-CH 
Anticancer active pyrazolines 
OCH, 
' - ^ ^ 
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3.1.2c. Anti-inflammatory, analgesic^' and antitubercularpyrazolines^^ 
N N. 
H 
R= H, 2-Cl, 4-Cl, 4-CH3, 4-OCH3, 
3,4-(OCH3)2, 2,4,6-(OCH3)3 
R= H, OH 
R'=H,OH 
R^= H, CI, OH, OMe, 2-Thiophenyl, 2-Furfur>l 
R^= OMe, H 
J 4 = 
Anti-inflammatory and analgesic pyrazolines 
R^= H, CI, OMe, OH 
R'= H, OMe 
R''= H, OMe 
Antitubercular pyrazolines 
3.1.3. Chemical relevance 
Many pyrazoline derivatives also found applications as dyestuffs, analytical reagents and 
agrochemicals.^^ It was more than a hundred years ago that Fischer and Knovenage! 
described the synthesis of a pyrazoline by the reaction of phenylhydrazine and acrolein.^ '* 
This report is probably the first example of pyrazoline formation by the reaction of an a, 
p-unsaturated carbonyl compound with a hydrazine derivative. Formation of l-phenyl-2-
pyrazoline in this way was corroborated by Auwers et al}^ Following these pioneering 
investigations, the reaction of a,|3-unsaturated carbonyl compound with hydrazines made 
possible the preparation of innumerable pyrazolines. 
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The reaction generally proceeds through the formation of hydrazone intermediate. The 
solubility, stereochemistry and electron distribution of hydrazones may influence the ring 
closure reaction providing 2-pyrazolines.^ ^ The reactions carried out in acetic acid with or 
without the isolation of the intermediate hydrazone is the commonly used efficient 
procedure for the preparation 2-pyrazolines in high yields?^ Hydrazines and a,P-
unsaturated ketones have also been allowed to react in a hot alcohol solution^^ or in a 
boiling mixture of benzene with ethanol.^' Reaction of a,P-unsaturated ketone with 
phenylhydrazine in refluxing pyridine also affords 2-pyrazolines?° The mechanism of 
these reactions providing 2-pyrazolines has also been investigated under various reaction 
conditions. On the basis of numerous experimental results, it can be concluded that the 
reaction of a, P-unsaturated ketones 1 and hydrazines 2 in acidic medium leads to 2-
pyrazolines via hydrazones 3 as intermediates. However, in the presence of piperidine, 
Michael addition takes place providing p-hydrazinoketones 4 instead of hydrazones 3 
formed from the same starting materials in acetic acid (Scheme 1) 
H 
I _ 
" ^^  ~Si ~^ ~^i ~^^ "*• R—NM -NH 2 
O 1 H 2 
Acetic acid / \ P i p e r i d i n e 
H 
Het—C—C==C—Ar ^ gj _ ( - . _ c _ c —Ar 
N H II I 
I ^ O N H - N H - R 
NH-R 
3 
Ar 
H et C ^ N 
N 
I 
R 
5 
Scheme 1. Mechanism of formation of 2-pyrazolines. 
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3.2. PRESENT WORK 
Now, with growing concern over the environmental impact of chemicals, cleaner green 
reaction conditions in synthetic processes have been advocated. One of the most 
attractive concepts in chemistry for sustainability is 'green' chemistry, which is the 
utilization of a set of principles that reduces or eliminates the use or generation of 
hazardous substances in the design, manufacture, and applications of chemical 
products.^' It should be noted that the rapid development of green chemistry is due to the 
recognition that environmentally friendly products and processes will be economical on a 
long term. The tight legislation to maintain greenness requires us to prevent the 
generation of waste, avoid the use of auxiliary substances (e.g., organic solvents, 
additional reagents), and minimize the energy requirement.^^ Microwave heating 
technique has attracted the attention of investigators in that it makes it possible to shorten 
the length of reactions significantly, to increase their selectivity, and to increase the 
product yields, which is particularly important in the case of high-temperature processes 
that take a long time. In the last decade microwave radiation (MWR) has been used more 
and more often in organic synthesis.^ ^ In most cases the investigations are carried out in 
domestic-type microwave ovens or in equipment for the preparation of samples and 
analysis (digests). 
Based on above findings we, herein, report the synthesis of a series of novel biologically 
important heterocyclic derivatives of chalcones both under conventional heating 
procedure and under the green environment assisting microwave irradiation technique. 
The present study also compares the efficacy of reaction techniques under the 
conventional and the microwave irradiation methods. 
83 
3.3. RESULTS AND DISCUSSION 
Condensation of a,P unsaturated ketone with nitrogen bases gives the corresponding 
pyrazolines.^ '* With the objective of synthesizing pyrazolines containing chromone and 
pyrazole moieties, chromonyl chalcones (la-c), and pyrazolyl chalcones (3a-c) were 
synthesized by Claisen Schmidt condensation as explained in the second chapter. The 
resulting chalcones were treated with variously substituted hydrazines. Initially reactions 
were attempted under conventional heating procedure using glacial acetic acid and 
catalytic amount of sodium acetate, which afforded the products 2a-h, 4a-c in 56-75% 
yield in a span of time period (20 min-i2 h) (Scheme 2, 4). However, microwave 
irradiation technique when applied increased yields of the products (78-94%) within 
shorter period of time (3-9 min) (Table 1). All the compounds isolated were purified by 
recrystallization from suitable solvents (Compounds have only partial solubilities in 
solvents like chloroform, dichloromethane, methanol, ethanol, benzene, ethyl acetate etc 
and were completely soluble in DMF, DMSO etc.) and characterized by elemental and 
spectral analysis (IR, ' H NMR, mass spectra). 
The IR spectrum of 2a (Fig. 1) displayed a band at 3285 cm"' due to the presence of NH 
group of pyrazoline moiety. The absorption bands for barbituric acid and chromone 
carbonyl groups were present at 1698 and 1649 cm"' respectively. The 'H NMR spectrum 
of the compound (Fig. 2) showed the diagnostic singlet of C-2 olefin ic proton of the 
chromone moiety at <5 8.20, which clearly indicated that the pyrone moiety in the 
compound did not suffer ring cleavage by the attack of nitrogen base.^ ^ This fact was 
further supported by the presence of doublet of doublet of C-5 proton appeared at (5 8.14. 
The remaining three aromatic protons of chromone nucleus appeared as multiplet at 5 
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lAl-1.16. The presence of pyrazoline unit was established by three doublet of doublet at 
5 3.66 (Hd), 4.01 (He) and 4.87 (He). A sharp singlet at 5 3.36 integrating for six protons 
was assigned to two N-CHj groups. The Mass spectrum of the compound (Fig. 3) showed 
M^ at m/z 368. The other peaks were obtained as shown in Scheme 3. 
Table 1. Synthesis of derivatives of chalcones (2a-7). 
Entry Product Thermal heating 
method 
Microwave 
irradiation technique 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
2a 
2b 
2c 
2d 
2e 
2f 
2g 
2h 
4a 
4b 
4c 
5 
Time 
Ih 
Ih 
20min 
l l h 
10.5 h 
30min 
12h 
1.5 h 
Ih 
45 min 
45 min 
14 h 
Yield 
(%) 
74 
74 
68 
63 
65 
65 
75 
56 
72 
70 
72 
76 
Time 
3 min 
3 min 
3 min 
7 min 
6 min 
3 min 
9 min 
3 min 
5 min 
4 min 
5 min 
7 min 
Yield 
(%) 
94 
92 
84 
86 
86 
82 
89 
78 
84 
82 
82 
92 
13 
14 
15 
-
6a 
6b 
7 
Not a 
20 min(RT) 
20 min(RT) 
28 h (RT) 
ttempted 
82 
80 
78 3 min 90 
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H, O 
R'NHNH. 
Q R 
Acetic acid / NaOAc, reflux 
orMW 
O 
=R=H Q = 
N 
CHj 
O^ N ^ O 
I 
CH3 
O 
b =R =CH, 
O^ N O 
I 
CH3 
O 
c = R=H Q = 
,H 
N 
O^ N O 
I 
H 
R 
2a H 
2b CH3 
2c H 
2d H 
2f H 
2h H 
R' 
H 
H 
H 
C6H5 
2e CHi CM 6"5 
C6H5 
2a-h 
Q 
O 
CH3 
O 
CH3 
O 
H 
O 
rCH-, 
CH3 
O 
j^N-CH3 
CH3 
O 
H 
O 
^  " -^ :iD o4C 
N 
CH3 
o 
H 
Scheme 2. Synthetic route of compounds 2a-h. 
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• ^ 
N N^ 
.N 
N—CH, 
k>x., ^ /CHJ 
-co 
H,C „,c-^^^-0-o 
wzlSS ffi/z 166 
2[-C0] (—C=CH) 
Scheme 3. Mass fragmentation of 2a. 
The IR spectrum of 4a (Fig. 4) showed a broad absorption band at 3200 cm"' indicating 
the NH group of pyrazoline moiety. The carbonyl absorption band of barbituric acid unit 
appeared at 1709 cm'. In 'H N M R spectrum of 4a (Fig. 5), the presence pyrazoline unit 
was manifested by the presence of two doublets of doublets at d 3.58 (Ha), 4.05 (He) and 
a doublet at 4.80 (He). The NH proton of pyrazoline unit appeared as broad singlet at d 
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6.95. The N-CHj protons were present as sharp singlet at S 3.34 whereas the three 
protons of CH3 group of pyrazole unit were discernible as another sharp singlet at S 2.24. 
The five aromatic protons were present as multiplets in the range of S 7.48-7.52. Further 
evidence of the structure was given by mass spectrometry (Fig. 6), which has shown M^ 
ion peak at 414.15 as base peak 
Ha o 
H3C, NH2NH2 
>- H3C 
Acetic acid / NaOAc, reflux 
orMW 
O 
4a= Q = 
N 
.CH, 
C ' N ' ^O 
I CH3 H 
Scheme 4. Synthesis of pyrazolylpyrazolmes (4a-c). 
Due to remarkable pharmacological activities exhibited by dihydropyrimidine 
derivatives^^ attempts were also made to synthesize dihydropyrimidine derivative of 
chalcone by reacting la with urea in the presence of NaOH in ethanol under conventional 
heating method and in solvent-free condition (Scheme 5). The reaction mixture as 
visualized, afforded 5 in quantitative yield (Table 1). The formation of 
dihydropyrimidine nucleus in 5 was established on the basis of 'H N M R spectrum (Fig. 
8) which showed two doublet of doublet at 5 3.20 (Hd), and 4.88 (He) whereas, the signal 
for He proton at d liAl is merged with N-CH3 protons of barbituric acid moiety. Slightly 
broad singlet (D2O exchangeable) at S 14.12 was assigned to OH proton. The other peaks 
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were obtained as explained in the experimental part. The mass spectrum (Fig. 9) further 
confirmed the structure of compound 5 by displaying M* at 396. 
0 
Q + H2N—C—NH2 
Ethanol/NaOH, 
reflux 
orMW e Hd 
O 
Q= A CH-, 
CH3 
Scheme 5. Synthesis of dihyropyrimidine derivative 5. 
a,P-Dibromodihydrochalcones are interesting intermediates for the synthesis of various 
biologically active heterocycles such as pyrazoles, pyrazolines, pyrimidines etc.^ ^ On the 
basis of these findings, bromination of heterochalcones was also attempted (Scheme 6). 
Thus, the reaction of heterochalcones la-b with Br2 in chloroform at room temperature 
afforded 2,3-dibromodihydrochalcones 6a-b in quantitative yield. The 'H N M R spectrum 
of the 6a (Fig. 11) showed two doublets attributable to Ha and Hb protons at 5 5.56 and 
7.76 with coupling constant of 11.3 Hz, which was in accordance to the erythro 
configuration. Further 6a was transformed to pyrazole derivative 7 in dry pyridine at 
room temperature and in solvent-free condition by carrying out reaction with hydrazine 
as shown in Scheme 7. The compound 7 showed a sharp singlet at 6 7.94 due to He 
proton of pyrazole moiety in its ' H NMR spectrum (Fig. 14). A broad singlet at 5 10.31 
was assigned to NH proton. The other peaks were present at their normal values and are 
mentioned in the experimental section. 
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a = R - H 
b = R =C H3 b = R = CH3 o ^ ^ ^ o 
CH3 
Scheme 6. Synthesis of dihromodihydro chalcones 6a-b. 
Br 9 
° + NH2NH2 Pyridine/RT^ 6 
Br °'^^ 7 
6a 
HN N 
Scheme 7. Synthesis ofpyrazole derivative (7) from dihromodihydro chalcone 6a. 
3.4. CONCLUSION 
In summary, we have described the synthesis of hitherto unknown 3-substituted 
chromone and 4-substituted pyrazole derivatives from readily synthesized starting 
materials, available reagents along with short reaction time, simple workup and isolation 
etc under green' reaction conditions, which making the current method feasible and 
attractive protocol for generation of series of novel heterocycles. The notable advantages 
of this procedure are: (a) reasonably good yields; (b) shorter reaction times; (c) mild 
reaction conditions; (d) reduction in unwanted side reactions (e) green synthesis avoiding 
toxic reagents and solvents. Thus, the present work describes the superiority of green 
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synthetic method over conventional solvent heating procedures and it added an efficient 
methodology for the generation of novel oxygen and nitrogen heterocycles in excellent 
yields, to the existing conventional solvent heating techniques. 
3.5. EXPERIMENTAL 
Melting points were taken in Riechert Thermover instrument and are uncorrected. The IR 
spectra were recorded on Perkin Elmer RXI spectrometer in KBr, ' H N M R on Bruker 
DRX-300 and Bruker Avance II 400 spectrometer using tetramethyl silane (TMS) as the 
internal standard and DMSO-de/CDCb as solvent. Mass spectra were recorded on JEOL-
Accu TOP JMS-TIOOLC DART-MS spectrometer, Micromass Quattro II triple 
quadrupol mass spectrometer and Jeol-SX-102 (FAB) spectrometer. The microanalytical 
data were collected on Elementar vario EL III elemental analyzer. Chalcones la-c, 5a-c 
were synthesized by Claisen Schmidt condensation reaction as explained in 
chapter-2. Hydrazinobenzothiazole was synthesized by reported method.^^ All 
other chemicals used were purchased from Merck (Mumbai, India), Fluka 
Chemicals (Switzerland) and used without further purification. The purity of the 
compounds was checked by thin layer chromatography (TLC) on glass plates coated with 
silica gel G254 (E. Merck) using chloroform-methanol (3:1) mixture as mobile phase and 
visualized by iodine vapors. All the experiments under microwave irradiation were 
carried out in a domestic microwave oven (National, Model NN-S557WF, 1.3 KW, 2450 
MHz). 
3.5.L Preparation of pyrazolines (2a-h) under thermal heating condition 
The mixture of la-c (2.52 mmol), hydrazine hydrate (2.52 mmoI)/phenylhydrazine (2.52 
mmoi)/hydrazinobenzothiazole (2.52 mmol) and sodium acetate (0.7 mmol) was refluxed 
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in 10 mL of acetic acid for 20 min-12 h (Table 1). After completion of the reaction 
(checked by TLC), the reaction mixture was cooled and the solid precipitated out was 
filtered, washed with water, acetone and dried to afford 2a-h. 
3.5.2. Preparation of Pyrazolines (2a-h) under microwave irradiation condition 
A mixture of la-c (2.52 mmoi) and hydrazine hydrate (2.52 mmol)/phenylhydrazine 
(2.52 mmoiyhydrazinobenzothiazole (2.52 mmol) was mixed thoroughly in a mortar and 
air dried. The reaction mixture was then transferred to an open Pyrex beaker and 
subjected to microwave irradiation (Multimode, full power). The progress of reaction was 
monitored by TLC and on completion, the reaction mixture was slurred in water (25 mL). 
The solid obtained was filtered, washed with water, alcohol and dried to get 2a-h. 
Spectral data 
3-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yl)-5-(4-oxo-4/^-l-benzopyran-3-
yOpyrazoline (2a) 
Purified by recrystallization fi-om ethanol-DMF (3:2 v/v) mixture. 
White solid. 
M.p 
IR (KBr) Uma./cm'' 
'H N M R (400 MHz, DMSO-ds) 
>300 °C. 
1649 (C=0), 1698 (C=0), 3285 (NH). 
8 (ppm) 3.36 (s, 6H, 2 N-CH3), 3.66 (dd, 
lH,J=19.0Hz, 6.0Hz,Hd),4.01(dd, IH, 
..^18.9 Hz, 9.8 Hz, He), 4.87 (dd, IH, J=9.7 
Hz, 6.0 Hz, He), 7.42-7.76 (m, 3H, Ar-H), 
8.14 (dd, lH,J=8.0Hz, 1.4 Hz, C-5) 8.20 
(s, lH,C-2). 
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MS-FAB (% rel. Int.) : m/z268 (M^ 55), 367 (40), 339(15), 247 
(5), 214 (60), 166 (5), 155 (10), 138 (25), 
120(10), 92(25). 
Elemental analysis 
forCisHi6N405 : Calculated C, 58.69; H, 4.38; N, 15.21. 
Found C, 58.54 H 4.43, N 15.12%. 
3-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yl)-5-(6-methyl-4-oxo-4//-l-benzopyran-3-
yl)pyrazoline (2b) 
Purified by recrystallization from ethanol-DMF (3:2 v/v) mixture. 
White solid. 
M.p : >300 °C. 
IR (KBr) Dma./cm' : 1646 (C=0), 1699 (C=0), 3241 (NH). 
' H NMR (400 MHz, DMSO-ds) : S (ppm) 2.46 (s, 3H, CH3), 3.34 (s, 6H, 2 N-
CH3), 3.70 (dd, IH, J= 19.0 Hz, 6.0 Hz, Hd), 
4.03 (dd, IH, J=19.0 Hz, 9.7 Hz, He), 4.89 
(dd, IH, J= 9.1 Hz, 6.6 Hz, He), 7.31 (br s, 
IH, NH), 7.39-7.91 (m, 3H, Ar-H), 8.13 (s, 
IH, C-2). 
MS-FAB (% rel. int.) : m/z 382 (M\ 100), 381 (70), 380 (40), 227 
(5), 155(20), 135(60), 106(50). 
Elemental analysis 
forCi9Hi8N405 : Calculated C, 59.68; H, 4.74; N, 14.65. 
Found C, 59.53, H, 4.83, N 14.49 %. 
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5-(4-Oxo-4//-l-benzopyran-3-yl)-3-(2,4,6-pyrimidinetrione-5-yI)pyrazoline (2c) 
Purified by recrystallization from ethanol-DMF (3:2 v/v) mixture. 
White solid. 
M.p 
IR(KBr)Umas/cm'' 
'H NMR (300 MHz, DMSO-da) 
MS-FAB (% rel. Int.) 
Elemental analysis 
for C16H12N4O5 
>300 °C. 
1628 (C=0), 1721 (C=0), 3069 (NH), 3214 
(NH). 
d (ppm) 3.49 (dd, 1H, J= 19.2 Hz, 6.8 Hz, 
Hd), 3.89 (dd, IH, J=I8.8 Hz, 9.6 Hz, He), 
4.75 (dd, IH, J=16.0 Hz, 6.4 Hz, He), 6.69 
(s, IH, NH), 7.49-7.84 (m, 3H, Ar-H), 8.09 
(dd, IH, J=8.0 Hz, 1.2 Hz, C-5), 8.29 (s, IH, 
C-2), 10.31 (s, 1H,NH), 10.45 (s, 1H,NH). 
m/z 340 (M^ 75), 339 (30), 322 (30), 311 
(20), 219 (15), 213 (20), 138 (30), 127 (40), 
120 (35), 92 (70). 
: Calculated C, 56.47; H, 3.52; N, 16.47. 
Found C, 56.31; H, 3.46; N, 16.54 %. 
l-Phenyi-3-(l,3-dimethyl-2,4,6-pyrimidinetrione-5-yl)-5-(4-oxo-4fl-l-benzopyran-3-
yl)pyrazoline (2d) 
Purified by coloumn chromatography using benzene-ethylacetate (3:1 v/v) as the eluent. 
Pale yellow crystals. 
M.p : 236 °C (dec). 
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IR (KBr) Dmax/cm"' : 1668 (C=0), 1715 (C=0). 
'HNMR(400MHz, CDCI3) : <5 (ppm) 3.38 (s, 6H, 2 N-CH3), 3.71 (dd, IH. 
^18.5Hz,7.9Hz, Hd), 4.23(dd, IH, .7=18.6 
Hz, 9.7 Hz, He), 4.49 (dd, 1H, J=10.0 Hz, 
7.9 Hz, He), 7.08-7.33 (m, 8H, Ar-H), 7.38 
(dd, IH, J=7.4 Hz, 1.7 Hz, C-5), 8.27 (s, IH, 
C-2). 
MS- FAB (% rel. Int.) : m/z 444 (M^ 90), 443 (40), 391 (40), 324 
(5), 289 (50), 215 (5), 155 (60), 120 (40), 92 
(30). 
Elemental analysis 
for C24H20N4O5 : Calculated C, 64.86; H, 4.54; N 12.61. Found 
C, 64.81; H, 4.61; N 12.53%. 
1 -Phenyl-3-( 1,3-dimethyl-2,4,6-pyriinidinetrione-5-yl)-5-(6-methyI-4-oxo-4//-1 -
benzopyran-3-yl)pyrazoline (2e) 
Purified by coloumn chromatography using benzene-ethylacetate (3:1 v/v) as eluent. 
Pale yellow crystals. 
M.p : 247 °C (dec). 
lR(KBr)u,„ax/cm' : 1622 (C=0), 1712 (C=0). 
'HNMR(400MHz,CDCl3) : d"(ppm) 2.25 (s, 3H, CH3),3.37 (s, 6H, 2 N-
CH3), 3.70 (dd, IH, J= 18.6 Hz, 7.9 Hz, Hj), 
4.20 (dd, 1H, J= 18.4 Hz, 9.9 Hz, He), 4.45 
(dd, IH, J= 10.0 Hz, 7.9 Hz, He), 7.10-7.58 
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(m, 8H, Ar-H), 8.27 (s, IH, C-2). 
MS-FAB (% rel. Int.) : w/z458 (M^ 75), 457 (50), 155 (60), 134 
(70), 106(40). 
Elemental analysis 
for C25H22N4O5 : Calculated C, 65.49; H, 4.84; N, 12.22. 
Found C, 65.42; H, 4.93; N, 12.16 % . 
l-Phenyl-5-(4-oxo-4//-l-benzopyran-3-yl)-3-(2,4,6-pyrimidinetrione-5-yl)pyrazoline 
(21) 
Purified by recrystallization from chloroform-methanol (4:1 v/v) mixture. 
Pale greenish crystals. 
M.p : >300 °C. 
IR (KBr) D,™x/cm' : 1649 (C=0), 1737(C=0), 3068 (NH), 3188 
(NH). 
' H NMR (400 MHz, DMSO-de) : S (ppm) 3.56 (dd, 1H, J=l 8.4 Hz, 7.6 Hz, 
Hd), 3.78 (dd, IH, J=18.6 Hz, 9.6 Hz, He), 
4.44 (dd, J=\ 1.3 Hz, 8.1 Hz, He), 7.25-7.45 
(m, 8H, Ar-H), 7.55 (s, IH, C-2), 7.79 (dd, 
l H , ^ 7 . 6 H z , l.8Hz,C-5), 10.60 (s, IH, 
NH), 10.76 (.y, IH,NH). 
MS-FAB (% rel. Int.) : m/z 416 (M^ 70), 415 (5), 326 (45), 290 
(25), 198(40), 171 (30), 127(5), 120(20). 
Elemental analysis 
for C22H16N4O5 : Calculated C, 63.46; H, 3.84; N, 13.46. 
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Found C,63.50;H, 3.71; N, 13.38%. 
l-Benzothiazolyl-3-(l,3-dimethyl-2,4,6-pyriinidinetrione-5-yi)-5-(4-oxo-4//-l-
benzopyran-3-yl)pyrazoline (2g) 
Purified by recrystallization from chlorofom-methanoi (3:2 v/v) mixture. 
Brown crystals. 
M.p 
lR(KBr)Dn„x/cm"' 
' H N M R ( 4 0 0 M H Z , CDCI3) 
MS- FAB (% rel. Int.) 
Elemental analysis 
forC.sHmNsOjS 
291 °C (dec). 
1647(C=0), 1709 (C=0). 
d (ppm) 3.37 (s, 6H, 2 N-CH3), 4.02 (dd, 1H, 
J=19.3 Hz, 4.8 Hz, Hd) 4.24 (dd, IH, J=19.2 
Hz, 10.6 Hz, He), 5.57 (dd, IH, J=10.6 Hz, 
4.7 Hz, He), 7.18-7.94 (m, 7H, Ar-H), 8.15 
(dd, IH, J= 8.0 Hz, 1.6 Hz, C-5), 8.41(s, IH, 
C-2). 
m/z 503 (M^ 40), 501 (20), 474 (5), 347 
(10), 354 (30), 381 (5), 135(40), 120(50). 
: Calculated C, 59.87; H, 3.82; N, 13.96. 
Found C, 59.81; H, 3.88; N, 13.84 % . 
l-BenzothiazoIyl-5-(4-oxo-4//-l-benzopyran-3-yl)-3-(2,4,6-pyriiiiidine-trione-5-yl) 
pyrazoline (2h) 
Purified by recrystallisation from methanoi-DMF (3:2 v/v) mixture. 
Brown crystals. 
M.p : >300 °C. 
97 
IR (KBr) v)„K,vCm ' : 1644 (C=0), 1701 (C=0), 3069 (NH). 3173 
(NH). 
'H N M R (400 MHz. DMSO-dft) : S (ppm) 3.87 (dd, IH, J= 19.2 Hz. 5.7 Hz. 
Hd), 4.17 (dd, 1H, J= 19.2 Hz. 1 1.4 Hz. He). 
5.53 (dd, 1H, J= II .4 Hz, 5.6 Hz. He). 7.12-
7.76 (m, 7H, Ar-H), 8.15 (dd, IH, ./= 8.0 
Hz, 1.6 Hz, C-5), 8.27 (s, IH, C-2). 11.17 
(s, IH,NH), ll.56(s, IH,NH). 
MS-FAB (% rel. Int.) : m/z 473 (M^ 50), 445 (15), 361 (10), 353 
(25), 326(20), 134(35), 127(15). 120(50). 
92 (50). 
Elemental analysis 
forC:3H,sN,().S : Calculated C, 58.35; H, 3.17; N, 14.79. Found 
C, 58.27; H, 3.25; N, 14.71 %. 
3.5.3. Preparation of pyrazolines (4a-c) under thermal heating condition 
A mi.xture ofJa-c (2.52 mmol), hydrazine hydrate (2.52 mmol) and sodium acetate (0.8 
mmol) was retluxed in 8 mL of acetic acid for 45 min-1 h. After completion of the 
reaction (checked by TLC), the reaction mixture was cooled and the solid precipitated out 
was filtered, washed with water, acetone and dried to afford 4a-c. 
3.5.4. Preparation of pyrazoHnes (4a-c) under microwave irradiation condition 
ihe mixture olJa-c (2.52 mmol), hydrazine hydrate (2.52 mmol) and sodium acetate (0.6 
mmol) v\as mixed thoroughly in a mortar and air dried. The reaction mixture was then 
subjected to microwave irradiation (Multimode, full power) in an open Pyrex beaker I he 
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progress of reaction was monitored by TLC and on completion, the reaction mixture was 
slurred in water (20 mL). The soMd obtained was filtered, washed with water, alcohol and 
dried to get 4a-c. 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)-3-(l,3-dimethyl-2,4,6-pyrimidinetrione-
5-yl)pyrazoline (4a) 
Purified by recrystallization from chloroform. 
White crystals 
M.p : >300T. 
IR (KBr) Unwcm"' : 1363 (C-N), 1633 (C=N), 1709 (C=0), 3200 
(NH). 
' H NMR (300 MHz. DMSO-dg) : S (ppm) 2.24 (s, 3H, CH3), 3.34 (s. 6H, 2 N-
CH3), 3.58 (dd, 1H, J= 18.6 Hz. 9.3 Hz, Hj), 
4.05 (dd, lH,,/= 18.9 Hz, 10.5 Hz, He), 4.80 
(d, IH, He), 6.95 (s, IH, NH), 7.48-7,52 
(m, 5H, Ar-H). 
MS-ESI : w/z 414.15 (M'), 413.15,412.15. 277.15 
Hiemental analysis 
forC|gH|c,H,()3CI : Calculated C, 55.01; H, 4.61; N, 20.25. 
Found C, 55.13; H, 4.78; N, 20.13 %. 
5-(5-Chloro-3-inethyl-l-phenyIpyrazol-4-yl)-3-(2,4,6-pyrimidinetrione-5-yl) 
pyrazoline (4b) 
Purified b\ recrystallization from chlorofom-methanol (4:1 v/v) mixture. 
White powder. 
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M.p 
IR(KBr)i)n,ax/cm ' 
H^ NMR (400 MHz. DMSO-ds) 
MS-ESI 
Elemental analysis 
forCiTHi.NfXijCI 
>300 °C. 
1294 (C-N), 1616 (C=N), 1727 (C=OX 3169 
(NH), 3215(NH). 
S (ppm) 2.32 (s, 3H, CH3), 3.74 (dd, IH. ./= 
18.9 Hz, 8.7 Hz, Ha), 4.07 (dd, IH../- 19.0 
Hz, 10.1 Hz, He), 4.93 (t, IH, J=18.7 Hz. H,). 
7.33 (s, IH, NH), 7.41-7.66 (m, 5H, Ar-H). 
10.23 (s, 1H,NH), l l . l2 (s , IH, NH). 
m/z 386.6 (M^), 376.6, 362.6. 361.6, 360,6. 
358.6, 332.6, 318.6, 301.5, 274.6, 202.6. 
Calculated C, 52.79; H, 3.90; N, 21.72. 
Found C, 52.86; H, 3.98; N, 21.64 %. 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)-3-(2-mercapto-4,6-pyrimidinedione-5-
yl)pyrazoline (4c) 
Purified by recrystallization fromchiorofom-methanoi (4;1 v/v) mixture. 
White powder 
M.p 
IR(KBr)i),™N/cm"' 
'H N M R (400 MHz. DMSO-dfe) 
>300 °C. 
1011 (C=S), 1313 (C-N), 1633 (C=N), 1688 
(C=0),3126(NH),3234(NH). 
S (ppm) 2.42 (s, 3H, CH3), 3.69 (dd, 1H. ./= 
18.6 Hz, 8.5 Hz, Hj), 4.09 (dd. 1H../- 18.9 
Hz, 10.1 Hz, He), 4.93 (t, 1H. J= 18.7 H/, 
100 
He), 7.35 (s, IH, NH), 7.47-7.61 (m. 511. 
Ar-H), 11.51 (s, IH, NH), 11.92 (.s, IH. NH). 
MS-ESl : m/z 402.6 (M^). 388.6, 362.6. 361.6. 360.6. 
358.6, 356.6, 332.6, 302.5, 301.5. 274.6. 
202.6,158.5. 
Elemental analysis 
forCi7Hi5N6()2SCI : Calculated C, 50.68; H, 3.74; N, 20.86. 
Found C, 50.73; H, 3.85; N, 20.77 %. 
3.5.5. Preparation of dihydropyrimidine (5) under thermal heating condition 
A mixture of la (5 mmol), urea (7 mmol) and NaOH (14 mmol) was reflu.xed in ethanol 
(20 mL) for 14 h. The reaction mixture was then cooled, and poured in to ice-cold water 
(50 mL), acidified with cone. HCI. The crude product, thus, obtained was filtered, 
washed with acetone and dried to afford 5. 
3.5.6. Preparation of dihydropyrimidine (5) under microwave irradiation condition 
The mixture of la (5 mmol), urea (7 mmol) and NaOH (10 mmol) was grounded well 
using a mortar and pestle. The reaction mixture was then transferred to an open Pyrex 
beaker and exposed to microwave irradiation (Multimode, full power). The progress of 
reaction was monitored by TLC and on completion, the reaction mixture was slurred in 
water (25 ml.) fhe solid obtained was filtered, washed with water, acetone and dried to 
afford 5. 
4-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yI)-6-(4-oxo-4//-l-benzopyran-3-yl)-
5//,6//-dihydropyrimidine-2-one (5) 
Purified by recrystallization from ethanol. 
White powder. 
M.p : 279-281 °C. 
iR(KBr)i),™vCiif' : 1651 (C=0), 1716 (C=0). 
^HNMR(30()Mllz, CDCb) : <5(ppm) 3.20 (dd, IH, .7=16.5 F^ z, 3.9 Hz, Hd). 
3.37 (s, 6H, 2N-CH3), 3.42 (dd. IH, He). 4.88 
(dd, IH, J= 9.9 Hz. 3.9 Hz, He). 7.44-7.76 (m. 
3H, Ar-H), 8.02 (s, 1H, C-2), 8,24 (dd, IH, 
y=7.8 Hz, 0.9 Hz, C-5), 14.12 (brs, IH, OH). 
MS-FAB (% rel. Int) : m/z 396 (M", 80), 395 (50), 289 (30), 199 
(5), 155.(40), 120(10). 
Elemental analysis 
forCi9H|(,N4()6 : Calculated C, 57.58; H, 4.07; N. 14.14. Found 
C, 57.42; H, 3.91; N, 14.12%. 
3.5.7. General procedure for the preparation of 2,3-dibromoderivatives of chalcones 
Bromine (5 mmol) was added dropwise with vigorous stirring to a solution of la-b (5 
mmol) in 12 niL of chloroform over a period of 20 min. After complete addition of Br; 
the reaction mixture was allowed to stand for 2 h. The dibromoderivatives 6a-b were 
precipitated, filtered off and washed with 20 mL of ether to remove the e.Kcess of 
broinine. 
l-(l,3-Diniethyl-2,4,6-pyrimidinetrione-5-yl)-2,3-dibronio-3-(4-oxo-4//-l-
benzopyran-3 yl)propan-l-one (6a) 
Purified b\ recrystallization from ethanol. 
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Yellow solid. 
M.p : 242 °C (dec). 
IR (KBr) u,™vcm ' : 1657 (C=0), 1729 (C=0). 
' H N M R ( 4 ( ) 0 M H Z , CDCb) : (5 (ppm) 3.42 (s, 3H, N-CHj). 3.44 (s. 3H 
N-CH3), 5.56 (d, IH, J=\ 1.3 Hz, H ,^), 7 44-
7.72 (m, 3H, Ar-H), 7.76 (d, 1H, .7= 11,3 
Hz, Hb), 8.15 (s, 1H, C-2), 8.34 (dd, 1H. 
y=7.9Hz,1.5Hz, C-5). 
MS-FAB (%rcl. Int) : m/z 514 (M\ 55) 513 (30), 434 (30). 354 
(30), 326 (40), 199 (20), 171 (20), 155 (55). 
128(35). 
Blemental analysis 
for CiKHi4N:()oBr2 : Calculated C, 42.05; H, 2.74; N, 5.45. Found 
C, 42.14; H, 2.75; N, 5.42%. 
l-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yl)-2,3-dibromo-3-(6-methyl-4-oxo-4//-l-
benzopyran-3-yl)propan-l-one (6b) 
Purified b\ recr\ stallization from ethanol. 
Yellow solid. 
M.p 
IR(KBr)uniaAnV' 
'HNMR(400MHz, CDCI3,) 
202-204 °C. 
1664 (C=0), 1730(C=O). 
6 (ppm) 2.47 (s, 3H, CH3), 3.42 (s, 3H, N-
CH3), 3.43 (s, 3H, N-CH3), 5.57 (d. 1H. ./= 
II.2 Hz, Ha), 7.38-7.75 (m, 3H, Ar-H), 
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7.77 (d, IH, J= 11.3 Hz, Hb). 8.14 (s, IH. C-
2). 
MS-FAB {%rel. int.) : w/z 528 (M*, 40) 527 (10), 526 (20). 448 
(10), 368 (30), 367( 10), 213 (30). 185(10). 
155(25). 
Elemental analysis 
tor CiqHifiN.DhBr: : Calculated C, 43.21; H, 3.05; N, 5.30. Found 
C, 43.13; H, 3.13; N, 5.22%. 
3.5.8. Preparation of pyrazole (7) under thermal heating condition 
Hydrazine hytlrate (2.5 mmol) was added with vigorous stirring to a solution of 6a (2.5 
mmol) in 10 niL of dry pyridine at room temperature. The reaction mixture was allowed 
to stand for 28 h. The pyrazole derivative 7 precipitated out, was filtered, washed with 
water, ethanol and dried. 
3.5.9. Preparation of pyrazole (7) under microwave irradiation 
A mi.xture of 6a (2.5 mmol) and hydrazine hydrate (2.5 mmol) was mixed well and air 
dried. The reaction mixture was subjected to microwave irradiation (Multimode. full 
power) in an open Pyrex beaker. On completion (as checked by TLC), the reaction 
mixture was slurred in water (20 mL). The crude product obtained was filtered, washed 
with water, ethanol and dried. 
3-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yl)-5-(4-oxo-4//-l-benzopyran-3-
yI)pyrazole (7) 
Purified b\ reci vstallization from ethanol-DMF (3:2 v/v) mixture. 
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White powder. 
M.p 
IR(KBr)u„urycm'' 
'H N M R (DMSO-dft. 300 MHz) 
MS-FAB (% rel. Int.) 
Blementai analysis 
forCsHuNaOs 
>300 °C. 
1645 (C=0), 1710 (C=0), 3247 (NH) 
d (ppm) 3.20 (s, 6H, 2N-CH3). 6.97-7.39 
(m, 3H, Ar-H), 7.77 (d, IH, ,7=7.5 Hz, C-5). 
7.94(s, IH, He), 9.56(s, IH. C-2). 10.31 (br 
s, IH,NH). 
m/z 366 (M", 90), 365 (50), 338 (10), 164 
(5), 155(45), 136(80). 
Calculated C, 59.02; H, 3.85; N. 15.29. 
FoundC, 59.14; H, 3.79; N, 15.22%. 
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CHAPTER-4 
Zn(PROLINE)2-CATALYZED KNOEVENAGEL CONDENSATION 
UNDER SOLVENT-FREE/AQUEOUS CONDITIONS 
4.1. REVIEW & LITERATURE 
Developing a simple, ecofriendly reaction protocol for the synthesis of compound 
libraries of medicinal scaffolds is an attractive area of research in both academic and 
pharmaceutical R&D.' Hence, the challenge for sustainable environment calls for the use 
of clean procedures, which can avoid the use of harmful solvents. The chemists are 
therefore, more interested in seeking new processes involving solvent-free reactions 
which are devoid of pollution, low cost and simplicity in processing." Microwave-
assisted organic reactions are nowadays a well established green protocol for synthesis of 
various heterocycles. The shorter reaction time, experimental simplicity, selectivity and 
easy work-up have given clear indication on the potentialities of this technique over 
conventional heating.^ Nowadays water has emerged as an ecofriendly solvent for the 
reaction medium because of its easy availability, noninflammability, nontoxicity and 
negligible cost. 
The Knoevenagel condensation reaction is an effective C=C bond formation reaction 
between carbonyl or heterocarbonyl compounds and any compounds having an active 
methylene group.^ This reaction has been widely used for the synthesis of several 
intermediates, which are useful in perfumes, cosmetics, and bioactive compounds.^ This 
reaction has also application in the preparation of natural products,*' functional polymers,*^  
finechemicals' and so forth. 
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The Knoevenagel condensation products also have widespread applications including 
inhibition of antiphosphorylation of EGF-receptor and antiproliferative activity.'" 
Because of the importance from pharmacological, industrial and synthetic point of view 
several methods have been reported for this reaction which includes homogeneous 
condition catalyzed by base such as a piperidine," ethylenediamine'^ or corresponding 
ammonium salts, dimethylaminopyridine,'^ organocatalysts like L-proline,''* natural and 
synthetic phosphates,'^ resins,'* montmorillonite KSF,'^ Lewis acid,'^ Al203,'^ ZnCl2,*° 
Cdl2,^ ' l2-K2C03,^ ^ K3P04,^ ^ KF-AbOs,^ '* AlP04-Al203,^^H20-Cetyl trimethylammonium 
bromide (CTMAB), * montmorillonite KlO-ZnC^, ' Zinc acetate,^ diammonium 
hydrogen phosphate,'^ ^ USY zeoIite,^° xonotlite,^' silica gel,^ ^ silica gel functionalized 
with amino groups,^ ^ aminopropyl-functionalized MCM-41,^'' ionic liquid-functionalized 
silica gel,^ ^ ionic liquid-functionalized SBA-15,^* basic ionic liquid^^ etc. Unfortunately, 
many of these methods have some drawbacks such as use of expensive, stoichiometric 
amount of reactants, low yields, extended time, tedious procedure etc. Thus, the need for 
the development of an alternative route to construct substituted electrophilic alkenes by 
reducing time from hours to minutes at ambient temperature is in demand. 
4.1.1. Some recent examples of Knoevenagel condensation under green 
environment 
4.1.1a. n-Butyl pyridinium nitrate as reusable ionic liquid medium 
The Knoevenagel condensation of carbonyl substrates with active methylene compounds 
proceeds smoothly with ammonium acetate as catalyst in «-butyl pyridinium nitrate to 
afford the desired products of good purity in moderate yields. 
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Ar-
H 
C = 0 + H-
CN 
R 
(( ©N—Bu-n 
NH4AC 
© 
NO3 Ar 
H 
72- 83% 
CN 
R 
Ar= 4-OMe C6H4, 4-OH C6H4, 4-OH-3-OMe C^Hj, 4-Me2N C6H4,4-Cl C6H4, CgHj 
R= f :O0Et, CN 
4.1.1b. l-Butyl-3-methylimidazolium tetrafluoroborate [Bmim] BF4 ionic liquid 
promoted Knoevenagel condensation '^ 
The Knoevenagel condensation of Meldrum's acid with aromatic aldehydes proceeded 
efficiently in the recyclable ionic liquid [Bmim]BF4 (l-Butyl-3-methylimidazolium 
tetrafluoroborate) at room temperature in the presence of catalytic amount of piperidine. 
o- H 
+ Ar C ^ O 
O-
[Bmim]BF4 
k 
Piperidine 
o-
O- Ar 
O 83-96% 
Ar= 4-CI C6H4, 4-OH C6H4,4-OMe C6H4, 2,4-(OMe)2C6H3, 
4-Me2N C6H4, 4-NO2 C6H4, CfiHj- CH=CH, 2-Furyl 
4.1.1c. 1-Methyl imidazolium trifluoroacetate [Hmim] TFA ionic liquid mediated 
Knoevenagel condensation. ' 
A simple, efficient, and green protocol for synthesis of coumarin-3-carboxylic acids and 
substituted electrophilic alkenes are reported through Knoevenagel condensation of 
Meldrum's acid with ortho-hydroxyaryl aldehydes and aromatic aldehydes respectively, 
in presence of reusable [Hmim]TFA (1-Methylimidazolium triflouroacetate) ionic liquid. 
which was found to give better results than other ionic liquids. 
I / O 
COOH 
75-90% 
R1=R2=R3=R'»=H, OH.Cl 
o- H 
Ar C = = 0 
Ionic liquid o-
o- o-
Ar 
O 49-91% 
Ar= 2-Cl C6H4, 4-OMe C6H4, 4-Me2N C6H4,4-NO2 C6H4, 2-NO2 C6H4, 4-OH C6H4 
4.1.Id. Ionic liquid mediated Knoevenagel condensation of aromatic aldehydes with (2-
thio)barbituric acids *^ 
The Knoevenagel condensation of aromatic aldehydes with (2-thio)barbituric acids 
proceeded efficiently in reusable ionic liquids, EAN (Ethylammonium nitrate), BmimBFj 
(l-Butyl-3-methyliniidazoliumtetrafluoroborate) and BmimPFe (l-Butyl-3 
methylimidazoliumhexafluorophosphate) at room temperature in the absence of any 
catalyst with high yields. 
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> 
/ V_i 
^
NH Ionic liquid 
>-
rt, 10-300 min / \ 
> NH 
-NH 
7— 
x=o,s 
o 
83- 98% 
R=4-OMe,4-OH,2-N02, 4-Cl, 4-Me, 2-NO2, 2-fijrfiiryl 
4.1.1e. Borate-Zirconia as a recyclable catalyst *^ 
Knoevenagel condensation of 4-oxo-(4/f)-l-benzopyran-3-carbaldehydes, 1,3-diphenyl-
l//-pyrazol-4-carboxaldehyde and aromatic aldeiiyde has been carried out with 3-methyl-
1 -phenylpyrazolin-5-(4//)-one as condensing agent in moderate to good yields by using 
Borate Zirconia (B203/Zr02) solid acid catalyst in water medium. In each conversion, the 
catalyst was successfully recovered and recycled without significant loss in yield and 
selectivity. 
R C H + 
O. 
N Ph B2O3 / Z1O2 
Water, 90°C 
H \ 
\ 
N Ph 
Me 
70-88% 
R = Ph N 
\ ^ 
-X3 , 
X|=H,CI 
Xj = H,C1, Br X3 = H, CI, Me, 
, • / • / 
V^x, 
X4 = H, CI, Me 
4.1.If. Mn (III) salen as a recyclable catalyst 
Knoevenagel condensations were catalysed by Mn(III) salen complex in quantitative 
yields under mild reaction conditions. The catalyst was reused for several cycles with 
consistent activity. 
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H A K ^ C N 
CN Mn(m)salen X 
Ar C = 0 + HjC *" H ^ ^R 
R 50-100% 
Ar= 2-OMe C6H4, 4-NO2 C6H4, 3-OMe C6H4, 4-CI C6H4, C^H^, Furfuryl 
R= COOEt, CN 
4.1.Ig. Leucomerald'me base as a recyclable catalyst'*^ 
A facile method for Knoevenagel condensation has been developed by using recyclable 
Leucoemeraldine base as a catalyst to give substituted alkenes in excellent yields. 
CN Leucomeraldine base 
Arv ^CN 
Ar C=0 + H2C *" H 
R 
83-95% 
Ar=4-OH C6H4, 4-OCH3 C6H4, 2-Cl C6H4, 4-NMe2 C6H4, CgHs 
R= COOEt, CN 
4.1.1 h. 12-Tungstophosphoric acid as reusable catalyst"*^ 
12-Tungstphosphoric acid is used as a reusable catalyst for Knoevenagel condensation of 
malononitrile and ethylcyanoacetate with various aldehydes in water. 
H 
I .CN H3PW,2O40 
R C O + H2C, 
n 
H 
\ 
/ 
82-
y ^ 
97% 
^ C N 
^ X 
\ Refluxing water 
X 
R= C(,n-,. 4-OMe C6H4, 4-Me C6H4 ,4-OH C6H4, 4-CI C6H4, 2-NO2 C6H4, S-NGj C6H4, Furyl 
X= -COOEt, CN 
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4.2. PRESENT WORK 
As a part of our ongoing research program aimed at developing new catalysts and 
subsequent application for various organic transformations, herein this chapter we report 
the recently explored Zn(proline)2 complex as an efficient and recyclable catalyst in 
Knoevenagel condensation reaction. To the best of our knowledge Zn(proline)2 has not 
been used as a catalyst before, for Knoevenagel condensation reaction. This prompted us 
to test the catalytic activity of the viable catalyst for this reaction employing 
heteroaldehydes with various cyclic active methylene compounds both under solvent-free 
condition using microwave irradiation and by using water as an ecofriendly reaction 
medium. 
4.3. RESULTS AND DISCUSSION 
Ever since the exploration of water soluble Zn(proline)2 complex by Darbre's group^ 
only few reports have so far appeared employing Zn(proline)2 as a Lewis acid catalyst for 
different organic reactions.'** Thus, there is a lot of scope to further explore the catalyst 
for its application in forming various heterocyclic rings. The Zn(proline)2 catalyst is 
easily preparable, stable, inexpensive and recyclable. The solubility nature of the catalyst 
facilitated the separation of products from the catalyst. The used catalyst can be recycled 
and used for the next reaction without any fiirther purification. We carried out first the 
reaction of 5~chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde 1 with various cyclic 
active methylene compounds 2a-i in conventional method using ethanol as a solvent in 
acidic/basic medium (Scheme 1). The reactions took longer period of time for 
completion (3-12 h) with lower yields. Then we studied the efficacy of the Zn(proline); 
complex by carrying reactions in green solvent, water. The reactions were completed 
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within 1-2 h and the products obtained were in good yield (81-89%). Further, the 
catalytic activity of the complex was tested under solvent-free condition by employing 
microwave irradiation. To our pleasant surprise, the reactions were completed in much 
shorter period of time (5-9 min) in excellent yields (90-95%) (Table 1). 
The reaction of 5-chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde 1 with indane-
1,3-dione 2a in the presence of Zn(proUne)2 in water as well as in microwave inadiation 
was taken as model reaction for recycling studies. After completion of reaction in 
specified time, the crude product obtained was extracted by dichloromethane and the 
catalyst was recovered by separation of aqueous and organic phases. The catalyst present 
in the aqueous medium was used for the subsequent cycle. The same procedure was 
applied for all recycling studies. The results (Table 2) revealed that catalyst exhibited 
good catalytic activity up to three cycles. The scope of the reaction was further 
investigated with different cyclic active methylene compounds with viable catalyst, and 
the results obtained were satisfactory. The reactions of heteroaldehyde with triacetic acid 
lactone 2h and 4-hydroxycoumarin 2i did not give the expected Knoevenagel 
condensation products, instead it afforded pyrazolo pyrones 3h and 3i as reported by us 
earlier '''^  in a very short period of time (Table 1). 
Similar type of Knoevenagel condensation was also carried out by treating 5-azido-3-
methyl-l-phenylpyrazole-4-carboxaldehyde 4 with various cyclic active methylene 
compounds (5a-f) in aqueous medium (Scheme 2). All reactions were found to be 
completed within 25 min-1 h with considerable increase in the yields of products (Table 
3) as compared to conventional method which took longer time period (2.5-6 h). Here 
again when the reaction of heteroaldehyde (4) was extended to 4-hydroxycoumarin (5e) 
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and triacetic acid lactone (5f) expected Knoevenagel condensation products were not 
obtained. Instead it afforded pyrazolo pyrones 6e and 6f as reported earlier from our lab 
in conventional organic solvent.'*^ This time, under the influence of the viable 
Zn(proline)2 complex, the reaction time was considerably reduced, and yield of products 
was also increased from the reported values (Table 3). The recycling studies results of 
the reaction of 5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde (4) with 1,3-
dimethylbarbituric acid (5c) are presented in Table 4. The reactions carried under 
microwave irradiation were not neat probably because of decomposition of much low 
melting 5-azido-3-methyl-l-phenylpyrazole-4-carboxaldehyde 4 and aqueous medium 
was, therefore, better alternative for the reactions. 
All the products obtained were recrystallized from suitable solvents, and characterized by 
spectroscopic data. The IR spectrum of 3a (Fig. 2) showed sharp and strong absorption 
band at 1689 cm"' for a,p unsaturated carbonyl group. The band for carbon-carbon double 
bond was present at 1623 cm"'. The proton nuclear magnetic resonance spectroscopy ( 'H 
NMR) (Fig. 3) exhibited a sharp singlet at d 2.40 for methyl group of pyrazole moiety. 
Nine aromatic protons appeared as multiple! in the aromatic region S 7.45-8.04. The five 
aromatic protons of phenyl group of pyrazole moiety were present in the form of three 
multiplets in the range of S 7.45-7.47, 7.50-7.54 and 7.61-7.63. Three multiplets may be 
due to H-2 /H-6 , H-37H-5 and H-4 protons. However four protons of benzene ring of 
indanedione moiety were visible in the form of two multiplets in the range d 7.81-7.84 
and 7.99-8.04. each multiplet integrating for two protons. These multiplets may be due to 
H-4, H-5 and H-6, H-7 protons. The olefinic proton was discernible as a sharp singlet at S 
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7.80. Further confirmation of the structure was provided by mass spectrometry (Fig. 4) 
which showed M^ at m/z 348. 
Figure-1. 2-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)methylene-l,3-indanedione (3a). 
The IR spectrum of 6c (Fig. 5) showed sharp and strong absorption band at 1683 cm' for 
a.p unsaturated carbony! group. Two other bands at 1596 and 1524 cm"' were assigned to 
C=C and C=N bonds. The proton nuclear magnetic resonance spectroscopy ( 'H NMR) 
(Fig. 6) exhibited three sharp singlets at 8 2.40, 3.40 and 3.45 for methyl protons of 
pyrazole and barbituric acid units. Five aromatic protons of pyrazole unit were appeared 
as multiplet in the region 5 7.40-7.69. The olefinic proton was discemable as a sharp 
singlet at 6 8.44. The '^ C NMR spectrum (Fig. 7) was informative in assigning the 
structure. The peaks were observed at 8 114.9 and 139.0 for the trisubstituted and 
tetrasubstituted olefinic carbon atoms respectively. Further confirmation of the structure 
was provided by mass spectrometry (Fig. 8), which showed M^ at m/z 365 followed by 
subsequent fragmentation pattern. The spectral data of other compounds followed similar 
pattern and are given in experimental section. 
The proposed mechanism for the Zn(proline)2-catalyzed synthesis of Knoevenagel 
products can be visualised as given in Scheme 3. 
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HaC^ O Zn(proline)2 water, reflux 
orMW 
2h-i H,C, 
~N CI 
I 1 
Ph 
Zn(proline)2 water, 
reflux or MW 
HaC^ Het h; Z= CH=C-CH;, 
i;Z= 
3a-g 
O 
Het= 
O la 
^ H ' 
It 
OH 
NH 
NH 
2b 
0 * ^ 0 
2f 
CHa 
CH3 H3C 2g 
o ^ ^ o - ^ ^ - ^ 
2i 
Scheme 1. Synthesis of comopounds 3a-i. 
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H.C 
N 
Water / Zn(proline)2 
reflux 
H.C 
Water / Zn(proIine)2 
reflux 
5e-f H3C, 
6e-f 
e; Z = 
f; Z = CH=C-CH. 
6a-d 
Het= 
h NH 
OH 
o^^o-
O 5d 
OH 
o-^^o' "CH-, 
5e 5f 
Scheme 2. Synthesis ofcomopounds 6a-f. 
[35 
o 
2a-g or 5a-d 
X= CI, N3 3a-g or 6a-d x 
Scheine-3. Mechanism ofZn(proline)2-catalyzedKnoevenagel condensation. 
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Table- 1. Synthesis of products 3a-i in refluxing water or microwave irradiation. 
Entry 
1 
2 
3 
4 
5 
6 
7 
8 
9 
product" 
Sa" 
3b 
3c 
3d 
3e' 
3f*' 
3g 
3h 
3i 
Thermal heating 
Time 
Ih 
45 min 
45 min 
Ih 
1.5 h 
2h 
45 min 
1 h 
Ih 
in aqueous medium 
Yield (%) 
85 
87 
89 
87 
84 
81 
86 
84 
83 
Microwave irradiation 
Time 
7 min 
5 min 
6 min' 
6 min 
9 min 
9 min 
5 min 
6 min 
6 min 
Yield (%) 
90 
93 
95 
94 
91 
91 
94 
92 
92 
The products were confirmed by elemental analysis, spectral data and compared with 
iported literature.'' 
New compounds. 
re t  lit t .''^' ^°'^' 
Table- 2. Recycling data of Zn(proline)2 complex for the Knoevenagel condensation of 
5-chloro-3-methyl-l-phenyl-4-carboxaldehyde (1) with 1,3-indanedione (2a). 
Catalyst recycle Conventional method Microwave irradiation 
(Aqueous medium) 
Time (h) Yield (%) Time (min) Yield (%) 
I 1 85 7 90 
II 1 85 7 90 
III 1 85 7 90 
IV 1 82 7 87 
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Table 3. Synthesis of products 6a-f in re fluxing water. 
Entry Product Mol. formula Time Yield M.p 
(%) (°C) 
1 6a' Ci5H,iN703 25min 82 167(dec) 
2 65" C15HUN7O2S 45min 76 174-176 
3 60" C17H15N7O3 35min 81 201-204 
4 6d' C20H13N5O2 30min 82 234(dec) 
5 6e^ C29H18N2O6 1 h 84 290-292 
6 61* C23H,8N206 Ih 80 231-233 
^ New compounds. 
'' The products were confirmed by elemental analysis, spectral data and compared with 
reported literature.'*^ 
Table-4. Recycling data of Zn(proline)2 complex for the Knoevenagel condensation of 
5-azido-3-methyl-l-phenylpyrazol-4-carboxaldehyde (4) with 1,3-
dimethylbarbituric acid (5c) in aqueous medium. 
Catalyst Time Yield (%) 
recycle 
I 35min 81 
II 35min 81 
III 35min 81 
IV 35min 77 
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4.4. CONCLUSION 
In brief, wc developed an efficient procedure for the synthesis of substituted alkenes 
through Knoevenagel condensation from various cyclic active methylene compounds and 
heteroaromatic aldehydes using stable, inexpensive, easily preparable and recyclable 
Zn(proline): complex in green solvent "water" and under solvent-free condition. The 
present protocol is devoid of pollution and involves mild reaction condition, excellent 
> ieids. short reaction time and simple operational and experimental procedure. 
4.5. EXPERIMENTAL 
Melting points were taken in Riechert Thermover instrument and are uncorrected. 1 he IR 
spectra were recorded on Perkin Elmer spectrometer in KBr. H NMR spectra on a 
Bruker DRX-300 and Bruker Avance 400 Spectrometer using tetra methyl silane (IMS) 
as an internal standard. Mass spectra were recorded on JEOL-Accu TOP JMS-TIOOLC 
DART-MS spectrometer, Micromass Quattro II (ESI) and Jeol-SX-102 (FAB) 
spectrometer The microanalytical data were collected on Elementar vario ET, III 
elemental aiial>zer. The Zn(proline)2 catalyst^" and the compounds 1.'^ 4""^  were 
synthesized by reported procedures. Other chemicals were of commercial grade and 
used without further purification. The purity of all compounds was checked by 1 LC 
on glass plates coated with silica gel (E-Merck 0254)- The plates were run in chloroforni-
methanol (4:1) mixture and were visualized by iodine vapours. All the experiments under 
microwave irradiation were carried out in a domestic microwave oven (National, Model 
NN-S557WF 1.3 KW, 2450 MHz). 
4.5.1. Synthesis of bis|(L) prolinato-N,0]Zn complex 
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Ten nimol of L-proline was dissolved in 25 mL absolute ethanol containing 10 mmol 
potassium hydroxide and stirred well for 15 min. In order to maintain the metal to ligand 
ratio 1:2. 5 mmol of Zn(N03)26H20 was dissolved in a small quantity of double distilled 
water and this solution was added in drops to the solution of L-proline. The contents were 
vigourously stirred at room temperature for 8 h. The Zn(proline)2 complex was obtained 
as white solid, was filtered and dried. Yield: 91 %. 
4.5.2. Thermal heating in aqueous medium 
A mixture ol' 5-chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde (l)/5-azido-3-
methyi-l-phenylpyrazol-4-carboxaldehyde (4) (1.00 mmol), active methylene compounds 
2a-i, 5a-f (1 00 mmol) and Zn(proline)2 (0.30 mmol) was dissolved in minimum volume 
of methanol, and water (7 mL) was added. The reaction mixture was then reflu.xed on a 
heating manlle for specified time (Table 1, 3) and cooled to room temperature. The solid 
product was extracted with dichloromethane, dried over anhydrous Na2S04, concentrated 
to furnish crude product, which was recrystailized from ethanol-chloroform mixture/ 
methanol-chioroform mixture. The catalyst was recovered by simple separation of 
aqueous and organic phases. The catalyst present in the aqueous layer was used for the 
subsequent cycle. 
4.5.3. Microwave irradiation 
A mixture of 5-chloro-3-methyl-l-phenypyrazole-4-carboxaldehyde 1 (1.00 mmol) and 
active methylene compounds 2a-i (1.00 mmol) was mixed with Zn(proline)2 (0.30 mmol) 
and grounded well using a mortar and pestle. The mixture was then taken in an open 
Pyrex beakei and subjected to microwave irradiation (Multimode, full power). The 
progress of reaction was monitored by TLC and, on completion the reaction mixture was 
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slurred in water, extracted with dichloromethane, dried over anhydrous Na2S04 and 
concentrated. The crude product as obtained was recrystallized from ethanol-chloroform 
mixture. The catalyst was recovered by simple separation of aqueous and organic phases. 
The catalyst present in the aqueous layer was used for the subsequent cycle. 
Spectral data 
2-(5-Chloro-3-methyl-l-phenylpyrazoi-4-yl)methylene-l,3-indanedione(3a) 
Purified by recrystallization from ethanol-chloroform (3:2 v/v) mixture. 
Pale greenish crystals. 
M.p 
IR (KBr) t)n,ax/cm-' 
'H N M R (400 MHz, CDCI3) 
MS-FAB (% rel. Int.) 
Elemental analysis 
for C20H13N2O2CI 
199-202 °C. 
1623 (C=C), 1689 (C=0). 
5 (ppm) 2.40 (s, 3H, CH3), 7.45-8.04 (m, 
9H, Ar-H), 7.80 (s, IH, -CH=C). 
OT/Z348(M^100). 
: Calculated C, 68.89; H, 3.72; N, 8.03. 
Found C, 68.96; H, 3.77; N, 8.08 %. 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)methylene-2,4,6-pyriiiiidinetrione(3b) 
Purified by recrystallization from chlorofonn-ethanol (4:1 v/v) mixture. 
Bright yellow crystals. 
M.p 
IR (KBr) Umax/cm"' 
'H N M R (300 MHz, DMSO-dg) 
>300 °C. 
1572 (C=C), 1679 (C=0), 3195 (NH). 
5 (ppm) 2.29 (s, 3H, CH3), 7.31-7.82 (m, 
5H, Ar-H), 8.12 (s, IH, -CH-C), 11.05 (s, 
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MS-ESl 
Elemental analysis 
forC,5Hi,N403Cl 
1H,NH), 11.36 (s,lH,NH). 
m/z 330.20 (M^). 
: Calculated C, 54.49; H, 3.32; N, 16.94. 
Found C, 54.56; H, 3.36; N, 16.87 %. 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yi)methylene-l,3-dimethyl-2,4,6-
pyrimidinetrione (3c) 
Purified by recrystallization from ethanol-chloroform (3:2 v/v) mixture 
Shining yellow crystals. 
M.p 
IR (KBr) Umax/cm' 
'H NMR (400 MHz, CDCI3) 
MS-FAB ( % rel. Int) 
Elemental analysis 
forC,7H,5N403Cl 
208-210 °C. 
1587 (C-C), 1664 (C=0). 
d (ppm) 2.43 (s, 3H, CH3), 3.42 (s, 3H, N-
CH3), 3.45 (s, 3H, N-CH3), 7.32-7.84 (m. 
5H, Ar-H), 8.48 (s, IH, -CH=C). 
m/z 358 (M ,^ 90). 
: Calculated C, 56.93; H, 4.18; N, !5.61. 
Found C, 56.99; H, 4.16; N, 15.56. 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)methylene-2-inercapto-4,6-
pyrimidinedione (3d) 
Purified by recrystallization from chloroform-ethanol (4:1 v/v) mixture. 
Pale yellow solid. 
M.p : >300 °C. 
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IR (KBr) Umax/cm" 
'H N M R (300 MHz, DMSO-de) 
: 1007 (C=S), 1618 (C-C), 1674 (C=0), 
3124 (NH). 
: d (ppm) 2.32 (s, 3H, CH3), 7.34-7.84 (m, 
5H, Ar-H), 8.22 (s, IH, -CH=C), 11.12 (s, 
1H,NH), 11.43 (s, 1H,NH). 
w/z346.]5(M^). 
: Calculated C, 51.97; H, 3.17; N, 
16.15. Found C, 51.99; H, 3.13; N, 16.07 
%. 
2-(5-Chloro-3-methyl-l-phenylpyrazoI-4-yl)inethylene-l,4-benzothiazine-3-one(3e) 
Purified by recrystaliization from ethanol-chloroform (3:2 v/v) mixture. 
Greenish yellow solid. 
MS-ESI 
Elemental analysis 
forCi5HiiN402SCl 
M.p 
IR (KBr) Umax/cm' 
'HNMR(400MHz,CDCl3) 
MS-FAB (% rel. Int) 
Elemental analysis 
forCi9H|4N30SCI 
114-116 °C (dec). 
1597 (C=C), 1653 (C=0), 3185 (NH). 
<5(ppm)2.33 (s, 3H, CH3) 7.12-8.02 (m, 
lOH, Ar-H + CH=C), 9.61 (br s, IH, NH). 
m/z 368 (M^, 70). 
Calculated C, 62.06; H, 3.80; N, 
11.42. Found C, 62.08; H, 3.83; N, 11.39 
%. 
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5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)inethylene-2,2-diinethyl-l,3-dioxane-4,6-
dione (3f) 
Purified by recrystallization from ethanol-chloroform (2:3 v/v) mixture. 
Pale yellow crystals. 
-1 
M.p 
JR (KBr) Umax/cm' 
' H N M R ( 3 0 0 M H Z , CDCI3) 
MS-FAB (% rel. Int) 
Elemental analysis 
forC,7H,5N204Cl 
240-242 °C. 
1582 (C=C), J725(C=0). 
S (ppm) 1.59 (s, 6H, 2 CH3), 2.52 (s, 3H, 
CH3), 7.00-7.73 (m, 6H, Ar-H + CH=C). 
m/z 347 (M ,^ 90). 
: Calculated C, 58.90; H, 4.32; N, 8.07. 
Found C, 58.94; H, 4.35; N, 8.03 %, 
4-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)methylene-3-methyl-l-phenylpyrazol-5-
one (3g) 
Purified by recrystallization from chloroform-ethanol (4:1 v/v) mixture. 
White powder. 
M.p 
lR(KBr)Vn,ax/cm-' 
'HNMR(400MHz,CDCl3) 
MS-FAB (% rel. Int) 
Elemental analysis 
forC2iH,7N4C)cl 
186-188°C. 
1602 (C=C), 1730 (C=0). 
S (ppm) 2.41 (s, 6H, 2 CH3), 4.93 (s, IH, 
CH=C), 7.23-7.76 (m, lOH, Ar-H). 
m/z 376 (M^ 100). 
Calculated C, 66.96; H, 4.51; N, 14.86. 
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Found C, 66.92; H, 4.49; N, 14.83 %. 
5-(5-Azido-3-niethyl-l-phenylpyrazol-4-yI)methylene-2,4,6-pyrimidinetrione(6a) 
Purified by recrystallization from chloroform-methanol (4:1 v/v) mixture. 
Pale yellow crystals. 
M.p 
IR (KBr) Dmax/cm' 
'H N M R (300 MHz, DMSO-de) 
13 C NMR (100 MHz, DMSO-dg) 
MS-FAB (% rel. Int.) 
Elemental analysis 
forCisHnNyOs 
167 °C (dec) 
1381 (C-N), 1528 (C-N), 1574 (C=C), 
1655 (C-0), 3067 (NH), 3194 (NH). 
d (ppm) 2.37 (s, 3H, CH3), 7.36-7.65 (m, 
5H, Ar-H), 8.32 (s, 1H, -CH=C), 11.10 
(s, 1H,NH), 11.20 (s, 1H,NH). 
(5 (ppm) 12.6, 115.9, 123.3, 127.7, 128.7, 
136.9, 138.7, 142.2, 150.0, 151.4, 161.2, 
162.6. 
m/z 337 (M^ 80), 336 (45), 309 (15), 
308 (65), 212 (5), 135 (80), 120 (15), 92 
(20). 
: Calculated C, 53.41; H, 3.28; N, 29. 60. 
Found C, 53.59; H, 3.44; N, 29.45 %. 
5-(5-Azido-3-methyl-l-phenylpyrazol-4-yI)methyIene-2-mercapto-4,6-
pyrimidinedione (6b) 
Purified by recrystallization from chloroform-methanol (4:1 v/v) mixture. 
Pale yellow solid. 
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M.p 
IR (KBr) Umax/cm-
'H NMR (300 MHz, DMSO-de) 
'XNMR(100MHz, CDCI3) 
: 174-176 T . 
: 1009 (C=S), 1350 (C-N), 1508 (C=N), 1594 
(C=C), 1648 (C=0), 3057 (NH), 3140 (NH). 
S (ppm) 2.43 (s, 3H, CH3), 7.39-7.67 (m, 
5H, Ar-H), 8.44 (s, IH, -CH=C), 11.14 (s, 
1H,NH), 11.16 (s,lH,NH). 
: d (ppm) 12.6, 115.7, 122.3, 127.7, 128.9, 
136.2, 138.4, 141.2, 150.0, 151.8, 161.6, 
172.1 
MS-FAB (% rel int) : m/z 353 (M^ 80), 352 (60), 325 (15), 
135(50), 120(5). 
Elemental analysis 
forCi5HiiN702S : Calculated C, 50.98; H, 3.13; N, 27.74. 
Found C, 50.89; H, 3.04; N, 27.70 %. 
5-(5-Azido-3-methyl-l-phenylpyrazol-4-yl)methyIene-l,3-dimethyl-2,4,6-
pyrimidinetrione (6c) 
Purified by recrystallization from methanol-chloroform (3:2 v/v) mixture. 
Bright yellow crystals. 
M.p 
IR (KBr) x)max/cm' 
'HNMR(400MHz,CDCl3) 
201-204 °C. 
1342 (C-N), 1524 (C=N), 1596(C=C), 1683 
(C=0). 
d (ppm) 2.40 (s, 3H, CH3), 3.40 (s, 3H, N-
CH3), 3.45 (s, 3H, N-CH3), 7.40-7.69 (5H, 
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Ar-H), 8.44 (s, 1H,-CH=C). 
'^ C NMR (100 MHz, DMSO-de) : S (ppm) 12.6, 27.7, 28.3, 114.9, 123.4, 127.7, 
128.6, 136.7, 139.0, 143.9, 150.6, 151.7, 
159.8, 161.2 
FAB-MS (% rel. Int.) : m/z 365 (M^ 85), 364 (50), 338 (15), 
213(5), J 55 (30), 135(70), 120(10). 
Elemental analysis 
forCnHisNvOs : Calculated C, 55.89; H, 4.13; N, 26.83. 
Found C, 55.81; H, 4.26; N, 26.74 %. 
2-(5-Azido-3-methyl-l-phenylpyrazol-4-yl)methylene-l,3-indanedione (6d) 
Purified by recrystallization from methanol-chloroform (4:1 v/v) mixture. 
Red crystals. 
M.p : 234 °C (dec) 
IR (KBr) Dmax/cm' : 1358 (C-N), 1520 (C=N), 1576 (C=C), 
1671 (C=0). 
'H NMR (400 MHz, CDCI3) : d (ppm) 2.43 (s, 3H, CH3), 7.39-8.03 (m, 
9H, Ar-H), 7.83 (s, IH, -CH=C). 
'^CNMR(100MHz, CDCI3) : c5(ppm) 13.0, 122.9, 123.3, 128.0, 128.2, 
131.6, 135.0, 135.3, 137.2, 138.9, 141.9, 
152.1, 188.5, 189.4 
FAB- M S (% rel. Int.) : m/z 355 (M^ 90), 354 (60), 327 (5), 306 
(70), 135(75), 120(10). 
Elemental analysis 
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for CzoHnNjOz : Calculated C, 67.60; H, 3.68; N, 19.70. 
Found C, 67.71; H, 3.75; N, 19.64 %. 
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CHAPTERS 
SYNTHESIS OF BIOLOGICALLY IMPORTANT COUMARIN 
DERIVATIVES FROM 3-BROMO-4-HYDROXYCOUMARIN 
5.1. REVIEW & LITERATURE 
5.1.1. Biological importance. 
The synthesis of coumarin derivatives has attracted considerable attention of organic and 
medicinal chemists as these compounds are widely used as fragrances, pharmaceuticals 
and agrochemicals.' Coumarins possess a variety of bioactivities including estrogenic, 
dermal, photosensitizing, antimicrobial, vasodilative, molluscacidal, anthelmintic, 
sedative-hypnotic, analgesic and hypothermic activity. ' Furthermore, three coumarin 
antibiotics, novobiocin, chlorobiocin and coumermycin Al exhibit significant activity on 
certain tumor cells.^ Various skin diseases are treated using photochemotherapy with 
linear furanocoumarins (psoralens) followed by irradiation with UVA."* Coumarins 
constitute an important class of compound due to their presence as an important 
constituent of natural products^ as well as their variety of medicinal applications such as 
anti-inflammatory,^ anticonvulsant,^ antiviral,* antioxidant,^ antibacterial,'° antifungal," 
anti-HIV,'^ anticarcinogenic, '^  antihistamine''' etc. 
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5.1.2. Biologically active coumarin derivatives 
5.1.2a. Representative biologically active coumarins 15 
OMe 
Wedelolactone 
(Venomous snakebite antidote) 
Carbochromen 
(Coronary Vasodilator) 
Novobiocin 
(Antibiotic) 
Seselin 
(Anti-HIV) 
5.1.2 b. Anticancer active coumarin 16 
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5.1.2c. Antioxidant coumarins 17 
R'=H, CI R'=H 
R-- CH3, CH2CI, CHjOH, CH2S(CH2)iiCH3, CfeHj j^2^ CH2C!, CH2S(CH2)| .CHj, CH2OH 
R^ = H. OH 
R'^ =H,OCll3 
R^ = H, OH, OCOCH3 
R^ = H, OH. COOH, COOCH3, OCOCH3. 
BK 
R^ = H, OH. 
R'=H 
R^ =CH2C1, QHj 
5.1,2d. Antimicrobial coumarins '* 
R=H,CH3, OCH3, Br, CI, F, NO2 
^ R ' = H , CH3 
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5.1.3. Chemical relevance 
Besides the wide spectrum biological applications of coumarin and its derivatives the 
chemical literature also embodies their some applications from the material view point 
such as cosmetics,' optical brightening agents'^ and laser dyes.^° A recent literature report 
has revealed the anion sensing ability of some coumarin derivatives.^' Coumarin 
derivatives afford a range of organic materials that are used commercially in a broad 
range of applications because of their intense fluorescence.^^ They not only operate as 
enzyme substrates for fluorimetric titrations in biomedical analysis but also provide a 
fundamental structure for the numerous fluorescent probes and advanced photo physical 
systems.^ ^ In addition, coumarin derivatives are intensively used in the coloring or 
fluorescent whitening of textiles and other materials. 
Naturally occurring coumarins are found in several plants, including grasses, orchids, 
citrus fruits, and legumes, and are involved in the actions of plant growth hormones and 
growth regulators, the control of respiration, photosynthesis and defense against 
infection.'^  Coumarins also act as intermediates for the synthesis of furocoumarins, 
chromenes, coumarones, and 2-acylresorcinols.^^ It is, therefore, of importance that the 
synthesis of coumarin derivatives should be achieved by an effective method. 
5.2. PRESENT WORK 
In continuation of our work on the synthesis of coumarin derivatives and the 
development ot novel synthetic methodologies, herein this chapter we are reporting one 
pot, efficient and simple methodology for the synthesis of coumarin derivatives by the 
reaction of 3-bromo-4-hydroxycoumarin with various heteroaldehydes. 
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5.3. RESULTS AND DISCUSSION 
4-Hydroxycoumarin possesses nucleophilic character due to the presence of carbon-
carbon double bond at position 3 and reacts with aldehydes and Icetones to give 
dicoumarol derivatives.^*''^ ' It was expected, therefore, that 3-bromo-4-hydroxycoumarin 
would also react with aldehydes to give dicoumarol derivatives. The reaction, as felt, 
afforded 3a-c in quantitative yields (76-81%) by refluxing in methanol, 1 and 
heteroaldehydes 2a-c in the presence of catalytic amount of pyridine (Scheme 1). 
However, the reaction of 1 with 5-chloro-3-methy]-l-phenylpyrazole-4-carboxaldehyde 
2d did not stop at dicoumarol product (3e) stage, instead subsequent cyclization took 
place to give pyrazolopyrone 3d in good yield (80%) (Table 1). A probable route for the 
formation of 3d has been shown in Scheme 2. The structural assignment of the 
compounds isolated was done by elemental and spectral (IR, 'H N M R , Mass) analysis. 
The high molecular weight of the compound 3b in the electron spray mass spectrum (M^ 
= 494.16) (Fig. 3), indicated the incorporation of more than one coumarin moiety in the 
product. The Infra red (IR) spectrum (Fig. 1) exhibited a strong absorption bands at 1636 
and 1710 cm"' for the carbonyl groups of chromone and coumarin moieties respectively. 
Absorbtion band at 1572 cm'' was due to C=C of coumarin units. Another absorption 
band at 3437 cm'' was assigned to OH group of coumarin unit. The proton nuclear 
magnetic resonance ( 'H NMR) spectrum (Fig. 2) showed a sharp singlet at 6 2.42 for the 
methyl protons of chromone moiety. The upfield singlet of methine proton appeared at 6 
6.25. The 11 aromatic protons (three protons of chromone moiety and 8 protons of 
coumarin units) were discernible in the form of multiplet at S 7.33-8.01. Diagnostic 
singlet of C-2 proton of chromone moiety was present as sharp singlet at 5 7.66. Another 
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singlet (D2() exchangeable) at S 11.20 integrating for more than one proton was assigned 
to OH protons ot'coumarin units. Further confirmation for the structure 3b, was provided 
h\ mass spectrum (Fig. 3) which has given subsequent fragmentation pattern. The 
spectral studies of the other compounds followed similar pattern. 
5.4. CONCLUSION 
in summar} we have developed a clean and convenient method to synthesize new 
coumarin derivatives in good yields. The method is advantageous in terms of reduced 
reaction time, high yield of products, simple experimental work-up procedure etc. thus, 
adding a useful procedure to existing methodologies. 
3a = 
-HL-1 -- 3b = 
3c = 
Scheme 1. Svnthelic pathway of products (3a-d) 
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Scheme 2. Mechanism ojformation of product 3d. 
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Table 1. Synthesis of compounds 3a-d. 
Entry products Molecular structure Time Yield" M.p. 
(h) (%) (°C) 
3a 
2 3b 
76 >300 
3.5 78 >300 
O "Oo*^ ^ O" 
3 3c 
3d 
2.5 81 242-245 
3 80 270-272 
All yields refer to isolated products. 
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5.5. EXPERIMENTAL 
Melting points of all synthesized compounds were taken in Riechert Thermover 
instrument and are uncorrected. The IR spectra (KBr) were recorded on Perkin [:lmer 
RXI spectrometer. 'H N M R spectra were recorded on Bruker DRX-300 and Bruker 
Avance 11-400 spectrometer using tetramethyl silane (TMS) as the internal standard and 
DMS()-d(, as solvent. Mass spectra were recorded on JEOL-Accu TOF JMS-TIOOIX 
DART -MS spectrometer, Micromass Quattro 11 triple quadrupol mass spectrometer and 
.leol-SX-102 (FAB) spectrometer. Elemental analyses (C, H, and N) were conducted 
using Carlo Erba analyzer model 1108. 3-Bromo-4-hydroxycoumarin." 3-
formylchromone. 6-methyl-3-formylchromone, indole-3-carboxaldehyde^" and 5-
chloro-3-methyl-l-phenylpyrazole-4-carboxa!dehyde," were prepared by reported 
procedures. Other chemicals were purchased from Merck (Mumbai, India), Sigma-
Aldrich (Switzerland) and used without further purification. The purity of all 
compounds v\as checked by TLC on glass plates (20 x 5 cm) coated with silica gel (E-
Merck G;54 0.5 mm thickness). The plates were run in chloroform-methanol (3:1) 
mixture and were visualized by iodine vapours. 
5.5.1. General procedure for the preparation of coumarin derivatives (3a-d) 
To a solution of 3-bromo-4-hydroxycoumarin 1 (4.14 mmol) in methanol (12 mL). 
containing 0.4 inE of pyridine, heteroaidehyde 2a-d (2.07 mmol) was added. The reaction 
mixture was rctluxed on a heating mantle for 2.5-3.5 hours. After completion of the 
reaction (checked by TLC), the reaction mixture was cooled at room temperature. The 
solid part separated out was collected by Alteration, dried and recrystallized either from 
chloroform or from benzene to afford 3a-d in pure form. 
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Spectral data 
l,l-Bis(4-hydroxy-l-benzopyran-2-one-3-yI)-l-(4-oxo-4//-l-benzopyran-3-
yl)methane (3a) 
F u^rified by recrystallization from chloroform. 
White powder. 
Yield 
M.p 
IR(KBr)u,„,x/cm' 
' H N M R (300 MHz, DMS0-d6) 
: 76 % 
: >300 °C. 
: 1570 (C=C), 1633 (C=0), 1708 (C=0). 
3428 (OH). 
: S (ppm) 6.02 (s, IH, CH), 7.18-7,79 (m, 
11H, Ar-H), 7.88 (d, IH, ,/=7.8 Hz. C-5, 
chromone), 7.98 (s, 1H, C-2. chromone). 
11.31 (s, 2H, OH). 
: Aw/z 480.13 (M') , 453.12, 451.11. 320.08. 
319.08,317.06,99.11. 
: Calculated C, 70.01; H, 3.35. Found C. 
70.18; H, 3.42%. 
1,1 -Bis(4- hy d roxy-1 - benzopy ran-2-one-3-yl)- l-(6-methyl-4-oxo-4//-1- benzopy ran-3-
yOmethane (3b) 
Purified b\ recrvstaliization from chloroform. 
MS-ESl 
Elemental analysis for C28H16O8 
White pouder. 
Yield 78% 
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M.p 
IR (KBr) bmax/cm"' 
'H NMR (400 MHz, DMSO-dfe) 
MS-ESI 
Elemental analysis for C29H1SO8 
>300 °C. 
1572 (C=C), 1636(C=0), 1710 (C=0). 
3437 (OH). 
S (ppm) 2.42 (s, 3H, CH3), 6.25 (s, IH, CH) 
7.33-8.01 (m, 11H, Ar-H), 7.66 (s, IH, C-2. 
chromone), 11.20 (s, 2H, OH). 
m/z 494.16 (M'). 493.16, 318.07, 317.06, 
277.15,99.11,74.09. 
Calculated C, 70.44; H, 3.66. Found C. 
70.56; H, 3.69%. 
l,l-Bis(4-hydroxy-l-benzopyran-2-one-3-yl)-l-(indoI-3-yI)methane (3c) 
Purified by rccrystallization from chloroform. 
Yellow solid. 
Yield 
M.p 
!R(KBr)u,™vCm' 
'H NMR (400 MHz. DMSO-de) 
MS-ESI 
81% 
242-245 °C. 
1290 (C-N), I572(C=C), 1719 (C=0), 3065 
(NH), 3398 (OH). 
S (ppm) 5.04 (s, 1H, CH), 6.46 (s. 1H. -C =C-
H, indole), 6.81-7.97 (m, 11H. Ar-H), 10.43 
(s, IH, NH), 11.63(8, 2H, OH) 
m/z 451.3 (M"^ ), 446.3, 413.5, 377.4. 375.4. 
360.6, 358.6, 332.6, 274.6, 238.5, 225.5, 
134.5, 116.5. 
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HIemental analysis for 
C:7H,7NOo : Calculated C, 71.83; H, 3.79; N. 3.10. 
Found C, 71.91; H, 3. 64, N. 3.06 %. 
4-(4-Hydroxy-2oxo-2//-l-benzopyran-2-one-3-yl)-3-inethyl-l-phenylpyrazolo|3,4; 
2,3|-4/f-pyrano|3,2-b)-l-benzopyran-5-one(3d) 
r^ iirified bv rccrvstallization from benzene. 
White crystals. 
Yield 
M.p 
lR(KBr)l),™^/cm' 
'H N M R (300 MHz, DMSO-dfe) 
MS- FAB (% rei. int) 
Elemental analysis for 
C29HisN,0, 
80% 
270-272 °C. 
1368 (C-N), 1608 (C=N), 1633 (C=C), 1719 
(C=0), 3480 (OH). 
S (ppm) 2.50 (s, 3H, CHj), 4.67 (s, 1H. 
CH), 7.09-8.40 (m, 13H, Ar-H), 11.38 (s, 
1H,0H). 
m/z 490 (M^ 25), 329 (50), 331 (60), 
346 (5), 302 (15), 318 (25), 317(100). 269 
(90), 267 (85), 185(5), 150(20), 149(70), 
142(5), 115(50). 
Calculated C, 71.02; H, 3.69; N, 5.71. 
Found C, 71.09;H, 3.81; N, 5.63%. 
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Fig. 1. IR spectrum of 3b. 
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Fig. 2. 'H NMR spectrum of 3b. 
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CHAPTER-6 
ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES 
6.1. INTRODUCTION 
In recent years, the number of life-threatening infectious caused by multi-drug resistant 
Gram-positive and Gram-negative pathogen bacteria have reached an alarming level in 
many countries around the world.''^ These enteric bacterial infections are responsible for 
morbidity and mortality globally, mostly in developing countries and areas such as the 
Indian sub-continent, part of South America and tropical part of Africa etc.^'' A number 
of clinical reports in the United States and worldwide have independently described the 
emergence of vancomycin resistance in methicillin-resistance Staphylococcus aureus 
(MRSA) isolates and other human pathogen Gram-negative isolates.^ Escherichia coli are 
responsible for the world's most common and serious infectious diseases such as invasive 
dysentery and diarrhea.^'' Generally broad varieties of symptoms like stomach ache, 
cramps, bloating or tenderness are shown by patients. Generally, there are complains of 
abscess of the brain which is a very bad problem of E. coli infection.^ In case of E. coli 
infection amoxicillin, norfloxacin and ciprofloxacin are generally used, but have harsh 
side effects.'^ Toxicity and resistance to the drugs also play important role in the 
treatment failure." The different parasitic bacteria such as Staphylococcus aureus. 
Streptococcus pyogenes, Salmonella typhimurium, E. coli have important effect on the 
human's mucosal health. The infection with these microorganisms may have significant 
impact on huge demolition of host tissue and severe diseases."''" More than 90% of the 
cases of vaginitis are of candidiasis, trichomoniasis and bacterial vaginosis.'^ Thus, the 
infections caused by these microorganisms pose a serious challenge to the medical 
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community and need for an effective therapy has led to search for novel antimicrobial 
agents. 
The synthesis of chalcones, pyrazolines, pyrazoles and coumarin derivatives has 
engrossed substantial attention from organic and medicinal chemists for many years as 
they belong to a class of compounds with potent utility in medicinal chemistry. These 
oxygen and nitrogen heterocyclic derivatives have been reported to possess antimicrobial 
activity by many research groups.'^''^ Thus, in a quest for new antibacterial and 
antifungal agents all the newly synthesized compounds were screened for their in vitro 
antimicrobial activities against the representative panel of microbial organisms. The 
evaluation of antimicrobial activities were carried out from Department of Agricultural 
Microbiology, Aligarh Muslim Univerity, Aligarh and from Interdisciplinary 
Biotechnology Unit, Aligarh Muslim University, Aligarh. The numbering for the 
synthesized compounds has been changed in this chapter for convenience. 
6.2 In vitro antibacterial and antifungal activities of chromonyl chalcones (la-b) 
and derivatives (Ic-k). 
6.2.1. Microorganisms used. 
All the newly synthesized compounds were screened in vitro antibacterial activity 
against an assortment of two Gram-positive bacteria, Staphylococcus aureus SA 22, 
Bacillus sub til is MTCC 121, and two Gram-negative bacteria, Escherichia coli K12, 
Salmonella typhimurium MTCC 98, in vitro antifungal activity was tested against three 
fungal strains, Candida albicans IOA-109, Aspergillus niger (Laboratory isolate) and 
Aspergillus fumigatiis (Laboratory isolate). 
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6.2.2. Antibacterial studies 
All the synthesized compounds were dissolved to prepare a stock solution of I mg/m! 
using DMSO and were seriously diluted to the concentration 100 ^g/mL. I he 
antibacterial activity of test compounds and standard chloramphenicol was done by filter 
paper disk method.''' Media with DMSO was set up as control. All cultures were 
routinely maintained on NA (nutrient agar) and incubated at 37 °C for overnight. The 
culture was centrifuged at 1000 rpm and pellets were resuspended and diluted in sterile 
NSS to obtain viable count 10 c.fu./mL. Approximately 0.1 mL of diluted bacterial 
culture suspension was spread with the help of spreader on NA plates uniformly. Sterile 8 
mm disks (Hi-Media Pvt Ltd) were impregnated with the test compounds. Antibiotic 
disk, chloramphenicol (30 |xg/disk, Hi-Media) was used as control. The disk was placed 
on to the plate. Each plate had one control disk impregnated with the solvent. The plates 
were then incubated for 24 h at 37 °C, and the resulting zones of inhibition (in mm) were 
measured. 
6.2.3. Antifungal studies 
The synthesized compounds were dissolved in DMSO. Media with DMSO was set up as 
control. All cultures were routinely maintained on SDA and incubated at 28 °C. Spore 
formation of lilamentous fungi was prepared from 7 day old culture in sterile normal 
solution (8% NaCI) and approximately diluted to obtain 10^  c.fu./mL. The inoculums of 
non-sporing fungi. C. albicium was performed by growing the culture in SO broth at 37 
'C for overnight. The culture was centrifuged at 1000 rpm and pellets were resuspended 
and diluted in sterile NSS to obtain viable count 10^  c.fu./mL. Approximately 0.1 mL of 
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diluted fungal culture suspension was spread with the help of spreader on SDA plates 
uniformly. Sterile 8 mm disks (Hi-Media Pvt Ltd) were impregnated with the test 
compounds. Antibiotic disk, nystatin (30 jig/disk, Hi-Media) was used as control. The 
disk was placed on to the plate. Each plate had one control disk impregnated with the 
solvent. The plates were incubated at 28 °C for filamentous fungi for 72 h or more, while 
for C. alhiran.s plates were incubated at 37 °C for 18-48 h. Antifungal activit) was 
determined by measuring the diameters of the inhibition zone. 
Compounds screened for antibacterial and antifungal activities 
o o 
l a - R = I I () 
lb = R =111^ I 
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Table 1 In vitro 
Compounds 
la 
11) 
h 
Id 
It 
n 
1^ 
Ih 
li 
antibacterial and antifungal activity of co 
Gram 
S. 
Diameter of inhibition; 
!-positive 
B. 
aureus suhtilis 
15 
12 
16 
II 
-
-
13 
8 
8 
20 
16 
13 
13 
-
-
10 
-
_ 
impounds la-
zone in mm at 100 jig/ 
Gram-negative 
E. 
coli 
20 
20 
15 
12 
8 
-
18 
15 
14 
typh 
S. 
mmrium 
16 
12 
12 
10 
12 
19 
9 
11 
16 
Fung 
C 
albicans 
16 
12 
14 
17 
15 
15 
14 
-
15 
•k. 
mL 
;al spec 
A. 
niger 
8 
12 
8 
-
-
-
14 
-
„ 
ies 
A. 
fumiguius 
10 
14 
14 
10 
12 
-
-
. 
n 15 17 
I k 
Chloramphenicol 
Nvstatin 
14 
26 
_ 
12 
24 
„ 
12 
25 
_ 
12 
20 
« 
DMSO 
20 18 
No activity detected 
6.2.4. Results and discussion 
The newly generated compounds la-k, exerted significant inhibitory activity against the 
growth of the tested bacterial and fungal strains. The data (Table 1) revealed that 
compounds ha\e significant influence on antibacterial profile of Gram-positive bacteria. 
The compounds also showed moderate to good inhibitory results against Gram-negative 
bacteria viz S. lyphimurium and E. coli. Among the tested compounds, chalcones la and 
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lb showed more potent inhibitory activity against both types of bacteria. However. 
derivatives ol chalcones exerted varying inhibitory action. Further, antifungal screening 
revealed that the compounds la-k exhibited moderate to good inhibition to C. albicans 
and lesser inhibition against^, niger and A. fumigatus. 
6.3. In vitro antibacterial and antifungal activities of Knoevenagel condensation 
products 2a-g 
The same organisms with the same protocol as explained above was used to evaluate the 
inhibitory aciivities of the compounds. 
Compounds screened for antibacterial and antifungal activities 
H3C, 
-Het 
N CI 
0 
2a = Het= ( | 
C 
Ph 
2i.-g 
] 2b = Het= ( V = 0 2c = Het= / 
^ V-NH V 
0^ / 
V = 0 2d = Het- ( 
\ 1/ 
CH3 0 
— NH 
— NH 
2e Het--
H 
2f=Het= 
A, 
O'^ 0 
0 / ^ ^Ph 
CH3 2g = H e t = / N 
CH3 
H3C 
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Table-2 In viiro antibacteria 
Compound 
.s: 
2a 
2b 
2c 
2d 
2e 
2f 
2g 
Chloram-
phenicol 
Nystatin 
DMSO 
Is 
(jram-
uiireiis 
12 
17 
::0 
12 
'4 
19 
-
26 
-
-
•po; 
B. 
iitive 
suhtilis 
8 
19 
16 
8 
-
15 
12 
24 
-
-
1 and antifungal activity of compounds 2a-g. 
Diameter of inhibition zone in mm 
1 
E. coli 
17 
15 
15 
15 
8 
-
8 
25 
-
-
Gram-negative 
S. typhimurium 
15 
12 
14 
17 
-
-
12 
20 
-
-
C. albicans 
12 
-
11 
16 
15 
14 
-
_ 
20 
-
at 100|ig/mL 
Fungal species 
: A. niger A. fiiniigaliis 
8 10 
-
8 11 
-
-
-
10 11 
_ 
18 18 
-
- No activit) detected 
6.3.1. Results and discussion 
The compounds 2b, 2c, 2d and 2f exhibited good activity against Gram-positive bacteria 
SiaphylococcNs aureus, Bacillus suhtilis and Gram-negative Salmonella typhimwiuni 
The other compounds were moderately active against both Gram-positive and Gram-
negative bacteria. Antifungal screening showed that the compounds were moderate to 
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good active against Candida albicans, while lesser active against Aspergillus nigcr and 
Aspergillus fiiiuigatus. 
6.4. In vitro antibacterial and antifungal activities of Knoevenagel condensation 
products 3a-r 
Antibacterial activity and antifungal activity of the newly synthesized compounds was 
completed by the disk diffusion method and measured by Halo Zone Test. The MIC of 
synthesized compounds against bacterial and fungal strains was performed by macro 
dilution test and results were observed visually and spectrophotometrically. 
6.4.1. Microorffdiiisms used 
The newly prepared compounds were screened for their antibacterial activity against 
Escherichia :oli (ATCC-25922), Methicillin resistant Staphylococcus aureus (MRSA 
-Ve). Pseudonionas aeruginosa (ATCC-27853), Streptococcus pyogenes and Klebsiella 
pneumoniae (Clinical isolate) bacterial strains by disk diffusion method."""'Antifungal 
activit> was also done by disk diffusion method. For assaying antifungal activity 
Candida albicans. Aspergillus fumigatus, Penicillium marneffei and Trichophyton 
inenlagrophy/es were recultured in DMSO by agar diffusion method."" "^  
6.4.2. Antibacterial studies 
A standard inoculums (1-2 x lO^c.f u./mL 0.5 McFarland standards) was introduced on to 
the surface of sterile agar plates, and a sterile glass spreader was used for even 
distribution ot the inoculums. The disks measuring 6 mm in diameter were prepared from 
Whatman no. 1 filter paper and sterilized by dry heat at 140 °C for I h. 1 he sterile disks 
previous!} soaked in a known concentration of the test compounds were placed in 
nutrient agar medium. Solvent and growth controls were kept. Ciprofloxacin (30 |ag) was 
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used as positive control, while the disk poured in DMSO was used as negative control. 
The plates were inverted and incubated for 24 h at 37 °C. The susceptibility was assessed 
on the basis of diameter of zone of inhibition against Gram-positive and Gram-negative 
strains of bacteria. Inhibition zones were measured and compared with the controls. The 
bacterial zones of inhibition values are given in Table 3. 
Minimum inhibitory concentrations (MICs) were determined by broth dilution technique. 
The nutrient broth, which contained logarithmic serially two fold diluted amount of test 
compound and controls were inoculated with approximately 5 x 10' c.fu./mL of active!) 
dividing bacteria cells. The cultures were incubated for 24 h at 37 °C and the growth was 
monitored visually and spectrophotometrically. The lowest concentration (highest 
dilution) required to arrest the growth of bacteria was regarded as minimum inhibitor} 
concentration (MIC). To obtain the minimum bactericidal concentration (MBC), 0.1 mL 
volume was taken from each tube and spread on agar plates. The number of c.fu. was 
counted alter 18-24 h of incubation at 35 °C. MBC was defined as the lowest drug 
concentration at which 99.9% of the inoculums were killed. The minimum inhibitorv 
concentration and minimum bactericidal concentration are given in Table 4. 
6.4.3. Antifungal studies 
Sabourauds agar media was prepared by dissolving peptone (1 g), D-glucose (4 g) and 
agar (2 g) in distilled water (100 mL) and adjusting pH to 5.7. Normal saline was used to 
make a suspension of spore of fungal strain for lawning. A loopful of particular fungal 
strain was transferred to 3 mL saline to get a suspension of corresponding species. 20 mL 
of agar media was poured into each Petri dish. Excess of suspension was decanted and 
the plates were dried by placing in an incubator at 37 °C for 1 h. Using an agar punch. 
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wells were made and each well was labeled. A control was also prepared in triplicate and 
maintained at 37 °C for 3-4 days. The fungal activity of each compound was compared 
with griseofulvin as standard drug. Inhibition zones were measured and compared with 
the controls, I he fungal zones of inhibition values are given in Table 5. 
The nutrient broth, which contained logarithmic serially two fold diluted amount of test 
compound and controls was inoculated with approximately 1.6 x 10''-6 \ lO^c.fu./mL. 
The cultures were incubated for 48 h at 35 °C and the growth was monitored. The lowest 
concentration (highest dilution) required to arrest the growth of fungus was regarded as 
minimum inhibitory concentration (MIC). To obtain the minimum fungicidal 
concentration (MFC), 0.1 mL volume was taken from each tube and spread on agar 
plates. The number of c.fu. was counted after 48 h of incubation at 35 °C. MFC was 
defined as the lowest drug concentration at which 99.9% of the inoculums were killed. 
The minimum inhibitory concentration and minimum fungicidal concentration are given 
in Table 6. 
Compounds screened for antibacterial and antifungal activities 
3f = Z = CH C-rH-, 
Hi 3e - f 
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Table 3. Antibacterial activity of compounds 3a-f. 
Diameter of zone of inhibition (mm). 
Compounds Gram-positive bacteria Gram-negative bacteria 
3a 
3b 
3c 
3d 
3e 
M 
Standard 
DM SO 
S. pyogenes MRS A * P. aeruginosa K. pneumoniae E. coli 
21.1i0.2 
20.3i0.3 
I9.5i0.5 
I8.li().4 
17.9i0.3 
17.8±0.2 
23.0±0.2 
18.4±0.8 
18.3±0. 6 
18.2±0.6 
17.6±0.4 
i7.6±0.2 
17.6±0.5 
22.0±0.2 
26.1±0.6 
23.3±0.2 
23.1±0.2 
22.9±0.4 
21.2±0.3 
21.1±0.2 
32.0±0.3 
17.6±0.2 
17.4±0.2 
17.2±0.2 
16.7±0.3 
15.8±0.3 
15.4±0.2 
19.0±0.2 
23.3±0.5 
22.9±0.3 
2I.7±0.2 
20.7±0.3 
20.4±0.2 
20.2±0.2 
27.0±0.2 
Positive control (Standard); ciprofloxacin and negative control (DMSO) measured by the Halo Zone 
lesl (Unit. mm). * Mcthicillin resistant Staphylococcus aureus (MRSA +Ve), 
Table 4. MIC and MBC results of compounds 3a-f: Positive control ciprofloxacin. 
Comp 
3a 
3 b 
3e 
3d 
3e 
3f 
Stand; 
ounds 
ird 
Cjram-positive bacteria 
S pyoi^c'K's 
MIC 
12.5 
12.5 
25 
25 
50 
50 
12,5 
MBC 
50 
50 
100 
100 
100 
100 
25 
MRSA 
MIC 
12.5 
25 
25 
50 
50 
50 
6.25 
MBC 
50 
50 
100 
100 
100 
100 
12.5 
Gram-ne 
P. aeruginosa 
MIC 
25 
25 
50 
50 
50 
100 
12.5 
MBC 
100 
100 
100 
100 
>100 
>100 
25 
gative bacteria 
K. pneumoniae 
MIC 
25 
25 
25 
50 
50 
50 > 
6.25 
MBC 
50 
100 
100 
100 
100 
•100 
25 
A coli 
MIC 
25 
25 
25 
50 
50 : 
50 > 
6.25 
MBC 
50 
100 
100 
100 
>100 
•100 
25 
MIC (|ig/mL) = minimum inhibitory concentration, that is, the lowest concentration of the 
compound to inhibit the growth of bacteria completely; MBC (|jg/mL) = minimum bactericidal 
concentration, that i.s, the lowest concentration of the compound for killing the bacteria 
completely. 
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Table 5. Antifungai activity of compounds 3a-f: Positive control (Griseofulvin) and negative 
control (DMSO) measured by the Halo Zone Test (Unit, mm). 
Compounds 
3a 
3b 
3c 
3d 
3e 
3f 
Standard 
DMSO 
Diameter of: 
CA 
2().l±0.2 
19.5±0.4 
29.2±0.2 
19.1 ±0.6 
]8.9±0.3 
I8.2±0.4 
30.0±0.2 
-
zone of inhibitio 
AF 
19.6±0.3 
19.5±0.4 
I8.9±0.3 
18.4±0.2 
17.8±0.3 
I7.2±0.3 
27.0±0.2 
-
n (mm) 
TM 
I8.2±0.2 
18.1±0.3 
I8.1±0.6 
17.9±0.4 
17.0±0.2 
16.8±0.2 
24.0±0.3 
-
PM 
I4.9±0.4 
14.2±0.2 
14.l±0.3 
14.1±0.6 
13.2±1.2 
13.2±0.2 
20.0±0.5 
-
C'A^ Candida albicans, AF= Aspergillusfumigatus, TM= Trichophyton 
ineiUitgrophytes. ?M' PctiiciUium marnejfei. 
Table 6. MIC and MFC of compounds 3a-f: Positive control griseofulvin. 
Conip. 
3a 
3b 
3c 
3d 
3e 
3f 
Standard 
I 
MIC 
12.5 
12.5 
12.5 
12.5 
25 
25 
6.25 
CA 
MFC 
25 
50 
25 
50 
50 
50 
25 
MIC 
12.5 
12.5 
25 
25 
25 
25 
12.5 
AF 
MFC 
50 
50 
50 
100 
100 
100 
25 
MIC 
12.5 
25 
25 
25 
25 
50 
6.25 
TM 
MFC 
25 
50 
50 
100 
100 
100 
25 
MIC 
12.5 
25 
25 
50 
50 
>100 
12.5 
PM 
MFC 
25 
100 
100 
100 
100 
>I00 
25 
CA= Candida albicans, AF= Aspergillus fumigatus, TM= Trichophyton mentagrophytes, PM= 
Penicillium marnejfei. MIC (pg/mL) = minimum inhibitory concentration, that is, the lowest 
concentration of the compound to inhibit the growth of fungus completely; MFC (pg/mL) = 
minimum fungicidal concentration, that is, the lowest concentration of the compound for killing 
the fungus completely. 
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6.4.4. Results and discussion 
The investigation of antibacterial screening data revealed that all the tested compounds 
(3a-f) showed moderate to good bacterial inhibition. Compounds 3a, 3b, 3c and 3d 
showed more potent inhibition against S. pyogenes, Methicillin resistant Staphylococcus 
uiireus (MRSA +Ve), P. Aeruginosa, K. pneumoniae and E. coli species than the 
compounds 3e and 3f. The compounds 3a and 3b were found to be almost equally potent 
(12.5 |ig/mL) as the reference drug ciprofloxacin in case of .9. pyogenes. ). The MlCs of 
other compounds were found to be 12.5 to 50 jig/mL. The MBC of compounds was 
found to be two, three or four folds higher than the corresponding MIC values. 
The antifungal screening data also showed moderate to good activity. Compound 3a, 3b. 
3c and 3d showed good fungicidal activity against C. albicans, A. fimiigalus. 
Trichophyton nientagrophytes and P. marneffei fungal strains. Among the screened 
compounds, 3a and 3b showed almost equal activity (12.5 |ag/mL) as the reference drug, 
greseofulvin in case of A. fumigatus. ). The MlCs of other compounds were in the range 
of 12.5 to 50 (ig/mL. The MBC of the compounds was found to be two, three or four 
folds higher than the corresponding MIC results. 
6.5. In vitro antibacterial and antifungal activities pyrazolyl chalcones (4a-c) and 
pyrazolines (4d-f) 
The same organisms with the same protocol as explained above was used to evaluate the 
inhibitory activities of the compounds (4a-f). The antibacterial inhibitory results are 
presented in Table 7 and Table 8. The antifungal inhibitory results are given in Table 9 
and Table 10. 
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Compounds screened for antibacterial and antifungal activities 
O 
H3Q 
4a = 0 --
4d =Q 
N. 
^N CI 
Tabic 7. Antibacterial activity of compounds 4a-f. 
Compounds 
4a 
4b 
4c 
4d 
4e 
4f 
Standard 
DMSO 
Gram-posit 
S. pyo^^cnes 
20.l±().4 
22.2±(i.2 
I8.4±(t.4 
17.1±(i.2 
!6.8±(i.l 
15.2±().i 
24.0±0,3 
-
Diameter of zone of inhibition (mm). 
ve bacteria 
MRSA * 
I7.3±0.4 
20.2±0.2 
i7.1±0.3 
I6.5±0.2 
15.3±0.6 
14.2±0.2 
25.0±0.4 
-
Gram-
P. aeruginosa K. 
25.2±0.3 
27.2±0.4 
22.1±0.3 
21.8±0.2 
20.1±0.5 
!8.2±0.4 
32.0±0.3 
-
negative bacter 
pneumoniae 
I6.1±0.4 
I7.i±0.2 
I5.4±0,3 
15.7±0.4 
14.7±0.4 
I4.4±0.3 
I8.0±0.2 
-
ia 
E. coli 
22.2±0.4 
24.8±0.2 
20,7±0.3 
19.6±0.2 
!9.2±0.4 
19.l±0.3 
26.0±0.4 
-
Positive control (Standard); ciprofloxacin and negative control (DMSO) measured by the Halo Zone 
Test (I nit, mm). * Methiciilin resistant Staphylococcus aureus (MRSA +Ve), 
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Table 8. MIC and MBC results of 4a-f and positive control ciprofloxacin. 
Compounds 
4a 
4b 
4c 
4d 
4e 
4f 
Standard 
.S', pvo; 
MIC 
25 
12.5 
25 
25 
50 
50 
12,5 
Gram-po 
.',CIK'.S 
MBC 
50 
25 
100 
50 
100 
100 
50 
sitive bacteria 
MRSA 
MIC 
25 
12.5 
25 
50 
100 
100 
12.5 
MBC 
50 
50 
50 
100 
>I00 
>100 
50 
P. at 
MIC 
25 
12.5 
25 
50 
50 
50 
12.5 
Gram-ne 
ruginosa 
MBC 
100 
25 
100 
100 
100 
100 
25 
gative bacteria 
K. pneumoniae 
MIC 
50 
12.5 
25 
50 
50 
50 
25 
MBC 
100 
25 
50 
100 
>100 
>100 
50 
i':.c(. 
MIC 
25 
12.5 
50 
25 
50 
50 
12,5 
i / / 
MBC 
50 
50 
100 
100 
>I00 
100 
50 
MIC (jig/mL) = minimum inhibitory concentration, that is, the lowest concentration of the 
compound to inhibit the growth of bacteria completely; MBC (^g/mL) = minimum bactericidal 
concentration, that is, the lowest concentration of the compound for killing the bacteria 
completel>. 
Table 9. Antifungal activity of compounds 4a-f. 
Compounds 
4a 
4b 
4c 
4d 
4c 
4f 
Standard 
DMSO 
Diameter of: 
CA 
21.3±0.4 
25.5±0.5 
20.4±0.3 
20.8±0.4 
20.4±0.5 
20.2±0.2 
30.0±0.2 
-
zone of inhibition (mm) 
AF 
18.6±0.4 
21.3±0.2 
17.9±0.3 
17.4±0.2 
16.8±0.3 
16.2±0.3 
27.0±0.2 
-
TM 
17.2±0.2 
17.1±0.3 
17.l±0.6 
16.9±0.4 
16.0±0.2 
15.8±0.2 
24.0±0.3 
-
PM 
14.8±0.4 
14.1±0.2 
I4.1±0.3 
14.2±0.6 
13.1±1.2 
13.1±0.2 
20.0±0.5 
_ 
C/\; Candida albicans. AF; Aspergillus fumigatus, TM; Trichophyton 
nicniagrophytes. PM: Pcniciilium marneffei. 
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Table 10. MIC and MFC of compounds 4a-f. 
Co nip. 
4a 
4b 
4c 
4d 
4e 
4f 
MIC 
25 
12,5 
25 
25 
50 
50 
Standard 6.25 
CA 
MFC 
50 
25 
50 
100 
100 
100 
12.5 
AF 
MIC 
25 
12.5 
25 
25 
50 
25 
12.5 
MFC 
50 
25 
50 
100 
100 
100 
25 
TM 
MIC 
25 
12.5 
25 
25 
50 
25 
6.25 
MFC 
50 
25 
50 
100 
100 
100 
25 
PM 
MIC 
25 
12.5 
25 
50 
50 
>100 
12.5 
MFC 
50 
25 
100 
>I00 
100 
>100 
25 
CA: Candida alhiciins, AF; Aspergillusfumigatus,TM; Trichophyton mentagrophyles, PM: 
I'enicilliiini niarneffei. MIC (ng/mL) = minimum inhibitory concentration, that is, the lowest 
concentration of the compound to inhibit the growth of fungus completely; MFC (jig/niL) = 
minimum fungicidal concentration, that is, the lowest concentration of the compound tor killing 
the fungus completeK. 
6.5.1. Results and discussion 
The investigation of antibacterial screening data revealed that all the tested compounds 4a-f 
showed moderate to good bacterial inhibition. All the compounds showed good inhibition 
against P. aeruginosa S. pyogenes, Methicillin resistant Staphylococcus aureus (MRSA +Ve), K. 
pneuDumiae and E. coli species. Compound 4b showed more potent antibacterial activity 
(MR =12.5 ng/niL) nearly equivalent to that of ciprofloxacin against all fungal strains tested. 
The VllCs of other compounds were found to be 12.5 to 100 \iglmL. The MBC of compounds 
was found to be two or three or four folds higher than the corresponding MIC results. A 
coinparative study also revealed that pyrazolyl chalcones 4a-c, are more potent antimicrobial 
agents than pyrazolines 4d-f. The potential bactericidal effects of chalcones can be 
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related to the ability of the a,p unsaturated ketone system to undergo a conjugated 
addition to a nucleophilic group like a thiol group in an essential protein. 
The antifungal screening data of the compounds rervealed good to moderate activitx. 
Among the screened compounds 4b showed good inhibition against all the fungal strains 
(MIC = 1^2.5 ug/mL). The MICs of other compounds were observed in the range of 12.5 
to 100 f.ig/ml . The MFC of compounds was found to be two or three or four folds higher 
than the corresponding MIC results. All the screened compounds 4a-f, showed good 
fungicidal activity against C. albicans, A. fumigatus and P. marneffei fungal strains. 
Again pyrazoiyi chalcones, 4a-c were found to show better inhibitory activity than 
pyrazolines 4(l-f. 
6.6. In vitro antibacterial and antifungal activities coumarin derivatives 5a-d 
The same organisms with the same protocol as explained above was used to evaluate the 
inhibitory activities of the compounds (5a-d). The antibacterial inhibitory results are 
presented in Table 11 and Table 12. The antifungal inhibitory results are given in Table 
13 and Table 14. 
Compounds screened for antibacterial and antifungal activities 
I l e t - 5 
()!I Hel o n 
H,C, 
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Tablell. Antibacterial activity of 5a-d. 
Diameter of zone of inhibition (mm). 
Compounds 
5a 
3b 
5c 
5d 
Standard 
DMSO 
Gram-positive bacteria 
S. pyogenes MRSA* 
21.3±0.3 
21. i ±0.5 
I9.3±0.3 
19.3±i).3 
24.()±i).3 
-
18.9±0.5 
20.1 ±0.3 
18.4±0.2 
18.4±0.2 
25.0±0.4 
-
Gi 
P. aeruginosa 
26.1±0.2 
26.3±0.5 
23.2±0.4 
23.2±0.4 
32.0±0.3 
-
-am-
K. 
•negative bacteria 
pneumoniae 
17.3±0.2 
18.2±0.4 
16.3±0.2 
16.3±0.2 
I8.0±0.2 
-
E. coli 
22.1±0.3 
2I.1±0.4 
20.2±0.2 
20.2±0.2 
26.0±0.4 
-
Positive control (Standard); ciprofloxacin and negative control (DMSO) measured by the Halo Zone 
Test (Unit, mm). * Mcthicillin resistant Staphylococcus aureus (MRSA ±Ve). 
Tabic 12. MIC and MBC results of 5a-d; Positive control ciprofloxacin. 
Compounds 
5a 
5b 
5c 
5d 
Standard 
.v. /;vo; 
MIC 
25 
25 
50 
50 
12.5 
(iram-positive 
i^eiies 
MBC 
50 
100 
100 
100 
50 
bacteria 
MRSA * 
MIC MBC 
25 
25 
50 
50 
12.5 
50 
100 
>100 
>100 
50 
P. aei 
MIC 
25 
50 
50 
25 
12.5 
Gram-negative 
-uginosa 
MBC 
50 
100 
100 
100 
25 
bacteria 
K. pneumoniae 
MIC 
12.5 
25 
50 
50 
25 
MBC 
50 
100 
>100 
>100 
50 
E. coll 
MIC MBC 
25 50 
25 50 
50 >100 
50 >100 
12.5 50 
MIC (|ig/mL) = minimum inhibitory concentration, that is, the lowest concentration of the 
compound to inhibit the growth of bacteria completely; MBC (|ig/mL) = minimum bactericidal 
concentration, that is the lowest concentration of the compound for killing the bacteria 
completel). 
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Table 13. Antifungcil activity of 5a-d; Positive control (Griseofulvin) and 
negative control (DMSO) measured by the Halo Zone Test (Unit, mm). 
Compounds 
5a 
5b 
5c 
5d 
Standard 
DMSO 
Diameter of: 
CA 
19.4±0.3 
23.4±0.4 
!7.9±0.5 
i8.3±0.5 
3().0±0.2 
-
zone of inhibiti 
AF 
16.5±0.2 
19.2±0.6 
I5.4±0.4 
15.8±0,4 
27.0±0.2 
-
ion (mm) 
TM 
15.1±0.3 
15.2±0.4 
15.1±0.2 
15.3±0.2 
24.0±0.3 
-
PM 
13.7±0.3 
13.2±0.6 
12.9±0.5 
13.1±0.5 
20.0±0.5 
-
CA Cundida albicans. AF; Aspergillus fumigatus, TM; Trichophyton 
nientiigrophytes. PM: Penicilliuni marneffei. 
Table 14. MIC and MFC of compounds 5a-d. 
Comp. CA AF 
MIC MFC MIC MFC MIC 
TM 
MFC MIC 
PM 
MFC 
5a 25 100 25 50 25 50 25 100 
5b 25 50 25 100 50 100 50 >100 
5f 50 100 50 >100 100 100 50 100 
5(1 50 100 50 >100 50 100 50 100 
Standard 6.25 12.: 12.5 25 6.25 25 12.5 25 
C.A.; Candida albicans, AF; Aspergillus fumigatus, TM; Trichophyton mentagrophvtes. PM; 
Penicilliwn marneffei. MIC ((ig/mL) = minimum inhibitory concentration, that is, the lowest 
concentration of the compound to inhibit the growth of fungus completely; MFC (ng/mL) = 
minimum fungicidal concentration, that is, the lowest concentration of the compound for killing 
the fungus completely. 
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6.6.1. Results and discussion 
The investigation of antibacterial screening data revealed that all the tested compounds 
5a-d. showed moderate to good bacterial inhibition. All the compounds showed good 
inhibition against .V. pyogenes, Methicillin resistant Staphylococcus aureus (MRSA +Ve). 
/'. aeruginosa. K. pneumoniae and E. coli species. Among the tested compounds 5a. 
showed more potent bactericidal activity against all fungal strains (MIC 12.5-25 |jg/mL). 
The higher susceptibility of Gram-positive bacteria is due to absence of a unique outer 
membrane ot peptidoglycon, hence the wall of these bacteria is permeable to these 
derivatives. The compounds also have significant influence on antibacterial profile of 
Gram-negative bacteria. The MICs of the compounds were found to be 12.5 to 50 [ig/mL. 
The MBC of the compounds was two, three or four folds higher than the corresponding 
MIC results. 
The antifungal screening data showed good to moderate activity. All Compounds 
showed good fungicidal activity against C. albicans, A. fumigatus, T. menlagrophyles and 
P. marneffei fungal strains. Among the tested compounds 5a showed more potent 
fungicidal activity against all fungal strains (MIC 25 fig/mL). The MICs of other 
compounds were found to be 25 to 100 |ig/mL. The MFC of the compounds was found to 
be two, three or four folds higher than the corresponding MIC results. 
6.7. CONCLl SION 
In summary, in vitro antibacterial and antifungal evaluation of the newly synthesized 
compounds has proved them as potent antibacterial and antifungal agents. The 
importance of such kind of work lies in the possibility that the new compounds might be 
more effective against microbes for which a thorough study regarding the structure-
196 
activity relationship, toxicity and their biological effects would be helpful in designin< 
more potent antimicrobial agents. 
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Abstract A series of novel chromone derivatives have 
been synthesized employing .l-formylchromones and 
5-acetyi-I.3-dimethylbarbituric acid as starting materials 
both under conventional heating method and microwave 
irradiation technique in good yields. The synthesized 
compounds were screened in vitro antibacterial activity 
against the representative panel of two Gram-positive 
bacteria and two Gram-negative bacteria. The synthesized 
compounds were also tested for their inhibitory action 
against three strains of fungus. The various compounds 
show potent inhibitory action against test organisms. 
Keywords l-Formylchromone • 5-Acetyl-l, 
3-dimethylbarbituric acid • Microwave irradiation • 
Antibacterial activity - Antifungal activity 
Introduction 
Development of new antibacterial agents with novel 
structure and mode of action remains the primary goal of 
scientists for the solution of increasing bacterial resistance 
gained by microorganism to classical antibacterial agents 
(Moneer et ai, 2(K)2). Chalcones and their derivatives are 
an attractive molecular scaffold for the search of new 
biologically active molecules. Also, chromones comprise a 
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vast array of oxygen containing compounds ubiquitous in 
plants (Barton and OUis, 1979). They form basic nucleus of 
flavones and have been recognized as the essential com 
ponent of phamacophores of a large number of bioactivt-
molecules (Dewick, 1994; Hansch etai, 1990). Molecules 
containing chromone structure possess a myriad of bio-
logical activities ranging from antifungal (Prakash er ai. 
2008), aDtioxidant (Kunxia et ai. 2009), neuroiHotective 
(Larget et ai, 2000), fflV-inhibitory (Yu et ai, 2(K)4), 
antibacterial (Deng et ai, 2000) to anticancer (Valenti et ai, 
2000) activities. Chromone derivatives are also active at 
benzodiazepine receptors and on lipoxygenases and cyclo-
oxygenases (Horton et ai, 2003). It was also sited in the 
literature that Hormothamnione, a naturally occurring sty-
rylchromone isolated from the blue green algae, Hor-
mothamnione enteromophoides has potent cytotoxicity to 
P-388 lymophocytic leukaemia and HL-60 human promy-
elocytic leukaemia cells (Alonso and Brossi, 198K; Grazul 
and Budzisz, 2009). Chalcones, the flavanoid and isoflav-
anoid precursors, display a wide spectrum of biological 
activities including antioxidant (Stevens etal, 2(K)3; Vogel 
et ai, 2008), antibacterial (Sugamoto et ai, 2(K)8; Avila 
et ai, 2008), antimalarial, antileishmanial (Liu et al., 2003; 
Quintin et al., 2009; Suryawanshi et ai, 2(K)8), anticancer 
(Lawrence et ai, 2006), antiangiogenic (Mojzis et ai. 
2008), anti-infective, anti-inflammatory (Nowaskowska, 
2007; Cheng et ai, 2008), antifungal (Lahtchev ei ai. 
2008), nitric oxide inhibition (Rojas etal., 2002), tyrosinase 
inhibition (Nerya et ai, 2004), etc. It is also worth men-
tioning that the derivatives of chalcones particularly pyr-
azoline nucleus forms the core structure of many drugs and 
have been reported to possess widespread biological 
activities (Chimenti et ai, 2005; Khode et ai, 2009). 
In view of variety of pharmacological properties 
exhibited by chromones, chalcones and its derivatives, we 
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were prompted to undertake synthesis of chromonyl chal-
cones and conversion to other heterocycles like 
pyrazolines, pyrazoles, dibromoderivatives and dihydro-
pyrimidines. which may show different or better physio-
logical activities. 
Results and discussion 
Chemistry 
Microwave-assisted organic reaction enhancement (MORE) 
is now a days a well-established technique for the synthesis 
of various heterocycles particularly from the viewpoint of 
green Chemistry. The e-Chemistry technique gives spec-
tacular results viz-shorter reaction time, experimental 
simplicity, selectivity of products and easy work up, etc. 
(Kappe and Dallinger, 2009; Varma, 1999). It was found 
that 3-fonnyl chromone has emerged as a valuable synthon 
for incorporation of chromone moiety into a number of 
molecular frameworks, which forms important component 
of pharmacophores of a number of biologically active 
molecules of synthetic as well as natural origin (Raj et al., 
2008). To the best of our knowledge, no reports have so far 
made in the synthesis of chromonyl chalcones and its 
derivatives under microwave irradiation. This inspired us 
to go with these reactions. Due to exceptional reactivity of 
formyl group in 3-formylchromone, as well as the versatile 
biological activities of chromone and barbituric acid 
derivatives (Aboul and Wainer, 1997), two chromonyl 
chalcones 3a-b were synthesized by employing 3-form-
ylchromones la-b and 5-acetyl-1,3-dimethylbarbituric 
acid 2 in the presence of mild base both under conventional 
heating and microwave irradiation method. The chalcones 
3a-b were synthesized in the presence of pyridine using 
ethanol as a solvent in conventional method, which took 
longer period for completion of reaction (7-7.5 h) with 
yields (78-79%) (Table 1). The reactions when carried out 
under microwave irradiation were completed within 6 min 
with substantial increase in yield of products (88%). 
Moreover, the reaction generated (E)-isomer only. The 
infrared (IR) spectrum of 3a exhibited chromone and bar-
bituric acid carbonyl groups at 1657 and 1719 cm' ' , 
respectively. The 'H NMR spectrum showed trans olefinic 
protons Ha and Hb as ortho-coupled doublets at S 9.26 
(J = 15.7 Hz) and 7.84 (J = 15.7 Hz), respectively. The 
N-CHj protons of barbituric acid moiety were present as 
two sharp singlets at S 3.37 and 3.39. The three aromatic 
protons of chromone moiety were discernible in the form 
of multiplet at <> 7.49-7.76 whereas C-2 and C-5 protons 
appeared as a singlet and doublet of doublet at 6 8.39 and 
8.32, respectively. Further, the structure was confirmed by 
mass spectrum, which showed M"*^  at m/z 354. 
Table 1 Synthesis of compounds 38-7 under thermal heating and 
Microwave irradiation 
Entry 
) 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Product 
3a 
3b 
4a 
4b 
4c 
4d 
4e 
5 
6a 
6b 
7 
Conventional heating 
method 
Time 
7 h 
7.5 h 
1 h 
1 h 
n h 
10.5 h 
12 h 
14 h 
20 min 
20 min 
(RT) 
(RT) 
28 h (RT) 
Yield (%)'' 
78 
79 
74 
74 
63 
65 
75 
76 
82 
80 
78 
Microwave 
irradiation" 
Time 
6 min 
6 min 
3 min 
3 min 
7 mm 
6 mm 
9 min 
7 mm 
3 min 
Yield ('* l" 
88 
88 
94 
92 
86 
86 
89 
92 
-
-
90 
' Microwave equipment multimode with full power was used 
'' All yields refer to isolated products 
Condensation of a,/f unsaturated ketone with nitrogen 
bases gives the corresponding pyrazolines (Wiley and 
Jarboe, 1967). Thus, the compounds 3a-b when treated 
with variously substituted hydrazines under conventional 
heating procedure using glacial acetic acid and catalytic 
amount of sodium acetate afforded the products 4a-e in 
63-75% yield in a span of time period (1-12 h) 
(Scheme 1). However, microwave irradiation technique 
when applied increased yields of the products (8f)-94%) 
within shorter period of time (3-9 min) even in the absence 
of catalyst (Table 1). The IR spectrum of 4a displayed a 
broad band at 3285 cm~' due to the presence of NH group 
of pyrazoline moiety. The absorption bands for barbituric 
acid and chromone carbonyl groups were present in the 
region 1698 and 1649 cm"', respectively. The ' H NMR 
spectrum of the compound showed the diagnostic singlet of 
C-2 olefinic proton of the chromone moiety at 6 8.20, 
which clearly indicated that the pyrone moiety in the 
compound didn't suffer ring cleavage by the attack of 
nitrogen base (Kostka, 1973). This fact was fiirther sup-
ported by the presence of doublet of doublet of C-5 proton 
appeared at 3 8.14. The remaining three aromatic protons 
of chromone nucleus appeared as multiplet at <) 7.42-7.76. 
The presence of pyrazoline unit was established by three 
doublet of doublet at S 3.66 (H^), 4.01 (H )^ and 4.87 (H )^-
A sharp singlet at S 3.36 integrating for six protons was 
assigned to two N-CH3 groups. The Mass spectrum of the 
compound showed M"*^  at m/z 368. 
Due to the remarkable pharmacological activities exhib-
ited by dihydropyrimidine derivatives (Pani et al., 2009), 
attempts were also made to synthesize dihydropyrimidine 
derivative of chalcone by reacting 3a with urea in the 
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Scheme t Synthesis of 
compounds 3»-5 EtfianoJ/Pyridine Reflux 
H H3C—C—Q ——*• 
O 
3a-b R'NHNH, 
Aceticacid / NaOAc 
Reflux 
orMW 
4a^ 
4a 
4b 
4c 
4d 
4e 
R 
H 
CH, 
H 
CH, 
H 
R' 
H 
H 
C,H, 
C^H, N 
- / 
H2N C NHj 
4 
Ethanol/NaOH 
Reflux 
orMW 
5 
R=H 
presence of NaOH in ethanol under thermal heating 
method and solvent free conditions (Scheme I). The 
reaction mixture as visualized afforded 5 in quantitative 
yield (Table I). The presence of dihydropyrimidine 
nucleus in 5 was established on the basis of ' H N M R 
sp>ectrum which showed two doublet of doublet at S 3.20 
(Hd), and 4.88 (H )^ whereas, the H^ proton at d 3.42 is 
merged with two N-CH3 protons of barbituric acid moiety. 
A broad singlet (D2O exchangeable) at 6 14.12 was 
assigned to OH proton. The other prominent peaks as 
obtained are mentioned in the experimental part. 
a,/?-Dibromodihydrochalcones are interesting interme-
diates for the synthesis of various biologically active het-
erocycies such as pyrazoles, pyra/olines and pyrimidines. 
(Joshi and Wadodkar, 1981; Abdel-Rahman et al, 2007). 
On the basis of these findings, bromination of heterochal-
cones was also attempted (Scheme I). Thus, the reaction of 
heterochalcones 3a-b with Brz in chloroform at room 
temperature afforded 2,3-dibromodihydrochalcones 6a-b 
in quantitative yields. The ' H NMR spectrum of the 6a 
showed two doublets attributable to H^  and Hh protons at 6 
5.56 and 7.76 with coupling coastant of 11.3 Hz, which 
was in accordance to the erythro configuration. The other 
prominent peaks are given in the experimental part. Fur-
ther, 6a was converted to pyrazole derivative 7 in dr) 
pyridine at room temperature and in solvent-free condition. 
The compound showed a sharp singlet at ^ 7.94 due to H^ . 
proton of pyrazole moiety in its ' H NMR spectrum. A 
broad singlet at d 10.31 was assigned to NH proton. 
Biology 
All the newly synthesized compounds were screened in 
vitro antibacterial activity against an assortment of two 
Med Chem Re 
Scheme 2 Synthesis of 
compounds 6a-7 
3a-b 
a=R=H 
b=R=CH3 
6a-b 
a=R=H 
b=R=CH3 
6a NTi^JNa'i2 
orMW 
HN N 
7 
R=H 
Gram-{X)S!tive bacteria. Staphylococcus aureus SA 22, 
Bacillus suhsilis MTCC 121, and two Gram-negative bac-
teria, Escherichia coli K12, Salmonella typhimurium 
MTCC 98, in vitro antifungal activity was tested against 
three fungal strains, Candida albicans IOA-109, Asper-
gillus niger (laboratory isolate) and Aspergillus fumigatus 
(laboratory isolate). The minimum inhibitory concentra-
tions (MIC) of the tested compounds were 1(X) ng/ml. The 
newly generated compounds 3a-7 exerted significant 
inhibitory activity against the growth of the tested bacterial 
and fungal strains. The data (Table 2) reveal that com-
pounds have significant influence on antibacterial profile of 
Gram-positive bacteria. The compounds also showed 
moderate to good inhibitory results against Gram-negative 
bacteria viz S. typhimurium and E. coli. Among the tested 
comix)unds, chalcones 3a and 3b showed more potent 
inhibitory activity against both types of bacteria. However, 
derivatives of chalcones exerted varying inhibitory action. 
Further antifungal screening revealed that the compounds 
3a-7 exhibited moderate to good inhibition to C. albicans 
and lesser inhibition against A. niger and A. fumigatus. 
Conclusion 
Experimental 
Melting points were taken in Riechert Thermover instru 
ment and are uncorrected. The IR spectra were recorded on 
Perkin Elmer RXI spectrometer in KBr, 'H NMR on 
Bruker DRX-3(X) and Bruker Avance II 40() spectrometer 
using tetramethyl silane (TMS) as the internal standard and 
DMSO-dfi/CDCls as solvent. Mass spectra were obtained 
on Jeol-SX-102 (FAB) spectrometer. The microanalyti-
cal data were collected on Elementar vario EL HI 
elemental analyzer. 3-Formylchromone, substituted-3-for-
mylchromone (Nohara et ai, 1974), 5-acetyl-l,3-dimeth-
ylbarbituric acid (Jursic and Neumann, 2001) and 
hydrazinobenzothiazole (Singh et al.. 1990) were synthe-
sized by reported methods. All other chemicals used were 
purchased from Merck (Mumbai, India) and Fluka Chem-
icals (Switzerland). The purity of the compounds was 
checked by thin layer chromatography (TLC) on glass 
plates coated with silica gel G254 (Merck, Mumbai, India) 
using chloroform-methanol (3:1) mixture as mobile phase 
and visualized by iodine vapours. All the experiments 
under microwave irradiation were carried out in an 
unmodified domestic microwave oven (National, Model 
NN-S557WF, 1.3 KW, 2450 MHz). 
In summary, we have described rhe synthesis of hitherto 
unknown 3-substituted chromone derivatives from readily 
synthesized .starting materials, available reagents along 
with short reaction time, simple workup and isolation, etc., 
under green reaction conditions, make the current method 
feasible and attractive protocol for generation of novel 
heterocycles. The antimicrobial activity of compounds 
showed that various compounds are potent antimicrobial 
acents. 
Preparation of chalcones under thermal heating 
conditions 
To a well stirred solution of 5-acetyl-l,3-dimethylbarbitu-
ric acid (5.05 mmol) in ethanol (25 ml) containing pyridine 
(0.5 ml) 3-formylchromone/substituted-3-formylchromone 
was added (5.05 mmol). The reaction mixture was then 
refluxed in a heating mantle for 7-7.5 h. cooled al room 
temperature. The bright yellow .solid thus obtained was 
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Tabic 2 In vitro antibacterial 
Compounds 
Diameter of 
3a 
3b 
4a 
4b 
4c 
4d 
4e 
5 
6a 
6b 
7 
inhibition 
Chloramphenicol 
Nystatin 
DMSO 
Grain 
an 
po 
5. aureu 
zone in 
15 
12 
16 
II 
-
-
13 
8 
8 
12 
14 
26 
-
-
d antifungal 
'Sitive 
mm at 
activity of 
B. sublili.s 
100 ^ tg/ml 
20 
16 
13 
13 
-
-
10 
-
-
12 
24 
-
-
compounds 3a-7 
Gram negative 
E. coti 
20 
20 
15 
12 
8 
-
18 
15 
14 
15 
12 
25 
" 
-
S. typhimurium 
16 
(2 
12 
10 
12 
19 
9 
11 
16 
10 
12 
20 
-
~ 
Fungal species 
C. albicans 
16 
12 
14 
17 
15 
15 
14 
~ 
15 
17 
-
-
20 
-
A. niger 
8 
12 
8 
-
-
-
14 
-
-
18 
-
A. jumigiiSus 
10 
14 
14 
10 
12 
-
-
' 
18 
-
No activity detected 
filtered, washed with water, alcohol and dried to afford 
3a-b. 
Preparation of chalcones under microwave irradiation 
condition.s 
3-Formylchromone/.substituted-3-formylchromone (5.05 
mmol), 5-acetyl-l,3-dimelhylbarbituric acid (5.05 mmol) 
and pyridine (0.3 ml) were mixed thoroughly in a mortar, 
and air dried. The reaction mixture was then transferred to 
an open Pyrex beaker and subjected to microwave irradi-
ation (multimode, full power). The progress of reaction 
was monitored by TLC and on completion, the reaction 
mixture was slurred in water (40 ml). The solid thus 
obtained was filtered, washed with water, alcohol and dried 
to afford 3a-b. 
(2E)-l-(IJ-Dimethyl-2,4,6-pyrimidinetrione-5-yl)-3-
I4-OXO-4H- l-henz.opyran-3-yl)-2-prapen€-1-one {3a) 
Purified by recrystallisation from chloroform. Bright yel-
low crystals; m.p., >300°C. Anal. Calcd. for CigHuNjOfi 
(%): C 61.02, H 3.98, N 7.91. Found (%): C 61.05, H 3.83, 
N 7.84. o^^/cm"' (KBr): 1657 (C=0, chromone), 1719 
(C=0. barbituric acid), ' H NMR (CDCI3, 400 MHz): 3 
3.37 (s, 3H. N-CHj), 3.39 (s, 3H, N-CH3), 7.49-7.76 
(m, 3H, Ar-H). 7.84 (d, IH. J = 15.7 Hz. H,,). 8.32 (dd. 
IH, C-5), 8.39 (s. IH, C-2), 9.26 (d. IH, J = 15.7 Hz, HJ. 
MS (% rel int) m/z 354 (M^ 80), 353 (60), 336 (30). 
(2E}-l-(l,3-Dimethyl-2,4,6-pyrimidinetri(me-5-yl)-3-t6-
methyl-4-oxo-4H- I-benzopyran-3-yl)-2-propene-1-one {3b 1 
Purified by recrystallisation from chloroform. Bright yel-
low crystals; m.p., >300°C. Anal. Calcd. for Ci^Hi^NzOb 
(%): C 61.95, H 4.38, N 7.61. Found (%): C 61.86, H 4.27. 
N 7.58. i;,„ax/cm"' (KBr): 1666 (C=0, chromone), 17)6 
(C=0, barbituric acid). 'H NMR (CDCl,, 400 MHz): 6 
2.48 (s, 3H, CH3), 3.38 (s, 3H, N-CH,), 3.40 (s, 3H, 
N-CH3), 7.31-7.46(m, 3H, Ar-H), 7.87 (d, IH, J = 16.3 Hz. 
Hb), 827 (s, IH, C-2), 9.18 (d, IH, y = 15.8 Hz, HJ. MS 
(% rel int) m/z 368 (M+, 30), 367 (10). 
Preparation of pyrazolines under thermal heating 
conditions 
The mixture of 3a-b (2.52 mmol), hydrazine hydrate 
(2.52 mmol)/phenylhydrazine (2,52 mmol)/hydrazinobenzo-
thiazole (2.52 mmol) and sodium acetate (0,7 mmol) was 
refluxedin 10 ml ofacetic acid for 1-12 h. After completion of 
the reaction (checked by TLC), the reaction mixture was 
cooled and the solid precipitated out was filtered, washed with 
water, acetone and dried to afford 4a-e. 
Preparation of pyrazolines under microwave irradiation 
conditions 
The mixture of 3a-b (2.52 mmol) and hydrazine hydrate 
(2.52 mmol)/phenyIhydrazine (2.52 mmol)/hydrazinobenzo-
thjazole (2.52 mmol) were mixed thoroughly in a mortar 
Med Chem RL-
and air dried. The reaction mixture was tlien transferred to 
an open Pyrex beaker and subjected to microwave irradi-
ation (multimode, full power). The progress of reaction 
was monitored by TLC and on completion, the reaction 
mixture was slurred in water (25 ml). The solid obtained 
was filtered, washed with water, alcohol and dried to g^t 
4a-e. 
3-( 1,3-Dimethyi-2.4,6-pyrimidinetrione-5-yi}-5-(4-oxo-4H-
I-henzop\ran-3-yl)pyrazoIini' (4a) 
Purified by recrystallisation from ethanoI-DMF (3:2 v/v). 
White solid; m.p., >300°C. Anal. Calcd. for Ci8H,6N405 
(%): C S8.69, H 4.38, N l.'i.21. Found (%): C 58.54, H 
4.43, N 15.12. Umax/cm~' (KBr): 1649 (C=0, chromone), 
16^8 (C=0, baibituric acid), 3285 (N-H, pyra2o\iny\). ' H 
NMR (DMSO-dfe, 400 MHz). 6 3.36 (s, 6H, 2N-CH3), 3.66 
(dd, IH. 7 = 1 9 . 0 Hz, 6.0 Hz, Hj), 4.01 (dd, IH, 
y = 18.9 Hz, 9.8 Hz, H^), 4.87 (dd, IH, 7 = 9.7 H?, 
6.0 Hz, H,.), 7.42-7.76 (m, 3H, Ar-H), 8.14 (dd, IH, 
J = 8.0 Hz, 1.4 Hz, C-5), 8.20 (,s, IH, C-2). MS (% rel int) 
m/z 368 (M+, 55), 367 (40). 
J-( 1,3-DiinelhyI-2,4,6-pyrimi{Jinetrione-5-yl)-5-(6-methyl' 
4-OXO-4H' I -benz(>pyran-3-yl)pyrazoline (4b) 
Purified by recrystallisation from ethanol-DMF (3:2 v/v). 
White solid; m.p., >300°C. Anal. Calcd. for C,9H,8N405 
(%): C 59.68, H 4.74, N 14,65. Found (%); C 59.53, H 
4.83, N 14.49. o„^/cm ' (KBr): 1646 (C=0, chromone), 
1699 (C=(). barbituric acid), .^241 (N-H, pyrazolinyl). 'H 
NMR (DMSO-dfi, 400 MHz): S 2.46 (s, 3H, CHj), 3.34 
(s, 6H, 2N-CH3), 3.70 (dd, IH, . / = 19.0 Hz, 6.0 Hz, Hj), 
4.03 (dd, IH, y = 19.0 Hz, 9.7 Hz, H^), 4.89 (dd, IH, 
y = 9.1 Hz, 6.6 Hz, H^). 7.3i (br .s,lH, NH), 7.39-7.91 
(m, 3H, Ar-H), 8.13 (s, IH. C-2). MS (% rel int) m/z 382 
(M+, 100), 381 (70). 
l-Phenyl-3'{l,3-dimethyl-2,4,6-pyrimidinetrione-5-yl)-5-
(4-OXO-4H-1 'henzopyran-3-yl)pvraz.oline (4c) 
Purified by recrystallisation from coloumn chromatography 
using benzene-ethylacetate (3:1 v/v) as the eluent. Pale 
yellow crystals; m.p.. 236°C (dec). Anal. Calcd. for 
C24H20N4OS (%): C 64.86, H 4.54, N 12.61. Found (%): C 
64.81, H 4 6 1 . N 12.53. v^Jcm'* (KBr): 1668 (C=0, 
chromone), 1715 (C=0, barbituric acid). ' H NMR (CDCI^, 
400 MHz): S 3.38 (s, 6H, 2N-CH,), 3.71 (dd, IH, 
/ = 18.5 Hz. 7.9 Hz, Hj) 4.23 (dd. IH, 7 = 18.6 H?, 
9.7 Hz. He). 4.49 (dd, IH, J = 10.0 Hz, 7.9 Hz, H J , 
7.08-7.33 (m, 8H, Ar-H), 7,38 (dd, IH, 7 = 7.4 H?, 
1.7 Hz, C-5), 8.27 (s, IH, C-2) MS (% rel int) m/z 444 
(M^ ,^ 90). 443 (40). 391 (40). 
I -Phenyl-3-( 1,3-dimethyl-2,4.6-p\rimidinetn(>ne-5-\l h5 
(6-methyl-4-oxo-4H-]-henzopyran-3-yl)pyraz(>line I4di 
Purified by recrystallisation from coloumn chromatographv 
using benzene-ethylacetate (3:1 v/v) as eluent. Pale yell()v\ 
crystals; m.p., 247°C (dec). Anal. Calcd. for C25H22N4OS 
(%): C 65.49, H 4.84, N 12.22. Found (%): C 63.42. H 
4.93, N 12.16. u „ ^ / c m ' ' (KBr): 1622 (C=0. chromone 1. 
1712 (C=0, barbituric acid). ' H NMR (CDCI3, 400 .MH/): 
S 2.25 (s, 3H, CH3), 3.37 (s, 6H, 2N-CH3), 3.70 (dd. IH. 
7 = 18.6 Hz, 7.9 Hz, H^), 4.20 (dd, IH. 7 = 18.4 H/. 
9.9 Hz, H^), 4.45 (dd, IH, 7 = 10.0 Hz. 7.9 Hz. H j . 
7.10-7.58 (m, 8H, Ar-H), 8.27 (s, IH, C-2). MS (% re! int) 
m/z 458 (M+, 75), 457 (50). 
1 -Benzothiazolyl-3-( 1,3-dimethyl-2,4,6-pyrimidinetrkme 
5-yl)-5-(4-oxo-4H- l-benzopyran-3-yl)pyrazoline (4e} 
Purified by recrystalHsation from chlorofom-methanol (3:2 
v/v). Brown crystals; m.p., 291 °C (dec). Anal. Calcd. for 
CzsHi^NsOsS (%): C 59.87, H 3.82, N 13.96. Found (%): C 
59.81, H 3.88, N 13.84. o^cnC' (KBr): 1647 (C=0. 
chromone), 1709 (C=0, barbituric acid). ' H NMR (CEXZlv 
400 MHz): 6 3.37 (s, 6H, 2N-CH3), 4.02 (dd. IH. 
7:= 19.3 Hz, 4.8 Hz, H^) 4.24 (dd, IH, 7 = 19.2 H/ 
10.6 Hz, H,), 5.57 (dd, IH, J= 10.6 Hz, 4.7 Hz, H^;. 
7.18-7.94 (m, 7H, Ar-H), 8.15 (dd,lH, 7 = 8.0 H/, 
1.6 Hz, C-5), 8.41 (s, IH, C-2). MS (% rel int) m/z .502 
(M+, 40), 501 (20), 354 (30). 
Preparation of dihydropyrimidine under thermal 
heating condition 
A mixture of 3a (5 mmol), urea (7 mmol) and NaOH 
(14 mmol) was refluxed in ethanol (20 ml) for 14 h. The 
reaction mixture was then cooled, and poured into ice-cold 
water (50 ml), acidified with conc.HCI. The cnide product 
thus obtained was filtered washed with acetone and dried to 
afford 5. 
Preparation of Dihydropyrimidine Under Microwave 
Irradiation Condition 
The mixture of 3a (5 mmol), urea (7 mmol) and NaOH 
(10 mmol) was grounded well using a mortar and pestle. 
The reaction mixture was then transferred to an open Pyrex 
beaker and exposed to microwave irradiation (multimode. 
full power). The progress of reaction was monitored b> 
TLC and on completion the reaction mixture was slurred in 
water (25 ml). The solid obtained was filtered, washed with 
water, acetone and dried to afford 5. 
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4-( IJ-Dimeihyl-2,4,6-p\nmid'metrione-5-yl}-6-(4-oxo-4H-
l-henzopyran-3-yl)-5H,6H-dihydropyrimidine-2-one (5) 
Purified by recrystallisation from ethanol. White powder, 
m.p., 279-281 °C. Anal. Calcd. for C,9H,6N406 (%): C 
57.58, H 4.07, N 14.14. Found (%): C 57.42, H 3.91, N 
14.12. iWx/cm"' (KBr): 1651 (C=0, chromone), 1716 
(C=0, barbituric acid). 351! (OH). ' H N M R (CDCI3, 
300 MHz): 0 3.20 (dd, IH, 7 = 16.5 Hz, 3.9 Hz, Hj), 3.37 
(s. 6H, 2N-CH3), 3.42 (dd, IH, H,), 4.88 (dd, IH, 
J = 9.9 Hz 3.9 Hz, H^), 7.44^-7.76 (m, 3H, Ar-H), 8.02 
(s, IH, C-2), 8.24 (dd, IH, J = 7.8 Hz, 0.9 Hz, C-5), 14.12 
(br s, IH, OH). MS (% rel int) m/z 396 (M+, 80), 395(50). 
General procedure for the preparation 
of 2,3-dibronioderivatives of chalcones 
Bromine (5 mmol) wa.s added dropwise with vigorous 
stirring to a solution of 3a-b (5 mmol) in 12 ml of chlo-
roform over a period of 20 min. After complete addition of 
Br2 the reaction mixture was allowed to stand for 2 h. The 
dibromoderivatives 6a-b were precipitated, filtered off, 
and washed with 20 ml of ether to remove the excess of 
bromine. 
1 -(1,3-Dimethyl-2.4,6-pyrimidinetnone-5-yl)-2,3-dibromo-
3-^4-oxo-4l^ 1 -henzopyran-3-yl] propan-1-one (6a) 
Purified b> recrystallisation from ethanol. Yellow solid; 
m.p., 242°C (dec). Anal. Calcd. for CigHuNsOsBfj (%): C 
42.05, H 2.74, N 5.45. Found (%): C 42.14, H 2.75, N 5.42. 
fm«/cm ' (KBr): 1657 (C=0, chromone), 1729 (C=0, 
barbituric acid). ' H NMR (CDCI3, 400 MHz): S 3.42 
(s. 3H, N-CH3), 3.44 (s, 3H, N-CH3). 5.56 (d, IH, 7 = 
11.3 Hz. H,). 7.44-7.72 (m, 3H, Ar-H), 7.76 (d, IH. 7 = 
11.3 Hz. Hh), 8.15 (s, IH, C-2), 8.34 (dd, IH, 7 = 7.9 Hz, 
1.5 Hz, C-5). MS (% rel int) m/z 514 (M+, 55), 513 (30), 
434 (30), 354 (30). 
I-I l,3-Dim<'lhyl-2A,6-pyrimiduirtriane-5-yl) -2,3-
dihromo- 3- (6-methyl-4-oxo-4H-1 -benzopyran-3-yl) 
propan-1 -one (6b) 
Purified by recrystallisation from ethanol. Yellow solid; 
m.p., 202-204°C. Anal. Calcd. for C^HieNjOftBrz (%); C 
43.21, H 3.05, N 5.30. Found (%): C 43.13, H 3.13, N 5.22. 
"max/cm^' (KBr); 1664 (C=0, chromone), 1730 (C=0, 
barbituric acid). ' H NMR (CIX:i3,400 MHz): S 2.47 (s, 3H, 
CH3), 3.42 (s, 3H, N-CHj), 3.43 (s, 3H, N-CHj), 5.57 (d, 
IH, 7 = 11.2 Hz, H3), 7.38-7,75 (m, 3H, Ar-H), 7.77(d, 
IH, J = 11.3 Hz, Hb), 8.14 (s, 1H, C-2). MS (% rel int) m/z 
528 (M+, 40) 527 (10), 526 (20), 448 (10) 368 (30). 
Preparation of pyrazole under thermal heating condition 
Hydrazine hydrate (2.5 mmol) was added with vigorous 
stirring to a solution of 6a (2.5 mmol) in 10 ml of dry 
pyridine at room temperature. The reaction mixture was 
allowed to stand for 28 h. The pyrazole derivative 7 pre-
cipitated was filtered, washed with water, ethanol and 
dried. 
Preparation of pyrazole under microwave irradiation 
A mixture of 6a (2.5 mmol) and hydrazine hydrate 
(2.5 mmol) was mixed well and air dried. The reaction 
mixture was subjected to microwave irradiation (multi 
mode, full power) in an open Pyrex beaker. On completion 
(as checked by TLC), the reaction mixture was slurred in 
water (20 ml). The crude product obtained was filtered, 
washed with water, ethanol and dried. 
3-(l,3-Dimethyl-2,4,6-pyrimidinetrione-5-yl}-5-(4-oxo-4H-
l-benzopyran-3-yl)pyrazole (7) 
Purified by recrystallisation from ethanol-DMF (3:2 v/v). 
White powder; m.p., >300°C. Anal. Calcd. for 
C,gH,4N405 (%): C 59.02, H 3.85, N 15.29. Found (%): C 
59.14, H 3.79, N 15.22. v^Jcm'^ (KBr): 1654 (C=0. 
chromone), 1710 (C=0, barbituric acid), 3247 (NH, pyra-
zole). ' H NMR (DMSG-dft, 300 MHz): d 3.20 (s, 6H. 
2N-CH3), 6.97-7.39 (m, 3H, Ar-H), 7.77 (d. IH. 7 = 
7.5 Hz, C-5), 7.94 (s, IH, pyrazole), 9.56 (s, IH, C-2), 10.31 
(br s, IH, NH). MS (% rel int) m/z 366 (M+, 90), 365 (50). 
Biological activity 
Antibacterial studies 
All the synthesized compounds were dissolved to prepare a 
stock solution of 1 mg/ml using DMSO. The antibacterial 
activity of test compounds and standard chloramphenicol 
was done by filter paper disc method (Bauer et al., 1%6). 
Media with DMSO was set up as control. All cultures were 
routinely maintained on NA (nutrient agar) and incubated 
at 37°C for overnight. The culture was centrifuged at 
1000 rpm and pellets were resuspended and diluted in 
sterile NSS to obtain viable count 10* cfu/ml. Approxi-
mately, 0.1 ml of diluted bacterial culture suspension was 
spread with the help of spreader on NA plates uniformly. 
Sterile 8-mm discs (Hi-media Pvt Ltd) were impregnated 
with the test compounds. Antibiotic disc, chloramphenicol 
(30 pg/disc Hi-Media) was u.sed as control. The disc was 
placed on the plate. Each plate had one control disc 
impregnated with the solvent. The plates were then 
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incubated for 24 h at 37°C, and the resulting zones of 
inhibition (in mm) were measured. 
Antifungal studies 
The synthesized compounds were dissolved in DMSO. 
Media with DMSO was set up as control. All cultures were 
routinely maintained on SDA and incubated at 28°C. Spore 
formation of filamentous fungi was prepared from 7 day 
old culture in sterile normal solution (8% NaCl) and 
approximately diluted to obtain 10^  cfu/ml. The inoculums 
of non-sporing fungi, C. alhicians was performed by 
growing the culture in SD broth at 37°C for overnight. The 
culture was centrifxiged at 1,000 rpm and pellets were 
resuspended and diluted in sterile NSS to obtain viable 
count 10^  cfu^ml. Approximately, 0.1 ml of diluted fungal 
culture suspension was spread with the help of spreader on 
SDA plates uniformly. Sterile 8 mm discs (Hi-media Pvt 
Ltd) were impregnated with the test compounds. Antibiotic 
disc, nystatin (30 ^g/disc Hi-Media) was used as control. 
The disc was placed onto the plate. Each plate had one 
control disc impregnated with the solvent. The plates were 
incubated at 28°C for filamentous fungi for 72 h or more, 
while for C. albicans plates were incubated at 37°C for 
18-48 h. Antifungal activity was determined by measuring 
the diameters of the inhibition zone. 
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Abstract A novel approach was adopted for the synthe-
sis of series of Knoevenagel condensation products from 
5-chloro-3-methyl-1 -phenylpyrazole-4-carboxaldehyde with 
different cyclic active methylene compounds, using water 
soluble and recyclable Zn(PrDline)2 as a Lewis acid catalyst 
both under solvent-free condition and using water as a reac-
tion medium in good yields. In each conversion, the catalyst 
was successfully recovered and recycled without significant 
loss in yield and selectivity. The compounds were screened 
for their antimicrobial activity. 
Keywords 5-Ch]oro-3-methyl-1 -phenylpyrazole-
4-carboxaldehyde - Zn(Proline)2 • Knoevenagel 
condensation • Microwave irradiation • Antibacterial 
activity • Antifungal activity 
Introduction 
Developing a simple, ecofriendly reaction protocol for the 
synthesis of compound libraries of medicinal scaffolds is 
an attractive area of research in both academic and phar-
maceutical R&D (Kanizsai et al, 2007). Hence, the chal-
lenge for sustainable environment calls for the use of clean 
procedures, which can avoid the u.se of harmful solvents. 
The chemists are, therefore, more interested in seeking new 
processes involving solvent-free reactions which are 
devoid of pollution with low cost and simplicity in pro-
cessing (Tanaka and Toda, 2000). Microwave-assisted 
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organic reactions are nowadays a well-established green 
protocol for the synthesis of various heterocycles. The 
shorter reaction time, experimental simplicity, selectivity, 
and easy reaction work up have given clear indication on 
the potentialities of this technique over conventional 
heating (Kappe and Dallinger, 2009; Caddick, 1995; Var-
ma, 1999; Galema, 1997). Nowadays, water has emerged 
as an ecofriendly solvent for the reaction medium becau.se 
of its easy availability, noninflammablity, nontoxicity, and 
negligible cost (Li, 2005). 
Knoevenagel condensation is one of the most well-
known reaction for the C-C bond formation in organic 
synthesis (Tietze and Beifuss, 1991). This reaction has 
been widely used for the synthesis of several intermediates 
which are useful in perfumes, cosmetics, and bioactive 
compounds (Meuly and Othmer, 1979; Xing and Zhu, 
2004). The Knoevenagel condensation products also have 
widespread applications including inhibition of antipho-
sphorylation of EGF-receptor and antiproliferative activity 
(Vijender et al., 2008). Because of the importance from 
pharmacological, industrial, and synthetic point of view, 
several methods have been reported for this reaction, which 
includes homogeneous condition catalyzed by base such as 
a piperidine, ethylenediamine, or corresponding ammo-
nium .salts like DMAP, organocatalysts such as glycine, 
L-proline, and alanine (Wada and Suzuki. 2(X)3, Zhang 
et al., 2009), natural and synthetic phosphates (Sebti et al., 
2002), resins (Simpson et al., 1999), montmorillonite KSF 
(Bigi et al., 1999), molecular iodine, ionic liquid (Ren and 
Cai, 2007; Tahmassebi et al., 2009), Lewis acid (Lu et al., 
2004; Peng and Song, 2003), etc. Unfortunately, many of 
these methods have some drawbacks such as use of 
expensive, stoichiometric amount of reactants, low yields, 
extended time, tedious procedure, etc. Thus, the need for 
the development of an alternative route to construct 
Published online: 17 June 2010 
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substituted electrophilic alkenes by reducing time from 
hours to minutes at ambient temperature is in demand. As a 
part of our ongoing research program aimed at developing 
new catalysts and subsequent application for various 
organic transformations, we report herein the recently 
explored Zn(proline)2 complex as an efficient catalyst in 
Knoevenagel condensation reaction. Ever since the explo-
ration of water soluble Zn(proline)2 complex by Darbre's 
group (Darbre and Machuqueiro, 2003), only few reports 
have so far appeared empioying Zn(proline>2 as a Lewis 
acid catalyst for different organic reactions (Kofoed et al., 
2004; Sivamurugan et al, 2006; Kofoed et al, 2(X)5; 
Ruben etal., 2005; Kofoed etal, 2(X)6). Thus, there is a lot 
of scope to further explore the catalyst for its application in 
forming various heterocyclic rings. To the best of our 
knowledge, Zn(proline)2 has not been used as a catalyst for 
Knoevenagel condensation reaction. This prompted us to 
test the catalytic activity of the viable catalyst for this 
reaction empioying heteroaldehyde with various cyclic 
active methylene compounds both under .solvent-free 
Scbeme 1 Synthesis of 
products 3«-i 
Het 
Zn(Pn)line)2 
• 
2h-i 
h; Z= CH=C-CH, 
i:Z= 
\ ^ 
Het= - hn Vy-
h NH 
/ J" \ 
.CH, 
^ N 
O ^ CH3 
H3C % 
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condition using microwave irradiation and using water as 
an ecofriendly reaction medium. 
Results and discussion 
Chemistry 
The Zn(proline)2 catalyst is easily preparable, stable, 
inexpensive, and recyclable. The soluble nature of the cat-
alyst facilitates the separation of products from the catalyst. 
The used catalyst can be recycled and used for the next 
reaction without any further purification. We carried out 
tirst the reaction of 5-chloro-.3-methyl-1-phenylpyrazole-4-
carboxaldehyde 1 with various cyclic active methylene 
compounds 2a-i in conventional method using ethanol as a 
solvent in acidic/basic medium (Scheme !). The teactimis 
look longej' period of time for completion (3-12 h) with 
lower yields. Then, we .studied the efficacy of the Zn(pro-
line)2 complex by carrying reactions in green solvent, 
water. The reactions were completed within 1-2 h, and the 
products obtained were in good yield (81-89%). Further, 
the catalytic activity of the complex was tested under sol-
vent-free condition employing microwave irradiation. To 
our pleasant surprise, the reactions were completed in much 
shorter period of time (5-9 min) in excellent yields (90-
95%) (Table 1). 
The reaction of 5-chloro-3-methyl-l-phenylpyrdzole-4-
carboxaidehyde 1 with indane-1,3-dione 2a in the presence 
of Zn(proline)2 in water as well as in microwave irradiation 
was taken as model reaction for recycling studies. After 
completion of reaction in specified time, the crude product 
obtained was extracted by dichloromethane, and the 
Table 2 Recycling data of ZnCpnriineh complex for the Knoevena-
gel condensation of 5-chloro-3-niethyl-l-phenyl-4-carboxaldehyde 
with 1,3-indanedione 
Catalyst recycle 
1 
11 
III 
IV 
Conventional method 
(aqueous 
Time (h) 
1 
! 
1 
1 
medium; 
Yield C/r) 
85 
85 
85 
82 
Microwave irradiation 
Time (min) 
7 
7 
7 
7 
Yield <'/. > 
90 
9() 
90 
87 
catalyst was recovered by separation of aqueous and 
organic phases. The catalyst present in the aqueous med-
ium was used for the subsequent cycle. The same proce-
dure was applied for all recycling studies. The results 
(Table 2) revealed that catalyst exhibited good catalytic 
activity up to three cycles. The scope of the reaction was 
further investigated with different cyclic-active methylene 
compounds with viable catalyst, and the results obtained 
were satisfactory. The reaction of heteroaldehyde with 
triacetic acid lactone 2fc and 4-hydfoxycoumarin 2i did not 
give the expected Knoevenagel condensation products: 
instead, it afforded pyrazolo pyrones 3h and 3i as reported 
earlier (Siddiqui and A s ^ 2(X)9) in a very short period of 
time (Table 1). 
All the products obtained were recrystallized from suit-
able solvents, and characterized by spectroscopic data. The 
IR spectrum of 3a showed sharp and strong ab.sorption band 
at 1689 cm~' for carbonyl group. The proton nuclear mag-
netic resonance spectroscopy ('H NMR) exhibited a sharp 
singlet at 6 2.40 for methyl group of pyrazole moiety. Nine 
aromatic protons appeared as multiplet in the aromatic region 
Table 1 Zn(proline)j complex-catalyzed Knoevenagel condensation 
Entry Product* Thermal heating in aqueous medium 
Time Yield (%) 
Microwave irradiation*^  
Time Yield (%)'' 
a 
h 
c 
d 
e 
f 
g 
h 
1 
38" 
3b 
3c 
3d 
3e'' 
3f^  
3g 
3h 
3i 
1 h 
45 min 
45 min 
1 h 
1.5 h 
2 h 
45 min 
1 h 
1 h 
85 
87 
89 
87 
84 
81 
86 
84 
83 
7 min 
5 min 
6 itun 
6 min 
9 min 
9 min 
5 min 
6 min 
6 min 
90 
93 
95 
94 
91 
91 
94 
92 
92 
The products were confirmed by elemental analysis, spectra! data and compared with reported literature (Fang el at., 2<K)5; Latif el al.. 19^^) 
" New compounds 
' Microwave equipment multimode with full power was used 
'' All yields refer ro isolated products 
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Sdwine 2 Proposed 
mechanism for the Zn(proline)2 
complex catalyzed Knoevenagel 
condensati(Ni 
PeHs 
3 * ^ CI 
S 7.45-8.04. The olefinic proton was discernible as a singlet 
at 6 7.SO. Further confirmation of the structure was provided 
by mass spectrometry which showed M'*' at m/z 349. 
The proposed mechanism for the Zn(proline)2-catalyzed 
synthesis of Knoevenagel products can be visualized as 
given in Scheme 2. 
Biology 
All the synthesized compounds were screened in vitro for 
antibacterial activity against an assortment of two Gram-
positive bacteria. Staphylococcus aureus SA 22 and Bacillus 
suhtilis MTCC 121, and two Gram-negative bacteria. 
Escherichia coli K12 and Salmonella typhimurium MTCC 
98, also in vitro for antifungal activity against three fungal 
strains Candida albicans IOA-109, Aspergillus niger (lab-
oratory isolate), and Aspergillus fumigatus (laboratory 
isolate). The results are summarized in Table 3. The com-
pounds 3b, 3c, 3d, and 3f exhibited good activity against 
Gram-positive bacteria Staphylococcus aureus. Bacillus 
subtilis, and Gram-negative Salmonella typhimurium. The 
other compounds were moderately active against both 
Gram-positive and Gram-negative bacteria. Antifungal 
screening showed that the compounds had moderate-to-
good activity against Candida albicans, while having lesser 
activity against Aspergillus niger and Aspergillus fumigatus. 
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Table 3 In vuro aruibaclerial and antifungal activity of compounds 3a-g 
Compounds Diameter of inhibition zone in mm at 100 )ig/ml 
Gram-posiiive 
3a 
3b 
3c 
3d 
3e 
3f 
H 
Chloram-phenicoi 
Nystatin 
DMSO 
S. aureus 
12 
17 
20 
12 
14 
19 
-
26 
-
-
B. 
8 
19 
16 
8 
-
IS 
12 
24 
-
-
. subtilis 
Gram-negative Fungal species 
E. coli 
17 
15 
15 
15 
8 
25 
5. typhimurium 
15 
12 
14 
17 
12 
20 
12 
11 
16 
15 
14 
20 
10 
IK 
C. albicans A. niger A. fumigatus 
10 
11 
IS 
- No activit\ detected 
Conclusion 
In brief, we developed an efficient procedure for the 
synthesis of substituted alkenes through Knoevenagel 
condensation from various cyclic-active methylene com-
pounds and heteroaromatic aldehyde using stable, inex-
pensive, easily preparable, and recyclable Zn(proline)2 
complex in green solvent "water" and under solvent-free 
condition. The present protocol is devoid of pollution and 
involves mild reaction condition, and simple operational 
and experimental procedure. The antibacterial and anti-
fungal screenings of the compounds reveal that .some 
substituted alkenes were strongly active against tested 
organisms. 
Experimental 
Melting pomts were taken in Riechert Thermover instru-
ment and are uncorrected. The IR spectra were recorded on 
Perkin Elmer spectrometer in KBr. ' H - N M R spectra on a 
Bruker DRX-300 and Bruker Avance 400 Spectrometer 
using tetra methyl silane (TMS) as an internal standard. 
Mass spectra were obtained on a Jeol-SX-120 (FAB) and 
Micromass Quattro II (ESI). The microanalytical data were 
collected on Elementar vario EL III elemental analyzer. 
The Zn(proline)2 catalyst (Sivamurugan et al, 2004) and 
the compound I (Pawar and Patil, 1994) were synthesized 
as per reported procedures. Other chemicals were of 
commercial grade and used without further purification. 
The purity of all compounds was checked by TLC on glass 
plates coated with silica gel (F-Merck G254). The plates 
were run in chloroform-methanol (3:1) mixture and were 
visualized hy iodine vapors. All the experiments under 
microwave irradiation were carried out in an unmodified 
domestic microwave oven (National, Model NN-S557WF. 
1.3 KW. 2450 MHz). 
Thermal heating in aqueous medium 
A mixture of 5-chloro-3-methyl-l-phenylpyrazole-4-car-
boxaldehyde 1 (1.00 mmol), active methylene compounds 
2a-i (1.00 mmol), and Zn(proline)2 (0.30 mmol) was dis 
solved in minimum volume of methanol, and water (7 ml) 
was added. The reaction mixture was then refluxed in a 
heating mantle for specified time (Table 1) and cooled to 
room temperature. The crude product was extracted with 
dichioronoethane, dried over anhydrous Na2S04, and con 
centrated to furnish crude product, which was then 
recrystallized from ethanol-chloroform mixture (6:4). The 
catalyst was recovered by simple separation of aqueous and 
organic phases. The catalyst present in the aqueous layer 
was used for the subsequent cycle. 
Microwave irradiation 
A mixture of 5-chloro-3-methyl-l-phenypyrazole-4-car-
boxaldehyde 1 (1.00 mmol) and active methylene com-
pounds 2a-i (1.00 mmol) was mixed with Zn(proline)2 
(0.30 mmol) and grounded well using a monar and pestle. 
The mixture was then taken in an open Pyrex beaker and 
subjected to microwave irradiation (multimode, full power). 
The progress of reaction was monitored by TLC and, on 
completion, the reaction mixture was slurred in water. 
extracted with dichloromethane, dried over anhydrous 
Na2S04, and concentrated. The crude product as obtained 
was recrystallized from ethanol-chloroform mixture (6:4). 
The catalyst was recovered by simple separation of aqueous 
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and organic phases. The catalyst present in the aqueous 
layer was used for the subsequent cycle. 
2-(5-Chloro-3-methyl-1 -phenylpyrazol-4-yl)methylene-l, 
3-indanedione (3a) 
m.p: 199-202°C. %CHN found. (Calcd) for CzoHu 
N2O2CI: C, 68.96 (68.89); H, 3.77 (3.72); N, 8.08 (8.03). 
IR (KBr, cm- ' ) : 1689 (C=0). ' H N M R (CDCI3, 
400 MHz): d 2.40 (s, 3H, CH3), 7.45-8.04 (m, 9H, Ar-H), 
7.80 (s, IH, -CH=C). FAB-MS: (%) m/z 349 (M+, 100). 
5-(5-Chloro-3-methyl-l-phenylpyrazol-4-yl)methylene-
2,4.6-pyrimidinetrione (3b) 
m.p: >300"C. %CHN found. (Calcd) forC,5H,,N403Cl: C, 
54.56 (54.49); H, 3.36 (3.32); N, 16.87 (16.94). IR (KBr, 
cm" ' ) : 1679 (C=0). 3195 (NH). ' H NMR (DMSO-d^, 
300 MHz): 6 2.29 (s, 3H, CH3), 7.31-7.82 (m, 5H, Ar-H), 
8.12 (s, IH, -CH=C). 11.05 (s, IH, NH), 11.36 (s, IH, 
NH). ESI-MS: m/z 330.20 (M^^). 
5-(5-Chl(<r<)-3-methyl-1 -phenylpyraz.ol-4-yl)methylene-l, 
3-dimethyl-2,4,6-pyrimidinetrione (3c) 
m.p: 208-210°C. %CHN found. (Calcd) for C,7H,5N403 
CI: C, 56.99 (56.93); H, 4.16 (4.18); N, 15.56 (15.61). IR 
(KBr, cm ' ) : 1664 (C=0). ' H NMR (CDCI3, 400 MHz): 8 
2.43 (s, 3H, CH3), 3.42 (s, 3H, N-CHj), 3.45 (s, 3H, N -
CH3), 7.32-7.84 (m, 5H, Ar-H), 8.48 (s, IH, -CH=C). 
FAB- MS: (%) w/z 358 (M+, 90). 
5-( 5-Chloro-3-methyl-1 -phenylpyrazol-4-yl)methylene-2-
mercapto -4,6-pyrimidinedione (3d) 
m.p: >300°C. %CHN found. (Calcd) for C,sH,,N402SCl: 
C, 51.99 (51.97); H, 3.13 (3.17); N, 16.07 (16.15). IR (KBr, 
cm" ' ) : 1(X)7 (C=S), 1674 (C=0), 3124 (NH). ' H NMR 
(DMSO-d<i, 300 MHz): 6 2.32 (s, 3H, CH3), 7.34-7.84 (m, 
5H, Ar-H). 8.22 (s, IH, -CH=C), 11.12 (s, IH, NH), 11.43 
(s, IH, NH). ESI-MS: m/z 346.15(M+). 
2-(5-Chlor<i-3-niethyl-1 -phenylpyiaz.ol-4-yl)methylene-l, 
4-benz.othiuzine-3-one (3e) 
m.p: 114-n6°C (dec). %CHN found. (Calcd) for 
C,9H,4N30SC1: C, 62.08 (62.06); H, 3.83 (3.80); N, 11.39 
(11.42). IR (KBr, cm" ' ) : 1653 (C=0), 3185 (NH). ' H NMR 
(CDCI3,400 M H Z ) : S 2.33 (s, 3H, CH3) 7.12-8.02 (m, lOH, 
Ar-H -f- CH=C), 9.61 (br s, 1H, NH). FAB-MS: (%) m/z 368 
( M + , 70). 
5-(5-Chloro-3-methyl-I-phenylpyrazol-4-yl)methylene-2, 
2-dimethyl-l,3-dioxane-4,6-dione (3f) 
m.p: 240-242°C. %CHN found. (Calcd) for CnH.sNz 
O4CI: C, 58.94 (58.90); H, 4.35 (4.32); N, 8.03 (8.07). IR 
(KBr, c m - ' ) : 1725 (C=0). ' H NMR (CDCI3, 300 MHz): fi 
1.59 (s, 6H, 2 CH3), 2.52 (s, 3H, CHj), 7.00-7.73 (m, 6H. 
Ar-H -I- CH=C). FAB-MS: (%) m/z 347 (M"^, 90). 
4-(5'Chloro-3-methyl-l-phenylpyrazol-4-yl)methyiene-3-
methyl-1 -phenylpyrazol-5-one (3h) 
m.p: 186-188°C. %CHN found. (Calcd) for C2iH,7N4CX:i: 
C, 66.92 (66.96); H, 4.49 (4.51); N, 14.83 (14.86). IR (KBr, 
c m - ' ) : 1730 (C=0). ' H NMR (CDCI3, 400 MHz): 8 2.41 
(s, 6H, 2CH3), 4.93 (s, IH, -CH=C), 7.23-7.76 (m, lOH, 
Ar-H). FAB-MS: (%) m/z 376 (M + , 100). 
Biological activity 
Antibacterial studies 
All the synthesized compounds were dissolved to prepare a 
stock solution of 1 mg/ml using DMSO. The antibacterial 
activity of test compounds and standard chloramphenicol 
was done by filter paper disk method (Bauer et al.. 1966). 
Media with DMSO was set up as control. All cultures were 
routinely maintained on NA (nutrient agar) and incubated 
at 37°C for overnight. The culture was centrifuged at 
10(K) rpm, and pellets were resuspended and diluted in 
sterile NSS to obtain viable count 10^ cfu/ml. Approxi-
mately, 0.1 ml of diluted bacterial culture suspension was 
spread with the help of spreader on NA plates uniformU. 
Sterile 8-mm disks (Hi-media Pvt Ltd) were impregnated 
with the test compounds. Antibiotic disk, chloramphenicol 
(30 |j.g/disc Hi-Media), was used as control. The disk was 
placed on to the plate. Each plate had one control disk 
impregnated with the solvent. The plates were then incu-
bated for 24 h at 37°C, and the resulting zones of inhibition 
(in mm) were measured. 
Antifungal studies 
The synthesized compounds were dissolved in DMSO. 
Media with DMSO was set up as control. All cultures were 
routinely maintained on SDA and incubated at 28°C. Spore 
formation of filamentous fungi was prepared from 7-dav-
old culture in sterile normal solution (8% NaCl) and 
approximately diluted to obtain lO' cfu/ml. The inoculum 
of non-sporing fiingi, Candida albicans were performed by 
growing the culture in SO broth at 37°C for overnight. Ihe 
culture was centrifuged at 1000 rpm, and pellets were 
resuspended and diluted in sterile NSS to obtain viable 
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count 10* cfu/ml. Approximately, 0.1 ml of diluted fungal 
culture suspension was spread with the help of spreader on 
SDA plates uniformly. Sterile 8-mm disks (Hi-media Pvt 
Ltd) were impregnated with the test compounds. Antibiotic 
disk, nystatin (30 ng/disk Hi-Media) was used as control. 
The disk was placed on to the plate. Each plate had one 
control disk impregnated with the solvent. The plates were 
incubated at 28°C for filamentous fungi for 72 h or more, 
while for Candida albicans, plates were incubated at 37°C 
18-48 h. Antifungal activity was determined by measuring 
the diameters of the inhibition zone. 
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A nvw sfi ics of 4-hydroxycoiimarin derivatives 3a-d was synthesized by the reaction of 3-bromo-4-
hydroxy coumarin 1 with various hcteroaldehydes 2a-d in good yields.The synthesized compounds 
were ihanicterized on the basis of their elemental and spectral (IR, 'H-NMR and mass spectrometry) 
analysis. All target compounds were evaluated for their in-vitro antimicrobial activity against 
.S'lrqifiiaicvii.-; pvogciics, niethicill in-rcsistant Staphylococcus aureus, Pscudomonas aeruginosa, Kkbsiella 
pneunionui. and E.scherjthid coli bacterial s trains and fungal cul tures of Candida albicans, Aspergillus 
fumvj.(ituf. Trichophyton incntagropliytes, and Penicillium marnejfei by disk diffusion assay wi th slight 
modilicarions. The minimum inhibitory concentration (MIC) was determined for the test 
compounds as well as ior reference standards. Among the tested compounds, 3a has shown the 
most potent antibacterial as well as antifungal activities. 
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Introduction 
hi recent years, the numlxr of life-threatening infectious dis-
eases I .lused by multi-drug resistant Granr-positive and Gram-
negativi' pathogen bacteria have reached an alarming level in 
many countries around the world |1, 2|. These enteric bacterial 
infectious are responsible for morbidity and mortality world-
wide, mostly in developing countries and areas such as the 
Indian sub-continent, part of South America, and tropical part 
of AfricM, etc. |3, 4|. A number of clinical reports in the United 
.States ,uid worldwide have independently described the 
emergence of vancomycin resistance in methicillin-resistant 
Staphyhiixcus aureus (MRS,'\) i.solates and other human 
pathogen Gram-negative isolates |5|. Escherichia coli are respon-
sible for the world's most common and serious infectious 
diseases like invasive dysenteiy and diarrhea j6, 7). The infec-
tion wall these microorganisms may have significant impact 
on huge demolition of host tissue and severe diseases (8, 9], 
More tli;\n 90')!, of the cases of vaginitis are of candidiasis, 
trichomoniasis, and bacterial vaginosis |10]. Thus, the 
infections cau.sed by these microorganisms pose a serious 
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challenge to the medical community and need for an effec tive 
therapy has led to a search for novel antimicrobial agents. I or 
this reason, the present stratagem for the synthesis of new 
compounds is aimed in the direction of developing new 
coumarin derivatives to inhibit the growth of Gram-positi\'e, 
Gram-negative bacteria, and fungi. 
The synthesis of coumarin derivatives has attracted con-
siderable attention of organic and medicinal chemists as these 
compounds are widely used as fragrances, pharmaceuticals, 
and agrochemicals | lli . Much research has been focused on 
the inhibition of bacterial and fungal growth by naturally 
occurring, synthetic coumarin derivatives |12-f 8|. 3-Acyl- and 
3-carbamoyl-4-hydroxycomarins, dicoumarols, and sonic 
other coumarin derivatives like novobiocin and its analogues 
have proven as poteirt antibiotics (19-221, Furthermore, three 
coumarin antibiotics, novobiocin, chlorobiodn, and coumer-
mycin Al exhibit significant activity on certain tumor cells 
(23|. The other biological applications such as anti-inflamma-
tory 124), anticonvulsant |25l, antiviral j261, antioxidant 127], 
anti-HrV(28|, anticarcinogenic (29|, and antihistamine |30|, etc. 
are also cited in the literature. Besides the wide spectrum 
biological applications of coumarin and its derivatives, the 
chemical literature also embodies their some applications 
from the material viewpoint such as cosmetics |11|, optical 
brightening agents 131), and laser dyes |321. 
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i In seaii ii of more potent iiiitibiotics, herein we report the 
2 one pot. utfic ient and simple methodology for tlie synthesis 
.1 of coum.n HI derivatives in uood yields by the reaction of 
4 3-bn)mo 4 hydroxycoumariii with various heteroaldehydes. 
^ The synthesized compounds were screened for their iii-vitro 
() antibacterial and antifungal activities. 
- Results and discussion 
s Chemistry 
'-) 4-Hydroxv;oumarin possesses a nucleophilic character due 
III to the presence of the carbon-carbon double bond at position 
11 3 and reac ts with aldehydes and ketones to give dicoumarol 
derivatives |21. 33|. It was therefore expected, that 3-bromo-4-
hydroxycoumarin would also react with aldehydes to give 
dicoumarol derivatives. I'he reaction afforded 3a-c in quan-
titative yields (76-81%) by retluxing 1 and the heteroalde-
hydes 2a-c in the presence of a catalytic amount of pyridine 
in methanol (Scheme 1). However, the reaction of 1 with 
5-chloro-3-methyl-l-phenylpyrazole-4-carboxaldehyde 2d did 
not stop at the dicoumarol product 3e stage rather sub-
sequent cyclization took place to give pyrazolopyrone 3d 
in good yield (80%) (Table 1). A probable route for the for-
mation of 3d has been shown in Scheme 2. The structural 
assignment of the compounds isolated was done by elemen 
tal and spectral (IR, 'H-NMR, mass) analysis. 
The high molecular weight of compound 3b in tlie electron 
spray mass spectrum (M^ = 494.16) indicated the mcorpora 
tion of more than one coumarin moiety in the product. The 
infra red (IR) spectrum exhibited a strong absorptio)i band ai 
1572 cm ^ for the carbon-carbon double bond of the cou 
marin unit whereas carbonyl groups of the chromone and 
coumarin moieties appeared at 1636 and 1710 cm ', respect-
ively. Another absorption band at 3437 cm"' was assigned to 
the OH group of the coumarin unit. 'I'he proton nuclear mag-
netic resonance ('H-NMR) spectrum showed a sharp singlet ai 
Het OH 
11 
20 
21 
")-) 
24 
2') 
!2 
}4 
} ^ 
l\c;i,soitls ;iiu: miuliliims: (a) mcili;ini>l/p\ i idiiii;- a'lliix 
Scheme 1. Synthetic route of compounds 3a-d. 
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Table 1. Synthesis of compounds 3a -d . 
Knti-y Products Molecular structure 
(I (^^f^ ^o 
Time (h) Yield" (%) M.p. ( C.) 
76 >30(i 
3b 
.t'H', 
>0'^ O 
3.5 78 300 
3c" 
"<r () 
2.5 81 242-24" 
3d 
(•„H5 
80 270-272 
All yields lelcr to isolalL'd products. 
The pi-o(hi( t wii.s confiniied Ijy ek-incntal analysis, spectral data and compared with reported literature |42| 
I) 2.42 lor the methyl protons of the chromone moiety. The proton of the chromone moietywas present as a sharp singlet 
upfield singlet of the methine proton appeared at (5 6.25. The 11 
aromatic protons (three protons of the chromone moiety and 8 
prot<ins of! he coumarin units) were discernible in the form of 
a nniiti>lei it S 7.33-8.01. 'fhc diagnostic singlet of the C-2 
at S 7.66. A broad singlet (DjO exchangeable) at H 11.20 inte-
grating for more than one proton was assigned to the OH 
protons of the coumarin units. Further confirmation for the 
structure 3b was provided by the mass spectrum which has 
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2.1 1 
XX! 
o o' a 
Cr.Ks 
Vir t I #sh,ft ] [ 
Scheme 2. Mechanism formation of product 3d. 
I given .sub.seqiR-nr fragmentation pattern. The spectral studies 
; of the other compounds followed a similar pattern. 
1 Biological studies 
4 Antibacterial and antifungal activities of the synthesized 
^ compounds WITC completed by the disk diffusion method 
(1 and measured liy the Halo Zone lest, the MIC of the synthes-
ized compounds against bacterial and fungal strains V^AS 
performed by the macro dilution test and results were 
observed visually and spectrophotometrically. 
Antibacterial Activity 
The newly prepared compounds were screened for their 
antibacterial activity against Vsdaaidua coli (ATCC-25922|, 
methicillin-resistant %ia^}xy\omaus aureus (MRSA +Ve), 
Pseudomonas aeruginosa (ATCC-27853), Streptococcus pyogt-ni-.s. 
and Klebsiella pneumoniae (clinical isolate) bacterial strains 
by the disk diffusion method |34, 35|. The results are pre-
sented in Tables 2 and 3. 
The investigation of the antibacterial screening data 
revealed that all the tested compounds 3a-d showed moder-
ate to good bacterial inhibition. All the compounds showed 
good inhibition against S. pyogenes, methicillin-resistant 
Staphylococcus ourciis (MRSA -l-Ve), P. aeruginosa. K. imeuinoiiici. 
and E. coli species. Among the tested compounds, 3a showed a 
more potent bactericidal activity against all fungal strains 
(MIC 12.5-25 (J-g/mL)- The higher susceptibility of Gram-
positive bacteria is due to absence of a unique outer mem-
brane of peptidoglycon, hence the wall of these bacteria is 
permeable to these derivatives. The compounds also have 
significant influence on antibacterial profile of Gram-nega-
tive bacteria. The MIC of the compounds was found to be of 
12.5-50 (ig/mL. The MBC of the compounds was two, three or 
four folds higher than the corresponding MIC results. 
Antifungal activity 
Antifungal activity was screened out by disk diffusion 
method. For assaying antifungal activity Candida albicans. 
Aspergillus fumigatus, Penicillium marncffei, and Trichophyton men-
tagrophytcs were recultured in DMSO by the agar diffusion 
method [36, 37|. The inhibitory results are presented in 
Tables 4 and 5. 
The antifungal screening data showed good to moderate 
activity. All compounds showed good fimgicidal activity 
s 
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Table 2. Antibacterial activity of compounds 3a-d. 
Compounds 
:ia 
,ib 
Sc 
3d 
siamUnxl 
DMSO 
S. pyogenes 
21.3 i 0.3 
21.1 t 0.5 
19.3 :. 0.3 
19.3 :: 0.3 
24.0 r 0.3 
-
Diameter of zone of inhibition (mm) 
Gram-positive bacteria 
MRSA" 
18.9 ± 0,5 
20.1 ± 0.3 
18.4 ± 0.2 
18.4 ± 0.2 
25.0 ± 0.4 
-
P. aeruginosa 
26.1 ± 0.2 
26.3 ± 0.5 
23.2 ± 0.4 
23.2 ± 0.4 
32.0 ± 0.3 
-
K. 
Gram-negative bacteria 
pneumoniae 
17.3 ± 0,2 
18.2 ± 0.4 
16.3 ± 0.2 
16.3 ± 0.2 
18.0 ± 0.2 
-
E. coli 
22.1 ± 0.3 
21.1 ± 0.4 
20,2 ;l 0.2 
20.2 ± 0.2 
26.0 ± 0.4 
-
Positive control (.standard); ciproflo.xacin and negative control (DMSO) measured by the Halo Zone Test (mm), 
' Melhieillin-vesisiant Sltipbylotoaus iiiireii.s (MRSA + Ve). 
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Table 3. MIC and MBC results of 3a-d. Positive control ciprofloxacin. 
Compounds 
3a 
3b 
3c 
3d 
SlandanI 
S. 
MIC 
25 
25 
50 
50 
12.5 
Gram-positive 
pyogenes 
MBC 
50 
too 
too 
ioo 
50 
bacteria 
MIC 
25 
25 
50 
50 
12.5 
MRSA L
MBC 
50 
too 
>100 
>100 
50 
P. aeruginosa 
MIC 
25 
50 
50 
25 
12.5 
MBC 
50 
100 
100 
100 
25 
Gram-negative bacteria 
K. pneumoniae 
MIC 
12.5 
25 
50 
50 
12.5 
MBC 
50 
100 
>100 
>100 
50 
E. coli 
MIC 
25 
25 
50 
50 
12.5 
MBC 
50 
50 
1 00 
iOO 
5l) 
MIC (|j,,u;nil,) -^-- minimum inliibiuii-y concentration, tlial is, the lowest concentration of the compound to inhibit the growth ol 
bacteri.i tomplelely; MBC ((x,i;/ml.) = minimum bacterial concentration, that is, the lowest concentration of the compound for killiii.t; 
the bacu'ria completely. 
Table 4, 
Compou 
Antifungal activity 
nds 
of 3a--d Positive control 
CA 
(griseofulvin) and negative control (DMSO) measured by the Halo Zone Test (mm) 
Diameter of zone of inhibit ion (mm) 
AF TM PM 
3a 
3b 
.3c 
3d 
.Standard 
DMSd 
19.4 I 0.3 
23.4 + 0.4 
1 7.9 + 0.5 
18.3 ± 0.5 
30.0 ± 0.2 
16.5 ± 0.2 
19.2 ± 0.6 
15.4 ± 0.4 
15.8 ± 0.4 
27.0 ± 0.2 
15.1 i 0.3 
15.2 ± 0.4 
15.) -h 0.2 
15.3 ± 0.2 
24.0 ± 0.3 
13.7 0 i 
13.2 - O.f) 
12.9 - 0 5 
13.1 .T 0,5 
20.0 - 0 5 
C:A: GMH/II/II iilbiauis. AF: Aspcri^ilhis j'limigatus, TM; Trichophyton mentogrophytcs, PM; PcnicilUum marneffei. 
Table 5. MIC and MFC of compounds 3a-d. Positive control griseofulvin. 
Compound 
3a 
3b 
3c 
3d 
Standard 
25 
25 
50 
50 
6.25 
CA 
MFC 
too 
50 
too 
100 
12.5 
MIC 
25 
25 
50 
50 
12.5 
AF 
MFC 
50 
100 
>100 
>100 
25 
MIC 
25 
50 
100 
50 
6.25 
TM 
MFC 
50 
100 
100 
100 
25 
MIC 
25 
50 
50 
50 
12.5 
PM 
MFC 
100 
>100 
100 
too 
25 
CA; (,(iii(lii!ii albiaim. AF; /I'^ jicrgiKii.-; (mnigaUK. TM; Trichophyton mentogrophytcs, PM; Pcniciiliiim marnejjei. MIC (fj,g/ml,) = miniiiuim 
inhibitory concentration, that is. ihe lowest concentration of the compound to inhibit the growth of fungus completely: 
MFC; iM-g/iiil) -^ minimum fungicidal concentration, that is, the lowest concentration of the compound for killing t)ie fungu.s 
c(implctel\'. 
.igainsl ( albicans. A. fnmiy,iitus, 'I', mcntagrophytcs. and 
r. iii(iriii;(f('! lungal strains. Among the tested compounds 3a 
showed a more potent fungicidal activity against all fungal 
strains (MIC 25 ^cg/mf). fhe MIC: of other compounds was 
found to be (if 25-100 p.g/nil..l]ie MFC of the compounds was 
t()und to be two, three or four folds higher than the corre-
sponding MIC results. 
Conclusion 
In summary, we have developed a clean and convenient 
method to synthesize new coumarin derivatives in good 
yields. The method is advantageous in terms of reduced 
reaction t ime, high yield of products, simple experimental 
work-up procedure, etc., thus, adding a useful procedure to 
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I existing nu'thodologies lairllier, in-vitro antibacterial and 
: antifungal I'valuation of coiiipoimds has proved them as 
? potent aniihacterial and antifungal agents. The importance 
4 of such kind of wor]< lies in the possilJility that the new 
^ compoimds might l5e more effective against microbes for 
(1 which a ihorough study regarding the structure-activity 
" relationship, toxicity and their biological effects would be 
N helpful in designing more potent antimicrobial agents. 
1 Experimental 
Chemistry 
Melling points of all synlhesized compounds were taken on a 
Riechen TluTiiiover instruineni and are uncorrected. The IR 
si)ectra (KBi) were recorded on a Perkin ElmerRXl spectrometer. 
'H-NMR spetira were recorded on Bruker DRX-300 and Bruker 
Avance 11-400 speclromeler using lelramethyl silane (TMS) as an 
iniernal standard and DMSO-d,, as solvent. Mass spectra were 
recorded on Micro mass Qiiatlro (1 triple ciuadrupol mass spec-
tiometer and |e()l-,SX-102 (FAB) speclroineter. Elemental analyses 
(C. H, and Ni were conducted using a C^arlo Erba analyzer model 
y^ 1108. 3-Broiiio-4-hydroxycoumarin |3,S|, 3-formylchromone, 6-
21 nielhyl-3-foiiiiylchromone |39|, indole-3-carboxaldehyde |40|. 
2; and 5-chloro-3-niethyl-l-plienylpyrazole-4-carboxaldehyde |41| 
2.' were prepared liy reported procedures. Other chemicals were 
24 purchased iioni Merck (Mnmbai, India) and Sigma-Aldrich 
2.^  (Switzerland) and used without fiirther purification. The purity 
2(' otall conipouiuls was checked byTl.C, on glass plates (20 x 5 cnr) 
2~ coaled with silica gel (E-Merck G s^ i. 0.5 mm thickness). The 
25 plates were run in chlorolorm/mcihanol (3:1) mixture and were 
2V visnali/.ed l>v iodine vapors. 
.'() General procedure for the preparation of coumarin 
.' I derivatives (3a-d) 
^2 To a solmion of 3-bromo-4-hydroxycoumarin 1 (4.14 mmol) in 
.Vi meilianol (12 niL), conlaining 0.4 ml. pyridine, the heteroalde-
}4 liyde 2a-d (2.07 mmol) was added. The reaction mixture was 
'o relluxed in a healing mantle lor 2 5-3.5 h. After completion of 
3(1 the reaclii)n (( becked by TLC ), llie reaction mixture was cooled at 
.^ " room lemperalure. The solid pari separated out was collected by 
N^ (ilualion, dried and recryslallized eilher from chloroform or 
w from benzene so afford 3a-d in pure Idrm. 
1-(4-Oxo-4H- 1-benzopyran-3-yi)-1,1-bis(4-tiydroxy-1-
benzopyran-2-one-3-yl)mett)ane 3a 
Purified by rei rysiallization from elihiiroform. Wliite powder. 
Yield 76"ii. M,)-.: .300 CI; FTIR (KBr) r: 3428 (OH, coumarin), 
1708 (t: --- 0, coumarin), 1633 (C: 0, chromone), 1570 (C=C, 
coumarin) cm ; 'H-NMR (300 MHz, nM,SO-((ft,) H: 6.02 (s, IH, CH), 
7.18-7.79 (m, 1IH, Ar-H), 7.88 (d, IH, (,-5, J = 7.8 Hz, chromone), 
7.98 (s, IH, C-2. chromone), 11.31 (s, 2H, OH) ppm; ESl-MS m/z; 
480.13 (M), 45,i.l2, 451.11, 320.08, 319.08, 317.06, 99.11, Anal. 
ealcd. lor C .^^ Hi^ Osi C. 70.01: H, 3.35. Foimd: C, 70.18; H, 3.42. 
>i) 1-(6-Metliyi-4-oxo-4H-1-benzopyran-3-yl)-1,1-bis(4-
•^  I liydroxy-1 -benzopyran-2-one-3-yl)mettiane 3b 
52 Purified by reciystallizalion Irom c Itloroform. While powder. 
.\^  Yield 7S"ii. M.ii. 300 C; FTIR (KBr) v. 3437 (OH, coumarin). 
1710 (C=0, coumarin), 1636 (C=0, chromone), 1572 (C=C, cou-
marin) cm" ' ; 'H-NMR (400 MHz, DMSO-ty ,5: 2.42 (s, 3H. CH,), 
6.25 (s, IH, CH), 7,33-8.01 (m, l l H , Ar-H), 7.66 (s, IH, C-2, chro-
mone), 11.20 (s, 2H, OH) ppm; ESI-MS m/z: 494.16 (M'), 493.16. 
318.07, 317.06, 277.15, 99.11. Anal, calcd. for C2,H,808: C, 70.44; 
H, 3,66. Found: C, 70.56; H, 3.69. 
1-(lndol-3-yl)-1,1-bis(4-fiydroxy-1-benzopyran-2-one-3-yl) 
methane 3c 
Purified by recrystallization from chloroform. Orange ci7SlaUine 
solid. Yield 81%. M.p,: 242-245X; FTIR (KBr) v. 3398 (OH, cou-
marin), 3065 (NH, indole), 1719 (C=0, coumarin), 1572 (C = C, 
coumarin), 1290 (C-N, indole) cm" ' ; 'H-NMR (400 MHz, DMSO-
dg) 8: 5.04 (s, IH, CH), 6.46 (s, IH, -C=C-H, indole), 6.81-7.97 (m, 
IIH, Ar-H), 10.43 (s, IH, NH), 11.63 (s, 2H, OH) ppm; ES1-M.S ni/;: 
451.3 (M'''), 446.3, 413.5, 377.4, 375.4, 360.6, 358.6, 332.6, 274.6, 
238.5,225.5, 134.5, 116.5. Anal, calcd. For CiyHiyNOf,: C,71.83; H, 
3.79; N, 3,10. Found: C, 71.91; H, 3. 64, N, 3,06. 
4-(4-Hydroxy-2oxo-2IH-1 -benzopyran-2-one-3-yl)-3-
methyl-1 -phenyl pyrazolo[3,4;2,3]-4H-pyrano[3,2-b]-1 -
benzopyran-5-one 3d 
Purified by recrystallization from benzene. Wliite ciyslals. Yield 
80%, M.p.; 270-272X; FTIR (KBr) v. 3480 (OH, coumarin), 1719 
(C=0, couinarin), 1633 (C=N, pyrazole), 1608 (C=C. coumarin). 
1368(C-N, pyrazolejcm"'; 'H-NMR (300 MHz, DMSO-dr,) <5: 2.50 (s. 
3H, CH3), 4.67 (s, IH, CH), 7.09-8.40 (m, 13H, Ar-H), 11.38 (s, IH. 
OH) ppm; FAB-MS mjz (%); 490 (M+) (25), 329 (50), 331 (60), 346 (5), 
302 (15), 318 (25), 317 (100), 269 (90), 267 (85), 185 (5), 150 (20), 
149 (70), 142 (5), 115 (50). Anal, calcd. for C^gHisNjOe: C, 71.02; H. 
3.69; N, 5,71. Found: C, 71.09; H, 3.81; N, 5.63. 
Antibacterial evaluation 
A standard inoculum (1-2 x lO ' cfu/mL 0.5 McFarland stand-
ards) was introduced to the surface of sterile agar plates and a 
sterile glass spreader was used for even distribution of the inoc-
ulum. The disks measuring 6 mm in diameter were prepared 
from Whatman no. 1 filter paper and sterilized by dry heal 
at 140°C for 1 h. The sterile disks previously soalced in a 
known concentration of the test compounds were placed in 
nutrient agar medium. Solvent and growth controls were kepi. 
Ciprofloxacin (30 ^x.g) was used as positive control while the disk 
poured in DMSO was used as negative control. The plales were 
inverted and incubated for 24 h at 37 C. The susceptibility was 
assessed on the basis of diameter of zone of inhibition against 
Gram-positive and Gram-negative strains of bacteria. Inhibition 
zones were measured and compared with the controls. The 
bacterial zones of inhibition values are given in Table 2. 
Minimum inhibitory concentrations (MICs) were determined 
by broth dilution technique. The nutrient broth, which 
contained logarithmic serially two fold diluted amount of test 
compound and controls were inoculated with approximately 
5 X 10^ cfu/mL of actively dividing bacteria cells. The cultures 
were incubated for 24 h at 37"C and the growth was monitored 
visually and spectrophotometrically. The lowest concentralion 
(highest dilution) required to arrest the growth of bacteria was 
regarded as the minimum inhibitory concentration (MIC). To 
obtain the minimum bacterial concentration (MBC:), 0.1 ml, 
volume was taken front each tube and spread on agar plates. 
The number of cfu was counted after 18-24 h of incubation at 
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35 C:. MBC: was dolincd as ihi- IOWL-SI drug concentration at which 
99.9% (4 iht' inoculum were killed. The minimum inhibitory 
couccuti-ation and ininimum bacioritidal concentration are 
given ill Tal)lc 3. 
Antifungal evaluation 
Saboiiiand.s agar media weie prepared by dissolving peptone 
(1 g), l)-gluc()se (4 g) and agar (2 g) in distilled water (100 ml) 
and adjusted to the pH ol' 5.7. Nonual saline was used to make a 
suspension o( spore o( (tmgal strain for lawn. A loop full of 
particular lungal strain was transferred to 3 ml. saline to get 
a suspension ol corresponding species. 20 niL of agar media were 
poured into each Petri disli. The excess of suspension was 
decanted and the plates were dried by placing in an incubator 
at 37 C' (or 1 h. Using an agar punch wells were made and each 
well was labeled. A control was also prepared in triplicate and 
mainl.iiiied a( 37 C for 3-4 days. The fungal activity of each 
compound was compared with griseofulvin as the standard drug. 
Inhibition zones were measured and coiupared with the con-
trols. The fungal /.ones of inhibition values are given in Table 4. 
The nutrient broth containing a logarithmic serially two-fold 
diluted .iniount of the test compound and controls was inocu-
lated with approximately 1.6 x 10''-6 x 10'' c.f.u./mL. The cul-
tures were incubated for 48 h at 35 C and the growth was 
monitored. The lowest concentration (highest dilution) required 
to arres( the growth ol fungus was regarded as the ininimum 
inhibitory concentration (MIC!). To obtain the minimum fungi-
cidal concentration (MFC), 0.1 mi, volume was taken from each 
lube and s))read on agar plates. The number ofc.f.u. was counted 
after 48 h of incubation at 35 C. MFC was defined as the lowest 
drug concentration at which 99.9% of the inoculums were 
killed. The minimum inhibitory concentration and minimum 
fungicidal concentration are given in Table 5. 
FiiiiiiK jiil II..•iisliimc ill Diejiiriii o[mii]oy raearch prnjecl /F.^ fo. 37-15/2009 
(.S'R)|jriiiii ('T.C, New Dcllii. if gnilcfully ucknowkdgcd. The authors would 
ilka like Ui Ihank SAW. CHRL l.iicknow and SAW. Panjab University, 
OuiiuUiKirli kir speetnil diilii. 
Die (iiilhor^ tuive deelared iht eoiijlu! i)f interest 
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